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ABSTRACT
Hepatitis A virus (HAV), the causative agent of food and water borne acute
hepatitis worldwide, is very difficult and expensive to propagate in tissue culture. Large
scale production of HAV proteins in E.coli by recombinant DNA techniques would be
invaluable for antisera production, biochemical analyses and in developing sensitive
diagnostic tests. Therefore, PCR amplifîed cDNA fragments encoding the HAV capsid
proteins were cloned individually into prokaryotic expression vectors for production of
either recombinant fusion or non-fusion proteins. Cloning and expression of HAV capsid
genes, which induced toxic effects in certain host E.coli, was tolerated better by
protease-deficient host cells.

HAV capsid proteins expressed from the prokaryotic

vector, pAX4b-H, as p-galactosidase fusions reacted with antisera generated against
intact HAV particles. However, fusion protein expression and subsequent affinity-based
purification were complicated by co-expression of p-galactosidase and its cross-reactivity
with anti-HAV antibodies.

An attempt was made to improve transcription by

incorporating the E.coli rmB BoxA sequence in frame between the lacZ and HAV VPl
gene segments in the fusion construct. Induction of protein expression from recombinant
pAX-BoxAVPl failed to yield HAV related protein but resulted in an overexpression of
a 33 kD protein with a strong homology to a hypothetical protein sequence derived from
the origin of replication of F and other related E.coli plasmids. HAV capsid sequences
were cloned successfully into the pT7-7 vector for expression of proteins in a non-fusion
form, and into the XSurfZAP™ vector for expression of a membrane-directed, surfacedisplayed

fusion protein in E.coli and for the generation of chimeric coliphages.
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However, expression of a —30kD protein following induction was seen in recombinants
carrying pT7-VP3 plasmids. Expression of recombinant V Pl was not discernible in cells
carrying either pT7-VPl or pSurf-VPl. A study of the codon usage profiles revealed
that the coding strategy in HAV might involve a higher frequency of codons recognized
as rare in both E.coli and human systems, and may be responsible for the inefficient
expression of HAV proteins in both E.coli and tissue culture.

XI
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LITERATURE REVIEW
Hepatitis is defined as inflammation of the liver caused by a variety of noxious
stimuli such as chemicals and drugs as well as bacterial, viral and parasitic agents. The
extent o f injury suffered by the hepatic tissue can vary from minor cell damage that is
detectable only by biochemical tests for liver function, to fulminant disease with massive
necrosis followed by coma and death.
Viral hepatitis is a term used to refer to an episode of hepatitis caused by a
hepatotrophic virus or a virus whose primary target is the liver. However, inflammatory
conditions o f the liver that are part o f a more generalized infection with viruses such as
yellow fever, varicella-zoster, herpes simplex, cytomegalo-, coxsackie, Epstein-Barr, and
rubella viruses, are not included under this definition.

Viral hepatitis can occur either as

an acute or as a chronic form of liver disease. At the present time, there are at least five
different forms of acute viral hepatitis: hepatitis A, B, C, D and E. The viral agents that
cause hepatitis A, B and D have been well characterized while those that cause hepatitis C
and E are not well characterized yet (Ross, et al., 1991)
Hepatitis A is an acute, contagious, necroinflammatory disease of the liver caused
by an infectious virus, the Hepatitis A virus (HAV) (Koff, et al 1992^.

It is one o f the

oldest diseases known to humankind and descriptions o f this disease can be traced as far
back as the fifth century BC (Coulepis, et al., 1987). It was noted by Hippocrates as a
disease that was accompanied by fever and Jaimdice, occassionally occuring in epidemic
form and probably due to alterations in the bile (Zuckerman, 1970). The earliest mention
o f the contagious nature of the disease is foimd in the correspondence between the
I
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Archbishop of Mainz and Pope Zacharias in 751 AD.

Since epidemic hepatitis is

particularly common during military campaigns, it was earlier called “jaunesse des camps”
by the French and “Kriegsickterus” by the Germans (Gust and Feinstone, 1988). The
term “Infectious Hepatitis” was coined by Cockanye to emphasize the contagious nature
of the jaundice.

Outbreaks of Hepatitis A during wars around the world have been

documented beginning in the seventh century, including the American Civil War, World
War I & II, Israeli War o f Independence, the Korean War, the war in Vietnam and more
recently, during the Bosnian Civil War and the various civil wars in Africa and A sia. The
term “Hepatitis A” was introduced by MacCallum in 1947 to distinguish infectious
hepatitis caused by HAV from a second form of hepatitis that was first reported in 1885 to
be transmitted through parenteral route following inoculation with unsterile syringes and
transfusion of blood or blood products.

The second form of hepatitis was shown

subsequently to be different from infectious hepatitis in its incubation period and the
etiologic agent and was referred to as Hepatitis B or “Serum Hepatitis” (Coulepis, et al.,
1987).
Infection with HAV occurs throughout most parts of the world and is
especially common in countries with a very high density of population such as China,
India, Bangladesh and Indonesia. In these nations, it is most often associated with
overcrowding, poor standards of sanitation and personal hygiene. The incidence of
Hepatitis A is comparitively low in the developed countries such as the United States
(8/100,000 population) and cases occur sporadically. Infection in the developed countries
is generally confined to certain groups-at-risk, such as children and staff of day-care
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centers, overseas travelers, inmates of instituitions, homosexual men, and intravenous drug
users. Still, the annual cost to the US economy due to Hepatitis A has been estimated at
$300 million (Gust and Feinstone, 1988)
Hepatitis A occurs in epidemic waves with peaks during late autumn and early
winter in many countries with temperate climates. However, in recent years, it has been
observed to occur in an endemic form in the developed countries probably due to the
decreased incidence of infection (Shapiro and Margolis, 1993). In developing countries,
most of the population affected are children in whom the symptoms of the disease tend to
be rather mild and provide the individual affected with a life-long immunity against the
disease. Hence, this disease is not of major public health concern. In the developed
countries, on the other hand, the risk o f getting infected in early childhood is reduced due
to improved living standards, resulting in an increased mean age of infection (Gust, et al.,
1978). However, in the absence of childhood exposure, there appears to be an equal chance
o f acquiring the infection, regardless of age (Gust, 1984).
The severity of HAV related liver disease can vary widely between individuals and
factors such as age, sex, physical condition and pre-existing illnesses can exert considerable
affect on the clinical course of the disease. Age, however, appears to be the most
significant factor influencing the outcome of HAV infection. A majority of adults, when
infected with HAV, tend to develop overt clinical symptoms unlike children in whom the
disease is most often asymptomatic. Symptomatic disase occurs among < 10% of children
younger than 6 years of age, 40-50% of older children, and 70-80% of adults (Alter and
Mast, 1994). HAV infections can present as a subtle subclinical infection detectable only
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by serological tests or they manifest in several different ways ranging from a relatively mild
"flu-like" syndrome to the more serious fulminant hepatitis that can lead to coma and death.
Case-fatality rates from Hepatitis A is highest (17.5 per 1000) amongst persons > 49 years
o f age, although the overall case-fatality rate is very low (4 per 1000). At least 100 deaths
each year in the United States are attributed to fulminant hepatitis A (Alter and Mast,
1994).
Hepatitis A infection exhibits an average incubation period of 30 days with a range
o f 15 to 45 days. The onset of clinically overt disease is often preceded by a brief
prodromal period or pre-icteric phase, lasting less than 1 week, during which patients may
complain of loss of appetite, nausea and abdominal discomfort (Coulepis, et al., 1987).
The prodromal phase is characterized by an abrupt onset of a "flu-like" state marked by
the major symptoms like fever, chills, headache, fatigue, malaise, myalgia, anorexia, nausea
and vomiting. However. Hepatitis A in children may present with atypical symptoms such
as diarrhoea, cough and coryza. The acute or icteric phase which succeeds the prodromal
phase begins with the appearance of dark urine (bilirubinuria) followed by a paler than
usual feces (steatorrhoea) and an yellow discoloration of the skin and sclera (jaundice). An
enlarged, tender liver may be palpable in the right upper quadrant of the abdomen during
this stage and persist for two to three weeks. Liver function tests during this phase usually
reveal an elevation in the levels of bilirubin (> 3 mg%) and the hepatic enzymes, alanine
aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase, which
suggests injury to liver tissue. The lesions in the hepatic tissue caused during HAV
infection are, however, indistinguishable from those owing to other viral causes.
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biopsies usually reveal a centrilobar cholestasis accompanied by hepatocyte necrosis and
portal inflammation with mononuclear cell infiltration (Gordon, et al, 1984).
Hepatitis A is normally a self-limiting disase which lasts for 3-4 weeks. The virus
is shed in the feces of infected adults late in the incubation period and before onset of
clinical illness. Children and infants may, however, excrete HAV for a longer period than
in adults, possibly for several weeks following the onset of clinical illness. Viral RNA has
been detected by the polymerase chain reaction (PCR) in fecal specimens for up to 6
months after infection in infants bom prematurely. Chronic fecal shedding o f HAV,
however, has not been observed in any patient group. The clinical symptoms and signs of
steatorrhoea, jaundice and hepatomegaly begin to subside during the second and third
week of the acute phase. Liver function tests return to normal at about the same time,
which signals recovery of hepatic function. The liver architecture will appear normal
without scar formation in most patients and there are no known chronic sequelae.
Occasionally, the disease might persist for upto 18 weeks as cholestatic hepatitis with high
bilirubin levels along with the other major symptoms and signs (Gordon, et al., 1984).
Although the disease is not known to exist in a chronic form, relapses do occur sometimes.
Also, in 0.4% of all hospitalized patients, the disease may progress to the rare fulminant
hepatitis with a case-fatality rate >50% despite aggressive therapy which includes liver
transplantation. Fulminant hepatitis is accompanied by an increasingly deep jaundice,
altered sensorium, fetor hepaticus, asterixis or flapping tremors, followed by
encephalopathy and coma.

A poor prognosis is indicated by prolongation of the

prothrombin time, steeply rising serum bilirubin levels, and occassionally a decrease in the
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levels of serum aminotransferases, all of which suggest an extensive liver damage. Death
usually ensues within 14 days (Ross, et al., 1991).
Human volunteer studies done during World War II to determine etiology and the
mode of transmission of hepatitis A showed that the disease could be acquired by healthy
individuals following oral administration of a bacteria-free suspension of feces and serum
from patients in their pre-icteric phase. These results implied that the disease was probably
caused by a virus and that transmission from person to person was by the fecal-oral route.
Experimentally infected individuals also failed to develop symptoms of the disease upon
reinoculation, 6 to 9 months later, suggesting development of immunity to hepatitis A.
Furthermore, convalescent serum from previously infected individuals when introduced
into susceptible persons, afforded protection against HAV infection. Studies with animal
models demonstrated that the disease is confined exclusively to humans and can be
mimicked only in certain non-human primates such as marmosets and chimpanzees
(Maynard, et al., 1975; Dienstag, et al., 1975). Further investigations in marmosets
revealed that the virus enters the gut and via the bile duct, gains access to liver which is the
major site of viral replication as shown by immunofluorescence (Mathieson, et al., 1980)
and electron microscopy (Shimizu, et al., 1978). Studies performed to establish HAV
pathogenesis failed to provide any direct evidence linking viral replication and
hepatocellular damage. Instead, the fact that histopathological signs o f liver damage
occured coincident with elevation in the levels of circulating antibody, suggested that the
damage may be immunologically mediated. Later studies involving HAV-infected tissue
culture cells (BS-C-1) have provided direct evidence that HAV-specific T-lymphocyte
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mediated cytotoxicity and natural killer cell activity

are more likely involved in

hepatocellular injury (Kurane, et al., 1985).
HAV transmission occurs following ingestion of virus particles shed in the feces
of an infected person. Feces of infected individuals during the incubation period can
contain upto 10* virions per ml and serves as the primary source of HAV. The virus is
spread mainly by close personal contact, especially between young children in day-care
centers. Among adults, HAV can also be acquired through sexual contact. Contaminated
water and food, particularly shellfish, also serve as vehicles of HAV transmission. Oysters,
which are usually

eaten raw, from sewage-contaminated waters can concentrate

enteroviruses upto 60-fold and are frequently implicated in outbreaks of hepatitis A
(Rippey, 1994). Since HAV can survive for 12 weeks to 10 months in water and since
gentle steaming alone is insufficient to inactivate HAV, outbreaks o f shellfish-associated
hepatitis A can potentially lead to large epidemics (Coulepis, et al., 1987). One such
outbreak in Shanghai, China in 1988 caused more than 200,000 cases (Communicable
Disease Intelligence, 1988). HAV transmission can also be water-borne and infections
may be acquired by drinking fecally contaminated water or by swimming in contaminated
pools and lakes. HAV transmission through parenteral route, although possible, is very
rare.
Hepatitis A virus is a pathogenic, hepatotrophic virus and belongs to the family
Picomaviridae. It is one of nearly 200 human-adapted picomaviruses but the only one that
has been documented as a cause of seafood-associated illness (Ahmed, 1991). Only one
serotype of HAV has been observed among HAV isolates collected from various parts of
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the world.

HAV was first identified as virus-like particles o f 27-nm diameter by

immunoelectron microscopy (IBM) using fecal samples from infected experimentally
human volimteers as source o f antigen and convalescent sera from patients with either
experimentally induced or naturally acquired hepatitis A infection, as a source of anti-HAV
antibody (Feinstone, et al., 1973). Subsequent studies revealed that HAV is a non
enveloped virus consisting of a single-stranded RNA genome enclosed within an
icosahedral protein shell or capsid. The majority o f the virus particles have a buoyant
density of 1.32-1.34 g/cm^when determined by density gradient equilibrium centrifugation
in cesium chloride (Coulepis, et al., 1982). HAV, like other picomaviruses, exhibits
remarkable stability against lipid solvents such as ether, acidic conditions such as pH 3.0
and prolonged exposure to heat (Rueckert, 1991).

The virus, however, is readily

inactivated by formaldehyde (Provost and Hilleman, 1978). Based on the biophysical and
biochemical features, HAV was classified previously as a member o f the genus Enterovirus
within the Picomaviridae family (Gust, et al., 1983). However, HAV differs significantly
from the other members of the genus Enterovims with regard to stability at elevated
temperatures and low pH (Flehmig, et al., 1985; Scholz, et al., 1989), mechanism of
replication, genome organization, and behaviour in cell cultures (Ticehurst, et al., 1989).
As a consequence, it has been proposed that HAV be classified under a separate genus
Hepatovirus within the family Picomaviridae (Minor, 1991)
The capsid o f HAV is made of at least three stmctural proteins VPl, VP2, and VP3
and a putative VP4 with inferred molecular weights 33,200 (V Pl), 24,800 (VP2), 27,800
(VP3), and 2500 (VP4) based on nucleotide sequence data. However, analysis of the viral
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structural proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis have
shown protein bands of apparent molecular weights 34,500 (VPl), 25,500 (VP2) and
23,000 (VP3) (Coulepis, et al., 1978).

Previously published reports suggest that the

migration of the HAV VP2 and VP3 capsid proteins upon gel electrophoresis varies
depending on the individual gel systems and the presence or absence o f urea (Linemeyer,
etal., 1985; Gauss-Muller, e/a/., 1986; Wheeler, e/a/., 1986). The putative VP4 protein
has not been characterized as well as the other HAV capsid proteins, and conflicting reports
exist in the literature with respect to the molecular weight of VP4 and whether it is
myristylated or not (Coulepis, et al., 1980; Palmenberg, 1989). However, like other
picomaviruses, HAV particles also appear to contain a few copies of VPO which is the
precursor of VP2 and VP4 proteins (Gauss-Muller, et al., 1986).
The genome of HAV is a linear, positive-sense, single-stranded RNA molecule of
approximately 7500 nucleotides (nt) or 7.5 kilobases (kb) (Coulepis, et al., 1981; Jameel,
1994). The HAV RNA, although transcribed in an eucaryotic system, does not possess the
5'-N-methylated Guanosine cap. Instead, the 5'-end of the RNA is protected by a covalent
linkage to a tyrosine residue o f one of the HAV-derived proteins, the Vpg terminal peptide.
Like other eucaryotic RNAs, however, the HAV RNA does possess a poly(A) tract towards
the 3'-end. The properties of the HAV genome were elucidated following the observations
that the hepatitis A genomic material was located exclusively in the cytoplasm of infected
hepatocytes, stained with Acridine Orange, sedimented at 33S with a buoyant density of
1.64 g/cm^and was sensitive to RNase but not DNase (Ross, et al., 1991). The naked RNA
genome, like the positive-sense genomic RNA of other picomaviruses, has been shown to
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be intrinsically infectious and readily translatable into HAV proteins once access to the
cytoplasm o f the host cell is gained (Anderson, et al., 1987; Cohen, et a i, 1987b). Since
there is no RNA-dependent RNA polymerase with the HAV genome in the intact virus
particle, translation of the viral RNA within the cytoplasm of the host cell is the first step
in the viral replicative cycle and hence the genome is considered intrinsically infectious.
According to the well-established L434 nomenclature for describing the genomic
organization of picomaviruses (Rueckert and Wimmer, 1984), the HAV genome can be
considered as functionally divided into a S' untranslated region (UTR) of ~733 nt, followed
by a single open reading frame (ORF) of -6,681 nt and a 3' UTR of -64 nt as shown in
Figure 1. The single ORF, which encodes a polyprotein precursor of 2227 amino acids
from which all HAV proteins are derived following post-translational processing, can be
subdivided into three regions; PI, P2 and P3. Proteins derived from the PI region (1 A,
IB, 1C and ID) constitute the structural capsid proteins VPl, VP2, VP3 and VP4. The P2
region accounts for a viral protease (2A) which cleaves the huge viral polyprotein precursor
between the PI and P2 regions, a second protein (2B) of unknown function, and a third
protein that is believed to anchor the 5'-terminal VPg peptide to the viral genome. The P3
region encodes the precursor of VPg (3 A), a second protein whose function remains
unknown, a major viral protease (3C™) involved in proteolytic processing of the
polyprotein and viral RNA replication and the viral RNA-dependent RNA polymerase
(3 O'”'). The non-structural P2 and P3 regions are actively involved in and are essential for
the replication and production of infectious HAV particles.
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Figure 1. The proposed genomic organization o f hepatitis A virus based on the L434
nomenclature. The figure also schematically depicts the post-translational events
contributing to the polyprotein-processing during poliovirus replication. Cleavage between
PI (1ABCD) and P2 (2ABC) is mediated by protease 2A and at all other sites except for
lA /lB , which is autocatalytic, by protease 3C.
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Events in the replicative cycle of HAV follow the scheme postulated for the
Picomaviridae virus family which is depicted in figures 2a, 2b and 2c. Following ingestion
of contaminated food or water by a susceptible individual, HAV is believed to attach to an
as-yet-uncharacterized cell-surface receptors in the gastrointestinal tract and gain access to
the liver via the portal circulation. The HAV particles attach to target hepatocytes and
penetrate the cell membrane by viropexis (a virus specific receptor-mediated-endocytosis)
and lose their protein shell, an event termed uncoating. During uncoating, viral RNA is
released into the cytoplasm over a period of approximately 12 hours mainly due to the high
affinity o f the viral RNA to the capsid proteins. Following the release, viral RNA serves
as a messenger RNA for synthesis and translation of the large FIAV ORF. The polyprotein
is processed by viral proteases such as 2A and 3C which are themselves derived from the
polyprotein. The polyprotein processing begins before translation of the ORF is fully
completed and results in a group of structural capsid proteins (PI) and a second group of
non-structural proteins (P2 and P3).

The non-stmctural proteins participate in the

transcription of the viral RNA into negative-strand templates from which more copies of
positive-strand viral genomic RNA are generated. Since the viral genomic RNA possesses
a high affinity for capsid proteins, encapsidation of the majority o f the positive-strand
copies occurs almost coincidental with the RNA synthesis, resulting in mature infectious
virions. Thus, in contrast to other picomaviruses, particularly poliovirus, a much higher
proportion o f progeny RNA is seen to be packaged into mature virus particles throughout
the replicative cycle of FIAV (Anderson, et al., 1988).
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Figure 2A. A schematic depiction o f the events during the hepatitis A virus infection
cycle. Virus particles gain access to the hepatocytes via the portal circulation following
entry into the cells lining the gastrointestinal tract by a mechanism not completely
elucidated. The virus particles then attach to the liver cells and enter the cytoplasm by
viropexis. The delivery and uncoating processes also are not fully understood at the present
time. Following uncoating, the viral RNA is released into the host cytoplasm whereupon
the host protein synthesizing machinery is recruited to translate the ORF encoding the viral
polyprotein that is subsequently processed into the precursor PI, P2 and P3 segments.
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Figure 2B. Events during the hepatitis A virus infection cycle. Post-translational events
in the processing of the polyprotein derived PI, P2 and P3 segments. The PI segment is
processed to yield the capsid proteins VPO, VPl and VP3 which initially form an immature
protomer (5S) consisting of one copy of each. The protomers then assemble into pentamers
(12-14S). The P2 and P3 segments are processed to yield the non-structural proteins
essential for the viral RNA synthesis via a complementary minus-stranded template.
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Figure 2C. Events during hepatitis A virus infection cycle. A smooth endoplasmic
reticulum-associated synthesis of (m) stranded genomic RNA copies through multi
stranded replicative intermediate. The replication of both (-) and (-h) strands is carried out
by the viral RN.A-dependent-RNA polymerase (3D'”‘) in steps that require the other nonstructural proteins as well. The (-h) RNA pool is used for translation, synthesis of more (-)
RNA and for packaging into progeny virions. The packaged infectious virions (150-160S)
then undergo a "maturation cleavage", an autoproteolytic event, in which the VPO peptide
is cleaved into VP2 and VP4. The progeny, mature virus particles are released following
Ivsis of the host cell.
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The specific diagnosis of naturally acquired acute HAV infection involves the
detection of IgM antibodies to HAV during the acute or early convalescent phase o f the
infection. The IgM anti-HAV antibodies are present in the serum o f patients by 5-10 days
into the incubation period and at the onset of clinical illness. Antibody titer rises rapidly
reaching a peak before onset o f jaundice

1 - 2

weeks following onset of the initial symptoms

and then declines gradually to non-detectable levels. IgG anti-HAV antibodies begin to
appear following the peak IgM response and stabilize between 3-8 months. The IgM
antibodies remain detectable for up to

6

months following the onset of symptoms while the

IgG remain detectable for the lifetime of the individual thereby indicating a life-long
protection against the disease (Kao, et al., 1984).
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INTRODUCTION
Although clinical diagnosis of viral hepatitis is based on the recognition of the
classical signs and symptoms compatible with acute inflammation of the liver, the
identification of the precise etiological agent responsible mandates laboratory
confirmation through specific tests. The diagnosis of acute hepatitis A is confirmed by
serological detection of IgM anti-HAV antibodies in the serum of patients. IgM antiHAV levels become detectable with onset of clinical symptoms, reach peak levels within
one to two weeks, and remain elevated for up to four months (Liaw, et al., 1986).
Later, as IgM antibody titers gradually decline, IgG anti-HAV antibodies appear in the
serum and may persist for years following the acute infection. The IgG anti-HAV confer
long-term immunity against HAV and is a serological indicator for previous exposure to
this viral agent.

Secretory immunity, mediated by IgA antibodies, which plays a

significant role in protecting against a number of enteroviral infections at the site of
primary entry of the viruses, however, does not appear to be effective against HAV
(Stapleton, et al. 1991).
Serological detection of anti-HAV antibodies in the serum of victims can be
accomplished by employing one of several approaches available such as complement
fixation (Provost, et al., 1975), immunoelectron microscopy (Feinstone, et al., 1973;
Feinstone, et al., 1974), radioimmunoassay (Blaine Hollinger, etal., 1975), and enzyme
immunoassays (Eble, et al., 1991; Fayol and Ville, 1991; Locamini, et al., 1978;
Robbins, eta l., 1991; Wang, etal., 1985). The commercial immunoassay kits currently
in use facilitate detection of either total anti-HAV, a mixture of IgG, IgM and IgA, or
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the acute phase IgM anti-HAV exclusively (Decker, et al., 1981; Safford, et al., 1980).
Unfortunately, tests which detect HAV particles or antigens in clinical specimens directly
are not commercially available. Those immunoassays which detect anti-HAV antibodies
are predicated on the specific reactivity of HAV-specific antibodies with relevant
antigens, that is, the HAV capsid proteins. Hence, most immunoassays require HAV
particles, raised in tissue culture, as the antigen source. Propagation o f HAV in tissue
culture is expensive, requires containment facilities and is compounded by factors such
as variation in the infectivity properties of individual virus isolates.

Additional

difficulties associated with cultivation of HAV are its poor and protracted growth in
tissue culture (Cohen,

et al., 1989; Wang, et al., 1985; Winokur, et al., 1991),

frequently resulting in cell-line infections without discernible cytopathic effects (Bitton,
et al., 1986; Fayol and Ville, 1991). These obstacles are further complicated by the
necessity to rid the virus particles of host cell debris which accumulates during viral
harvest and purification steps. Therefore, replacement of tissue culture generated virions
required in immunoassays with an in vivo or in vitro generated, recombinant subunits
of the viral capsid as antigens, holds promise as a simple, time-saving and inexpensive
alternative. Recent advances in recombinant DNA technology coupled with availability
of the complete nucleotide sequence of HAV genome for analysis, have provided a means
by which the individual capsid proteins can be produced synthetically or be expressed in
either prokaryotic or eukaryotic systems.
Several putative, dominant epitopes in HAV capsid proteins have been identified
by various investigators for constructing recombinant DNA and synthetic peptides, and
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their potential use in diagnostic assays and in vaccine development (Baroudy, et al.,
1985; Emini, eta l., 1985b; Gauss-Muller, eta l., 1990; Hughes, e ta l., 1984; Hughes,
e, 1985; Stapleton and Lemon, 1987). Mapping studies which identifîed these epitopes
were done using monoclonal antibodies against HAV (Hughes, et al., 1984; McGregor,
et a/., 1983; Stapleton and Lemon, 1987) and the results suggests that capsid protein VPl
contains a major neutralization epitope. Reports from other studies (Ping, et al.. 1988)
suggested that capsid proteins VP3 and VP2 may also contribute amino acid residues to
the neutralization epitope within VPl or may contain neutralization epitope(s) of their
own. Thus, while consensus has emerged that the capsid peptide VPl possesses the
dominant conformational epitope against which a neutralizing immune response is
directed, the contribution of the VP2 and VP3 peptides to the conformation of the major
neutralization epitope(s) on the capsid remains unresolved.

Further immunological

studies are required to clarify the immunochemistry of these capsid proteins before they
are used as a efficient vaccine to confer a long-term protection against HAV infection or
as an antigen in the development of inexpensive immunodiagnostic assays.
Molecular biological techniques have enabled investigators to characterize the
single- stranded RNA genomes of various picomaviruses including HAV, and to identify
those nucleotide sequences which correspond to the various HAV structural and nonstructural proteins (Baroudy, eta l., 1985a; Cohen, e ta l., 1989; Hughes, et al., 1984;
Malcolm, et al., 1992; Ross, et al., 1991; Rueckert, 1991; Ticehurst, e ta l., 1983).
Complementary DNA (cDNA) sequence corresponding to the HAV RNA genome has
been cloned successfully (Baroudy, eta l., 1985b), facilitating production of recombinant
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HAV proteins in prokaryotic or eukaryotic systems, and has made studies directed
towards a systematic and precise elucidation of the nucleotide sequences which encode
immunodominant epitopes, more promising.
Several studies concerning the recombinant expression of HAV capsid proteins
and their antigenicity have been reported (Emini, et al., 1985a; Ostermayr, et at., 1987;
Gauss-Muller, eta l., 1990; Stapleton, etal., 1991; Winokur, etal., 1991). Cloning and
expression in Escherichia coli have resulted in the production of HAV fusion peptides
containing limited portions of the different capsid proteins, especially VPl and VP3 and
E.coli proteins encoded by the lacZ (Ostermayr, eta l., 1987) or TrpE gene (Johnston,
et al., 1988). These recombinant fusion proteins, representing only portions of E.coli
and HAV capsid proteins,were poorly soluble and failed, to induce any significant antiHAV neutralizing antibody response in laboratory animals upon immunization (Emini,
et al., 1985b; Johnston, et al., 1988) and to react with rabbit anti-HAV polyvalent sera
but not with human convalescent sera (Gauss-Muller, et al., 1990; Ostermayr, et al.,
1987). These reports suggest that the immunogenicity of recombinant HAV peptides can
vary among species and attempts to improve the immunogenicity are a prerequisite
towards successful development of a synthetic, recombinant vaccine. Also, synthesis of
complete, not just portions of capsid proteins, or even "empty" capsids may be essential
and crucial to achieve this goal. In this regard, eukaryotic expression in recombinant
baculoviral (Stapleton, et al., 1991) and in Vaccinia viral (Winokur, et al., 1991)
systems of whole or portions of HAV capsid has been achieved although the methods
employed still involved time-consuming and expensive tissue culture procedures and
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resulted in unpredictable yields. However, there are no reports thus far on any attempts
to express any of the individual HAV capsid proteins in their entirety, either in the fusion
or in the non-fusion form, in prokaryotic systems.
One of the main objectives of our investigations was to study the potential for
cloning and expression of entire HAV capsid proteins in E.coli, either as a fusion or in
the non-fusion format. The recombinant capsid proteins could be used subsequently in
studies directed to assess their antigenicity and utility in immunoassays, in the production
of diagnostic antibody reagents from laboratory animals, and possibly, as a potential
recombinant vaccine.

We report the individual cloning of the complete nucleotide

sequences for V P l, VP2 and VP3 capsid protein genes of HAV, their subsequent
expression as p-galactosidase fusion proteins in Escherichia coli (or E.coli), and the
purification of the resulting recombinant products.

The antigenicity of the p-

galactosidase-HAV fusion proteins was assessed by ELISA and Western Blot techniques
using polyclonal and monoclonal antibodies raised against tissue culture grown, intact
HAV particles.
MATERIALS AND METHODS
Bacterial Strains and Plasmids; Bacterial strains and plasmids used in this study
are listed in Table 1. Prokaryotic expression vector pAX4b is schematically represented
in Figure 3.
Anti-HAV Polyvalent and Monoclonal Antibodies: Rabbit anti-HAV polyvalent
serum and Mouse anti-HAV monoclonal antibodies (Mab) used in this study were
generated previously in a separate study in Dr. Siebeling's lab by Dr. Baez. These
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Table 1. Bacterial strains and plasmid vectors used in cloning for expression
of HAV capsid genes as p-galactosidase üisions
Strains/
Plasmids

Description

Reference

Escherichia
coli
GWIOOO

xyl-5, m tl-l, galK2, A-rac ,
rpsL3\,kdgk5\, à(gpt-proA)62, lacY l,
tsx-33, supEM , thi-l, leuB6, hisG4, mgl51, arg-3, ^ D l , ara-14, thr-l, recA441,
sulA,
A/acU169, pro^

G.Walker/
J R.Battista (L.S.U.)

Escherichia
coli
UT2300

azi-6,fhuA23, la cY l, leu-6, mlt-l,
proC l4, purEAl, rpsLl09, thi-l, trpE3S,
tsx-61, entAAQ3, purE*, fh u A ^ , fepA ,
A/o/i::TnlO

Elish, e ta l., 1988

Escherichia
coli
ToplO

mcrA, \{mrr-hsdKMS/McrBC),(|>80A/<3cAM15,A/acX74, deoB,
recA l, aroDl39,^{ara,leu) 7697 galü,
ga/K.A.' rpsE, end A l, nupG

Grant, e ta l., 1990

Plasmid
pAX4b +

United States
Biochemical
Corporation,
Cleveland, OH

Plasmid
pGEMHAV

R.H. Purcell (N.I.H)
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Plac

bla

pA X 4b+
6202 bps
fl ori

lacZ

MCS

CS

Figure 3. A schematic diagram of the prokaryotic expression vector, pA X 4b+, used
for cloning and expression of proteins as p-galactosidase fusions. Plac=lacZ gene
promoter; IacZ=Complete gene for beta-galactosidase; CS=Collagen fragment which
also contains endoproteinase Xa cleavage site; MCS= Multiple Cloning Site; tO=Lambda
to terminator; fl ori= Phage fl origin of replication; and bla: Ampicillin resistance gene.
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antibodies had been purified and characterized for specificity against HAV by various
immunoassays using HAV HM-175 strain. MAb P2G9 and P lE ll were IgG isotypes
while Mab P6B5 and P2G11 were IgM isotypes. P2G9 was also a neutralizing anti-HAV
antibody as characterized in the earlier study (Baez, 1993).
Amplification of Nucleotide Sequences Encoding HAV Capsid Proteins: The
plasmid pGEM-HAV (kindly provided by Dr. Robert H. Purcell, NIH) was used as a
template to amplify individually the genes encoding the three major capsid proteins of
the Hepatitis A virus. Oligonucleotide primers containing flanking restriction enzyme
recognition sequences were designed to facilitate the directional cloning of the amplified
viral genomic fragments and were synthesized by beta cyanoethyl phosphoramidite
chemistry (Appligene Inc., Pleasanton, CA.). These oligonucleotide primer sequences
are shown in Figure 4. The DNA regions encoding individual capsid protein genes were
generated by PCR amplification of the relevant regions on pGEM-HAV. PGR reactions
were set up in a final volume of lOOfd containing 200/iM concentrations of dATP,
dCTP, cGTP and dTTP; 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCU,
0.01% gelatin, 5 units AmpliTaq polymerase (Perkin-Elmer Cetus, Norwalk, CT), 1.0
/iM of each primer, and 500 ng of template DNA. PCR amplification was performed
using a Perkin-Elmer Cetus, Norwalk, CT). Thirty cycles of amplification were run
under the following conditions: dénaturation at 94°C for 90 sec, annealing at 50“C for
90 sec, extension at 72°C for 90 sec, with a cycle extension of

6

sec per cycle and then

cooling to 4°C. The amplified products were detected by electrophoresing lO/il of the
reaction mixture through a 2% agarose gel in Tris-Acetate-EDTA (TAE) buffer and
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Ax-VPl-PS
5'-d(C C G AAT TCT GTT GGA GAT GAT TCT GGA)-3
EcoRI

Ax-VPl-NS
5 dfCCC TGC AGG CTC AAA TCT TTT ATC TTC)-3'
Pstl

AX-VP2-PS
5 -dfCCG AAT TCT ATG GAC ATT GAG GAA GAG)-3'
EcoKl

AX-VP2-NS
S -dfCCA GAT CTT GTG TAG AAA GAG GAG TTA)-3’
B gai

Ax-VPS-PS
5 -dfCCG AAT TCT ATG AGA AAT GAA T TT AGG) 3
fcoR I

Ax-VPB-NS
5 -dfC C C TGC AGT TTG TGT AGT AAC ATC CAT)-3'
Pstl

Figure 4. Oligonucleotide Primer Sequences for PCR Amplification of Insert HAV
Capsid DNA for forced directional cloning into the pAX4B+ vector. (VP) Viral
peptide, (PS) positive strand primer and (NS) negative strand primer. The restriction
endonuclease recognition sequences (£coRI, Pstl, BglH) within each primer are
underlined.
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stained with ethidium bromide. The PCR-amplified DNA was extracted by ethanol
precipitation and resuspended in sterile distilled water. The DNA concentration was
calculated by measuring absorbance at 260 nm (Ajeo) of duiuted samples.
Approximately 5 ng of the PCR amplified DNA was digested with 20 units
restriction enzyme, EcoEl (GBBCO BRL,Gaithersburg, MD), in a 100 /zl restriction
enzyme reaction to generate the 5'-cohesive ends required for ligation into plasmid vector
pAX4b4- (United States Biochemical Corporation, Cleveland, OH).
reaction mix was incubated at 37°C for a minimum of

8

The digestion

hours to ensure complete

digestion of the DNA and then heated to 65“C for 10 minutes to inactivate EcoRl. The
digested VP DNA was resolved on a 2% agarose H (Anaresco, Salon, OH.) gel and
recovered by using Geneclean II (Bio 101 Inc., La Jolla, CA). The recovered DNA was
resuspended in 30 ^1 of sterile distilled water and then subjected to digestion with 20
units of the second restriction enzyme (Pstl for DNA encoding VPl and VP3, BglU for
DNA encoding VP2; GIBCO BRL, Gaithersburg, MD) for at least

8

hours at 37°C to

generate 3 -cohesive ends for ligation. The double-digested DNA was purified and
recovered from a 2% agarose II gel by using Geneclean H and resuspended in 15 to 20
^1 of sterile water. The DNA concentration was determined by measuring Ai» and
samples were stored at -20°C until needed.
Cloning of Digested PCR Products Encoding Viral Capsid Proteins: The
procaryotic expression vector pAX4b+ was selected for the cloning the PCR amplified
products as lacZ fusions (Markmeyer, et al., 1990). The plasmid was propagated in each
Escherichia coli strain in the presence of ampicillin (100 ^g/ml) following transformation
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and purified by a modification of the alkaline lysis method (Bimboim and Doly., 1979).
The plasmid DNA was subjected to appropriate restriction enzyme digestions (EcoRI and
Pstl or EcoRl and BglU) to generate compatible cohesive ends for ligation of insert VP
DNA digested similarly as described earlier.

The double -digested plasmid DNA

representing mainly the larger vector fragments following the second restriction enzyme
digestion was purified by the Geneclean II procedure to eliminate the smaller plasmid
fragment from the multiple cloning site that could potentially allow reaimealing of the
vector in any subsequent ligation reaction. The purified vector DNA was resuspended
in 20 /il of TE buffer (lOmM Tris-HCl, pH 8.0, 1 mM EDTA) and its concentration
estimated following A^go measurement of diluted samples.
Prior to setting up ligation reactions, molar ratios for the plasmid vector and the
individual VP DNA fragments were calculated using the formula as follows: /ig
dsDNA= fmoles of dsDNA ends X (1 /ig/3000 fmol) X (size of dsDNA in bp/1000 bp)
(Focus on applications. Technical Bulletin 5224-1, GIBCO BRL, Gaithersburg, MD).
The relative amounts of insert and vector DNA necessary to yield insert:vector molar
ratios of 1:1, 2:1, 4:1 and 10:1 in separate ligation reactions were thus determined.
Ligation reactions containing 0.5 to 2 units of T4 DNA Ligase (GIBCO BRL,
Gaithersburg, MD) in a 5 X DNA ligase reaction buffer (250 mM Tris-HCl, pH 7.6,
50 mM MgCl%, 5 mM ATP, 5 mM DTT, and 25 % (w/v) PEG 8000) in addition to
appropriate amounts of vector and insert DNA were set up in final volumes of 15 or 20
microliters. The reactions were incubated overnight at 22°C (Room Temperature, RT)
and used subsequently in the transformation experiments or stored at -20°C until needed.
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Escherichia coli strains GWIOOO and UT2300 were chosen as candidates for the
transformation and amplification of recombinant plasmids. Transformation of these
strains with recombinant DNA was performed by one of the following approaches: (i)
The calcium chloride transformation protocol or (ii)

The high efficiency electro-

transformation of E.co/f protocol.
To prepare competent E.coli cells for transformation by the calcium chloride
method, a 500 fil sample from an overnight culture was diluted in 25 ml of fresh LB
broth (1% Tryptone, 0.5% yeast extract, 0.5% NaCl, pH 7.0) and the cells were
incubated at 3TC for 2-3 hours with vigorous shaking. Following the incubation, the
culture was centrifuged at 3,000 X g to pellet cells. After carefully discarding the
supernatant, the cell pellet was resuspended in 20 ml of ice cold 100 mM CaCl; and
centrifuged again. After centrifugation, the cells were resuspended in 10 ml o f the ice
cold 100 mM CaClz and incubated on ice for 45 min to 1 hour. Then, the cells were
centrifuged at 3,000 X g for 15 min, resuspended in 2 ml of the ice cold 100 mM CaCl;
and stored at 4°C overnight before use in a transformation reaction. Transformation
reactions were performed by incubating 200 fil of the CaClj-treated competent cells with
15 fil of a 1:5 dilution of the ligation mix together on ice for 30 min and heat shocking
at 42°C for 2 min.

Following the transformation,

one ml of SOC medium (2%

tryptone, 0.5 % yeast extract, 8.5 mM NaCl, 25 mM Kcl, 10 mM MgClj, 20 mM
glucose, pH 7.0) was added and the cells incubated at 37°C for 2-3 hours. Control
transformation reactions with E.coli host cells and either uncut plasmid vector or single
digested plasmid (£coRI or BglU. or Pstl) or double digested plasmid (£coRI and Pstl or
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£coRI and BglH) or double digested and religated plasmid or plasmid pBR322 were set
up to monitor the efficiency of transformation. In addition, a transformation reaction
with E.coli host cells but without any plasmid DNA was set up as a negative control.
The transformed cells were plated in triplicates at 200 /il/plate onto SOC agar containing
100 ^g/ml ampicillin and incubated at 37°C overnight. The remaining ligation mix was
stored at 22°C overnight and plated the next day, if necessary. The SOC plates were
screened for colonies and representative colonies were selected and amplified in

1 0

ml

SOC-Amp medium for plasmid isolation and further analysis.
To prepare competent cells for the high efficiency electro-transformation method,
1 liter of LB broth was inoculated with 1/100 volume of an overnight E.coli culture.
The cells were then grown at 37°C with vigorous shaking to an A^oo of 0.5 to 1.0 and
chilled on ice for 15 to 30 minutes. The culture was then centrifuged in a cold rotor at
4,000 X g for 15 minutes. After carefully removing the supernatant, the cell pellets were
resuspended in a total of 1 liter of ice cold sterile distilled water. The resuspended cells
were centrifuged again and resuspended in 0.5 liter of cold water. The centrifugation
step was repeated again, and the resulting cell pellet was resuspended in
10% glycerol.

—

2

0

ml of cold

The glycerol suspension was centrifuged again and the cell pellet

resuspended in a final volume of 2-3 ml in cold 10% glycerol.

Aliquots of this

suspension were used in the electroporation reactions or were frozen on dry ice and
stored at -70°C or below until needed. To set up an electroporation reaction, 40 /il of
the cell suspension (firesh or gently thawed if from frozen stock), was mixed with

1 - 2

/il

of the ligation reaction mix and left on ice for 1 min. Then, the mixture of cells and
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DNA was transferred into a cold, 0.2 cm Gene Puiser electroporation cuvette (Bio-Rad
laboratories, Hercules, CA) and subjected to an electric pulse with a time constant of 4-5
ms using the Gene Puiser apparatus (Bio-Rad laboratories, Hercules, CA) set at 25 fiF
and 2.5 kV and with the Pulse Controller set at 2000. Following the pulse, 1 ml of SOC
medium was added immediately to the mixture in the cuvette and the cells were quickly
resuspended with a sterile Pasteur pipette. The resulting cell suspension was transferred
into a sterile 17 X 1(X) polypropylene tube and incubated at 37°C for 1 hour with
shaking. The cell suspension was then plated onto SOC-Amp medium as described
earlier and incubated overnight at 37°C.

The next day, plates were screened for

recombinant colonies and representative colonies were chosen for further study.
Plasmid DNA from several selected recombinants was extracted by the alkalinelysis method and DNA concentration of each sample was estimated by measuring AgooPlasmid DNA samples were linearized by restriction enzyme digestion with £coRI and
the relative size of each linearized recombinant plasmid DNA was compared to that of
the linearized control plasmid, pAX4b-f- without any inserts, by 0.8% agarose gel
electrophoresis. A relative shift in the position of the linear plasmid bands corresponding
to 900 base pairs for V Pl, 660 base pairs for VP2 and 738 base pairs for VP3 strongly
suggested that cloning of the viral DNA segments was successful. Further, using the
linearized recombinant plasmids as template, PCR reactions were performed with
corresponding sets of VPl or VP2 or VP3 primers. The reaction conditions for PCR
were as already mentioned in the PCR amplification of viral DNA from pGEM-HAV.
Successful amplification of specific VP regions, as revealed by
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electrophoretic analyses, confirmed the presence of insert DNA in the recombinant
plasmids.
Expression of p-galactosidase-Viral Peptide

Fusion

Proteins:

Three

representative recombinant clones: E.coli cells carrying either AX-VP 111 with VPl
DNA or AX-VP2B2 with VP2 DNA or AX-VP3T3 with VP3 DNA were chosen for
studying the expression of fusion proteins as follows. Briefly, one ml of overnight
cultures of each clone in LB broth containing 100 fig ampicillin/ml (Lbamp) and 0.5%
glucose was subcultured into 10 ml of fresh LB-Amp-Glucose medium, incubated for

1

h at 37°C with vigorous shaking, and subcultured again into 10 ml of fresh LB-AmpGlucose medium and incubated as before. After 1 h, a 5 ml volume of the culture was
inoculated into 50 ml of fresh LB-Amp-Glucose medium and incubated at 37“C with
vigorous shaking until the culture attained an A«o of 0.5 units. Then, the culture was
centrifuged at 3,000 X g for 5 min and resuspended in 50 ml pre-warmed, fresh LB-Amp
medium in a 250-tnl Erlenmeyer flask and the first 1 ml sample (To) collected. To
induce expression of the fusion product, iso-propy 1-thio-p-D-galactoside (BPTG) was
added to the cultures to yield a final concentration of 1.3 mM. Cultures were incubated
at 37°C with vigorous shaking and 1 ml samples were removed every hour through four
hours post-induction. The 1 ml samples were centrifuged at 12,000 rpm for 2 min at RT
and the resulting cell pellets were resuspended in 1(X) yX of a SDS gel-loading buffer (50
mM Tris-HCl, pH

6

. , 100 mM Dithiothreitol (DTT), 2% SDS, 0.1% Bromophenol
8

blue, 10% Glycerol). Then, the samples in SDS gel-loading buffer were heated to 100°C
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for 3 min, centrifuged at 12,000 X g for 2 min at RT and stored at -20°C until further
use.
SDS-PAGE Analysis of Fusion Products: Whole cell lysates of IPTG-induced
recombinant clones were analyzed for expression of p-galactosidase fusion products by
7.5% and/or 12% discontinuous Sodium Dodecyl Sulfate-Poly Aery lamide Gel
Electrophoresis (SDS-PAGE; Laemmli, 1970). Polyacrylamide gels of 1.5 mm thickness
were used along with a Mighty Small R280 electrophoresis apparatus (Hoefer Scientific
Instruments, San Franscisco, CA). Following electrophoresis at a constant current of 18
milliamperes for 4 to 5 h, the gels were stained in a Coomassie blue staining solution
(0.25% Coomassie Brilliant Blue R-250 (Sigma Chemical Co., St.Louis, M O.), 40%
methanol, 7% acetic acid) for 3 to 4 h with gentle shaking and destained for 1 h in a
destaining solution I (50% methanol, 10% acetic acid), followed by a destaining solution
n (5% methanol, 7% acetic acid) for 4 to

6

hours.

W estern Blot Analysis of Fusion Products: Bacterial cell lysates intended for
Western Blot analysis were resolved first by SDS-PAGE under the conditions mentioned
above. Following electrophoresis, the gels were equilibrated for 30 minutes in 500 ml
of a Tris-glycine transfer buffer (25 mM Tris; pH8.3, 192 mM glycine, 20% v/v
methanol). While the gel was equilibrating, pieces of filter pads along with pieces of
3MM Whatman filter paper (Whatman LabSales, Hillsboro, OR) and pure nitrocellulose
transfer and immobilization membrane (Schleicher & Schuell, Keene, NH), all of which
were the same size as the polyacrylamide gel, were soaked to saturation in the Trisglycine buffer in separate trays. A Western Blot transfer sandwich was assembled for

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

34

effecting transfer of proteins onto nitrocellulose using a Trans-Blot™ Cell (Bio-Rad
Laboratories, Richmond, CA) according to the manufacturer's recommendations. First,
a saturated filter pad was placed on the inner side of the gel holder. Next, a saturated
piece of 3MM filter paper was placed on top of the pad followed by the pre-equilibrated
gel. Any air bubbles trapped underneath the gel were removed by rolling a glass pipet
on the surface of the gel and thereby ensuring that the gel remained in close contact with
the filter paper support. Then, the nitrocellulose membrane was placed on top of the gel
and any air bubbles trapped between the gel and the membrane were removed as before.
This was followed by placement of a saturated filter paper with removal of air bubbles
and then, a piece of buffer-saturated filter pad to complete the six-layered sandwich. The
gel holder was closed with the sandwich inside and placed in the Trans-Blot™ Cell,
with the nitrocellulose membrane side towards the anode.

Blotting was performed

overnight under a low field (30V/0.1A), with constant stirring and cooling conditions.
A standard field 2 h transfer was performed at 60V/0.21A, following the overnight
transfer. After completing the transfer procedure, the sandwich was disassembled and
the nitrocellulose membrane utilized in the later steps for immunoscreening of fusion
proteins with the ProtoblotTM immimoscreening system (Promega, Madison, WI) by the
Protoblot™ Immunoscreening method.
The nitrocellulose membrane with the electro-blotted proteins was incubated in
TBST-1% BSA (10 mM Tris-HCl; pH8.0, 150 mM NaCl, 0.05% Tween 20) buffer for
30 min at RT with gentle shaking, to saturate any nonspecific protein binding sites on the
membrane. Next, the filters were incubated with the primary antibody (rabbit anti-
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HAVpolyvalent; mouse anti-HAV monoclonal) in TBST buffer for 30 min at RT with
gentle shaking. The primary antibody from the affinity purified rabbit polyvalent antiHAV serum was diluted 1:1000 in TBST before use. Following the incubation, the
membranes were washed thoroughly at least 3 times in 15-20 ml of TBST buffer with 510 min for each washing step.

After the third wash, the membranes were transferred

into TBST containing an appropriate dilution (1:5000 to 1:10,000) of an alkalinephosphatase (AP)-secondary antibody conjugate (Cappel/Organon Teknika Corp., West
Chester, PA) and incubated for 30 min at RT with gentle shaking. The membranes were
then washed three times with TBST buffer as described earlier. Following the wash,
damp membranes were dried briefly on clean, absorbent filter paper and transferred to
a freshly prepared AP color development substrate solution (5 ml AP buffer containing
100 mM Tris-HCl; pH 9.5, 100 mM NaCl, 5 mM MgCl; and

6

6

^1 o f nitroblue

tétrazolium (NBT; 50 mg/ml), 33 /il of 5-bromo-4-chloro-3-indoyl phosphate (BCIP; 50
mg/ml)). The color development was monitored carefully to avoid over exposure and
resultant high non-specific background. The reaction was stopped by discarding the
substrate development solution at the appropriate time, rinsing the membrane under
running water for one min and treating it with a stop solution (20 mM Tris-HCl; pH 8.0,
5 mM EDTA) for 5-10 minutes at room temperature. Subsequently, the membranes
were dried on a piece of clean filter paper and stored inside individual filter paper
envelopes in the dark.
Affinity Purification of Fusion Peptides: Purification of the fusion proteins was
done using a commercial APTG (para-aminopheny 1 -thio- p-D-galactopyranoside)
- 1
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affinity matrix (United States Biochemical Corp., Cleveland, OH). Whole cell lysates
were diluted in loading buffer (20 mM Tris-HCl, pH 7.4, 10 mM MgCl;, 1.6 M NaCl,
10 mM 2-mercaptoethanol), to a final concentration of 4 mg/ml and were applied to the
gel matrix to yield a flow rate of 1 ml per 10-15 minutes. After loading, the column was
washed with 50 - 70 ml of the loading buffer. The bound protein was eluted with 15 20 ml of an elution buffer (0.1 M borate, pH 10, 10 mM 2-mercaptoethanol). The eluted
fraction was immediately neutralized by collection into a dialysis bag immersed in borate
buffered saline (0.67 M H BO , pH 8.4, 0.15 M NaCl). The column was washed
3

3

thoroughly with additional 50 ml of the elution buffer followed by 50-70 ml of storage
buffer (10 mM Tris-HCl, pH 7.4). The dialyzed peptides were concentrated with a
carboxymethyl cellulose adsorbent (AQUACIDE, CALBKX3HEM Corp., La Jolla, CA).
The total protein concentration was determined by the BCA method (Pierce, Rockford,
IL), and the purified peptides were analyzed by SDS-PAGE.
ELISA for antigenicity of Recombinant HAV Capsid Proteins:

Purified,

formalin inactivated HAV HM-175 strain virus particles were kindly provided by Dr.
Mark D. Sobsey, Univ. of North Carolina, Chapel Hill, NC. Ninety-six well microtiter
plates (Immulon II; Dynatech Laboratories Inc., Alexandria, Va.) were coated in
duplicate with each of the following components: 5 ng per well of each of the three
partially purified recombinant HAV peptides (50 /xg/ml), £. coli p-galactosidase (50
Aig/ml; Sigma Chemical Co., St. Louis, MO.) and 10* virions per well of intact HAV
(10’ virions/ml) in carbonate coating buffer (600 mM NaHC

0

3

, 600 mM Na C
2

0

3

, pH

9.6). The proteins were allowed to adsorb overnight at 4°C. Following the incubation.
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the coating buffer was removed and 200-/d of blocking buffer (50 mM Tris-HCI, pH 7.2,
1 mM EDTA, 150 mM NaCl, 2% BSA, 10% fetal calf serum) was added to each well.
The plates were incubated for 45 min at room temperature (RT) and then washed twice
with 200 nl of TEN buffer (50 mM Tris-HCI, pH 7.2, 1 mM EDTA, 150 mM NaCl,
0.05% Tween-20). Next, 100 fil aliquots of either rabbit pre-immune serum, affinity
purified/absorbed polyvalent anti-HAV antiserum, or a purified rabbit anti-pgalactosidase antibody (Cappel/Organon Teknika Corp., West Chester, Pa.) in TEN-10 %
fetal calf serum (PCS) were added to appropriate wells in individual plates and incubated
for 1 h at RT on a rotary platform. The plates were washed six times with TEN and 50
fil of goat-anti-mouse Ig-alkaline-phosphatase enzyme conjugate (Cappel/Organon
Teknika Corp., West Chester, Pa.) in TEN-10% PCS were added to each well. After
a 45 min incubation at RT, wells were washed as before and then 200 fil of the substrate
para-nitrophenyl phosphate (1 mg/ml) (Sigma Chemical Co., St.Louis, Mo.) in
diethanolamine buffer (9.7% (v/v) diethanolamine, 0.02% (w/v) NaNj, 0.01%
MgClz.ôHzO, pH 9.8) were added to each well. The plates were incubated at 37°C in
the dark and the reaction was stopped by adding 50 fil of 3N NaOH per well after 30
min. The absorbance was read using a Bio-Tek EIA Reader (Bio-Tek Instruments) at a
406 nm.
Phase C ontrast and Electron Microscopy of E.coU Expressing Fusion
Proteins:

Overnight cultures of recombinant £.co/i cells carrying HAV genes were

inoculated into 10 ml of fresh LB-amp-glucose media and incubated either at 30°C or
37°C with vigorous shaking for 1 h. One ml of these cultures were transferred into
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appropiately labeled Erlenmeyer flasks with 10 ml of fresh LB-amp-glucose and
incubated as before for 3-4 h. Each recombinant was inoculated into 2 separate flasks
of LB-amp. Following the incubation, 1 ml samples of each culture were collected into
individual sterile microfuge tubes (gr) and the remaining cells were centrifuged at 3,000
X g for 10 min. After discarding the supernatant carefully, one cell pellet of each
recombinant was gently resuspended in fresh LB-amp without any glucose and the other
with fresh LB-amp-glucose. Cells in media without glucose were subjected to IPTG
induction as described earlier. One ml samples of each culture (Time Oh) were collected
again immediately following the addition of IPTG to one set of cultures. The remaining
cultures were incubated at 30°C or 37°C for 2h before collecting the next set of samples
(Time 2h).

E.coli UT2300 cells ( i.e. without any recombinant plasmid) and cells

carrying vector pAX4b+ without any insert DNA were used as negative and positive
controls in this experiment.
The live cells from various time points mentioned above were transferred onto
microscopic slides immediately after sample collection and the individual preparations
were examined under a phase contrast

microscope shortly thereafter.

Selected

microscopic fields were photographed with phase optics on a Nikon Microphot HFX-2A.
Bacteria from time 2h were also examined by Transmission Electron Microscopy
after preparing cells as follows.

Cells were fixed in 2% glutaraldehyde and 1-2%

Osmium tetraoxide for 20 min and then en bloc stained in 0.5% Uranium acetate. The
cells were then dehydrated in absolute ethanol and embedded in LR White resin; thin
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sections were poststained with lead citrate. Grids were examined and photographed on
a JEOL JEM lOOCX transmission electron microscope.
Large Scale Expression and Partial Purification of Recombinant Proteins by
Sarkosyl Extraction of Inclusion Bodies: Large scale production of the fusion peptides
was accomplished by a modification of a method previously reported (Stark, 1987).
Bacterial clones were inoculated onto LB-Amp-Glucose medium and incubated as
described before. One liter cultures were grown at 37“C with continuous shaking to an
optical density of 0.5 units at a wavelength of 600 nm. The cells were centrifuged at
5,900 X g for 15 min and the cell pellets were resuspended to the same density in LB
media containing ampicillin (100 ^g/ml), with no glucose.

Expression of the

recombinant plasmids was induced by addition of IPTG and the cultures were incubated
at 37°C in a shaker incubator for 4 h.

The fusion peptides were extracted by a

modification of the method described previously (McNally, et al., 1991). Following
IPTG-induction, the cells were sedimented at 5,900 x g for 30 min and resuspended in
100 ml of washing buffer (100 mM Tris-HCI, pH 7.4, 10 mM EDTA, 10 mM 2mercaptoethanol, 1 mM phenyl methyl sulfonyl fluoride (PMSF)).

The cells were

washed three times and the pellet was weighed. Cells from 1 liter of induced culture
(

6 - 8

g/L) were then resuspended in 15 ml of a low salt buffer (10 mM triethanolamine,

0.5 mM ATP, 0.5 mM DTT, 0.1 mM C a C y containing protease inhibitors (Aprotinin
20 /ig/ml, Leupeptin 10 /xg/ml, Pepstatin 2.5 ;zg/ml, Chymostatin 2.5 uglm i, OPhenanthroline 0.5 mM, PMSF 1 mM) (27). The cells were disrupted by two passages
through a French Press cell at 1000 Ib/in^ followed by centrifugation at 500 rpm for 10
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min to remove unbroken cells. The supernatant fluid was then centrifuged at 116,500
X g for

8

min and the resulting pellet was resuspended in

1 0

ml of extraction buffer

(1.5% Sarkosyl, 25 mM triethanolamine, 4 mM ATP, 0.8 mM DTT, 1 mM EDTA,
0.02% sodium azide) containing protease inhibitors using a Teflon-glass homogenizer
and centrifuged again at 116,500 x g for 16 min. The supernatant was collected into a
sterile beaker and 58.5 ml of octylglucoside (OG) buffer (to sequester Sarkosyl) was
added. This resulted in a final concentration of 2% octylglucoside and 0.2 % Sarkosyl
in a solution containing 25 mM triethanolamine, 800 mM NaCl, 1.0 mM ATP, 0.8 mM
DTT, 0.02% sodium azide, 0.13 mM EDTA, and protease inhibitors. After mixing
thoroughly, CaCl was added to a final concentration of 100 mM.
2

The protein

suspension was then transferred into Spectra/Por CE membranes (MWCO 100,000;
Spectrum, Houston, TX) and dialyzed for 96 h at 4°C against a dialysis buffer (25 mM
triethanolamine, 800 mM NaCl, 1 mM ATP, 0 .2 mM DTT, 0.02% NaN], 0.13 mM
EDTA and protease inhibitors). The dialysate was replaced with fresh buffer every

8

h.

The total protein concentration of the dialyzed protein suspension was determined by the
Bicinchoninic acid (BCA) method (Pierce, Rockford, IL ), followed by SDS-PAGE and
Western Blot analysis.
RESULTS
The nucleotide sequences selected to design flanking oligonucleotide primers for
each capsid sequence were reported previously (Cohen, 1987a).

Restriction

endonuclease sequences were incorporated to flank the viral sequences to facilitate
directional cloning into the plasmid vector. Figure 5 shows the PCR-amplified products
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Figure 5. Agarose gel analysis of DNA segments amplified from pGEM-HAV by PCR
and encoding HAV capsid proteins. Lane 1: BioMarker low molecular weight DNA
standard. Lane 2: VPl (899 bp), Lane 3: VP2 (665 bp), Lane 4: VP3 (737 bp), Lane 5;
BioMarker low molecular weight DNA standard.
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encoding V P l, VP2, and VP3. The molecular size of each product corresponded to
thatof each specific capsid gene.
Following cloning and confurnation that the relevant insert DNA was present in
the recombinant plasmids, Ax-VPlIl, -VP2B2 and -VP3T3, expression of individual pgalactosidase fusion proteins was assessed in three different E. coli strains. Optimum
protein expression occurred when overnight cultures were expanded through two
consecutive passages in fresh medium supplemented with glucose and ampicillin prior
to IPTG induction.
Expression from recombinant pAx-VPlIl was assessed first in E. coli UT 2300.
Analysis of protein expression under IPTG induction revealed two prominent over
expressed protein bands of 125 kD and 150 kD (Figure

6

).

The 125 kD band

corresponding to p-galactosidase was also expressed from the vector pAX4b-f (Figure
6

).

The 150 kD corresponded to the fusion product and was detectable one hour

following IPTG-induction,

Western blot analysis revealed that both E. coli p-

galactosidase and the recombinant fusion protein bands were stained by rabbit anti-HAV
polyvalent antiserum (Figure 9). Surprisingly, the anti-HAV antiserum appeared to
possess serological activity against £. coli p-galactosidase (MW = 116 kD) present in the
commercial molecular weight markers (Figure 9; Biorad laboratories, Richmond, CA)
and p-galactosidase expressed from the plasmid pAx4b-t- in£. coli UT2300 (not shown).
The anti-HAV serum was absorbed with commercial E. coli p-galactosidase (Sigma
Chemical Co., St.Louis, MO) and the Western Blot experiment was repeated. Neither
the recombinant protein nor the p-galactosidase protein bands were stained with the
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Figure . SDS-PAGE analysis of fusion proteins expressed from recombinant plasmid
pAX4b-VPlIl in host E. coli UT2300 ceils. E. coli lysates from various time points
before and after IPTG induction were examined. Lane 1: Host cells without vector.
Lane 2: Biorad molecular weight marker. Lane 3: Cells under glucose repression. Lane
4: Cells at mM IPTG induction (Tq). Lane 5: 1 h after induction. Lane : 2 h. Lane
7 :3 h . Lane : 4 h. Lane 9: Rainbow™ molecular weight marker. Lane 10: Host cells
carrying vector pAX4b+ .
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absorbed antiserum (Figure 9).

When these experiments were performed with a

neutralizing IgG mouse MAh (P2G9), and a non-neutralizing IgM mouse MAb (P6B5),
both MAbs stained the fusion protein as well as p-galactosidase, similar to the polyvalent
anti-serum before absorption with the p-galactosidase (Figure 9). Induction of protein
expression from pAX-VP III in E. coli GWI(XX) showed no discernible expression of the
fusion product (not shown). Similarly, recombinant pAX-VPlIl in E. coli Top 10 also
exhibited poor expression of the fusion protein (not shown).
Induction of pAX-VP2B2 in E. coli UT23(X) led to expression of the recombinant
p-gal-VP2 protein as the predominantly overexpressed protein (Figure 7). A marked
increase in the production of the recombinant product was observed by examination of
the level of expression between time 0 and time Ih (Figure 7). Western blot studies
revealed findings similar to those observed with p AX-VP 111 (Figure 9). Expression of
the recombinant p-gal-VP2 fusion protein in £. coli GWKXX) revealed overexpression
of the galactosidase protein only (Figure 9).

Similarly, expression of both p-

galactosidase and the p-gal-VP3 recombinant protein increased as the induction period
progressed in the UT2300 host strain (Figure ). Fusion protein expression from pAX8

VP3T3 in the GWKXX) host strain was low and p-galactosidase was the predominant
overexpressed protein (not shown). Again, Western blot analyses showed that the antiHAV antibodies reacted with both protein bands, p-galactosidase and the fusion proteins
(Figure ).
8

Large-scale production in one liter cultures and purification of the fusion proteins
P-gal-VPl, -VP2 & -VP3 was done. The cells were fractured by sonication and the

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

45
1

2

3

4

5

6

7

8

9

10

A.

:200

:116
[97
<m

*

C69

46

B.
1 2

3 4

5 6

7

8

9

10

:200

:il6

; 97
[ 69

46

Figure 7. SDS-PAGE analysis of fusion proteins expressed from recombinant plasmid
pAX4b-VP2B2 in host E. coli UT2300 (A), and in GWIOOO cells (B). E. coli lysates
from various time points before and after IPTG induction were examined. Lane 1: host
cells without vector. Lane 2: molecular weight marker. Lane 3; Cells under glucose
repression. Lane 4: Cells at I mM IPTG induction ( T q) . Lane 5: 1 h after induction.
Lane : 2 h. Lane 7: 3 h. Lane : 4 h. Lane 9: molecular weight marker. Lane 10:
Host cells carrying vector pAX4b + .
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Figure . 7.5% SDS-PAGE analysis of fusion proteins expressed from recombinant
plasmid pAX4b-VP3T3 in host E. coli UT2300 cells. E. coli lysates from various time
points before and after IPTG induction were examined. Lane 1: host cells without
vector. Lane 2; Biorad molecular weight marker. Lane 3: Cells under glucose
repression. Lane 4: Cells at 1 mM IPTG induction ( T q). Lane 5: I h after induction.
Lane : 2 h. Lane 7: 3 h. Lane : 4 h. Lane 9: Rainbow™ molecular weight marker.
Lane 10: Host cells carrying vector pAX4b4-.
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Figure 9. Western Blot analysis of fusion proteins expressed in E. coli UT2300 cells
from recombinant plasmids pAX4b-VPlIl, -VP2B2, and -VP3T3. Whole cell lysates
4 h after IPTG induction were resolved by a 6.5% SDS-PAGE, transferred onto
nitrocellulose and screened with rabbit anti-HAV polyvalent antiserum adsorbed with E.
coli whole cell extract (A), rabbit anti-HAV polyvalent antiserum adsorbed with E. coli
whole cell extract and p-galactosidase (B), mouse anti-HAV monoclonal IgM antibody
P6B5 (C), neutralizing mouse anti-HAV monoclonal IgG antibody P2G9 (D). Lane 1:
BioRad molecular weight marker. Lane 2: VP1I1/UT2300. Lane 3: VP2B2/UT2300.
Lane 4: VP3T3/UT2300. Lane 5: Rainbow™ molecular weight marker.

R eproduced with perm ission o f the copyright owner. Further reproduction prohibited w ith o u t perm ission.

48
fusion proteins precipitated at 30% ammonium sulfate concentration. However, upon
attempts to dissolve the precipitate in buffer, a significant portion of this preparation
formed insoluble aggregates. Further, both phase contrast and electron microscopic
examination revealed aberrant changes in the morphology of the recombinant bacterial
cells (Figure 10), which suggested the possibility that the fusion proteins were organized
into inclusion bodies within the host cells (Figure 11). In an attempt to extract and then
solubilize the fusion proteins in a more efficient manner, a combination o f French Press
lysis and Sarkosyl extraction was used and fusion protein p-gal-V PlIl was recovered.
A significant fraction of the fusion protein remained in solution following extraction and
high speed centrifugation, and sequestration of the Sarkosyl by octylglucoside and
dialysis employed to remove the detergents from the protein solution (Figure 12).
An APTG affinity column was used to immobilize the fusion proteins from the
fractionated cell lysates obtained by the sonication-ammonium sulfate precipitation
procedure, or by the French Press lysis-Sarkosyl extraction. Fusion proteins ( ~ 150 kD)
obtained from the pAX4b+ recombinant plasmids, and containing the entire pgalactosidase molecule were copuriHed with p-galactosidase ( —125 kD) (Figure 13).
The affinity purified recombinant HAV capsid proteins, V P lII, VP2B2 and
VP3T3 were examined for serological activity (antigencity) by ELISA (Table 2).
Escherichia coli p-galactosidase and intact HAV particles were included as controls in
the immunoassay.

The HAV particles and recombinant HAV proteins, V P lII and

VP2B2 reacted with the absorbed rabbit polyvalent antibodies at high titer as indicatedby
OD

4 0 5

readings. The recombinant VP3T3 and E. coli p-galactosidase proteins reacted
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Figure 10. Phase contrast microscopy of E. coli cells induced for expression of fusion
proteins from recombinant plasmids encoding sequences for HAV capsid proteins. All
fields are at same magnification (X 1200). (A) Host E. coli UT2300 cells. (B)
VP1I1/UT2300. (C) VP2B2/UT2300. (D) VP3T3/UT2300. Some inclusion bodies (IB)
are marked by arrows.
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Figure 11. Electron microscopy of E. coli ceils induced for expression of recombinant
fusion proteins from recombinant plasmid pAX4b-VPlIl. The host cells display
intracellular inclusion bodies (IB). Transmission electron micrograph of thin sections ( <
100 nm) of E. coli AX-VP1I1/UT2300 cells. (A) Magnification X 13,000. (B)
Magnification X 33,000. Some of the amorphous, homogeneous and predominantly
polar inclusions are marked by arrows.
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Figure 12. SDS-PAGE analysis of samples from various solubilization steps during the
large scale extraction of V P lIl fusion protein by the French Press-Sarkosyl extraction
method. Lane 1: Whole cell lysate from host UT2300 strain. Lane 2: Biorad SDSPAGE molecular weight standards-High. Lane 3; Whole cell lysate of VP1I1/UT2300
prepared from sample collected prior to the French Press lysis step. Lane 4: Whole cell
lysate of VPII1/UT2300 following French Press lysis at 1000 Ib/in^. Lanes 5 and :
Samples prepared from pellet (Lane 5) and supernatant (Lane ) obtained after French
Press lysis and centrifugation at 5(X) rpm for 10 min. Lanes 7 and : Samples
representing inclusion body pellet (Lane 7) and supernatant (Lane ) following
centrifugation at 116,5(X) x g for min. The IB pellet was solubilized in extraction
buffer. Lanes 9 and 10: Samples representing pellet (Lane 9) and supernatant (Lane 10)
following centrifugation of sarkosyl-extracted IB sample at 116,500 x g for 16 min. The
supernatant was mixed with buffer containing octylglucoside.
6

6

8

8

8

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

52

Figure 13. SDS-PAGE analysis of affinity-purified fusion proteins expressed from
recombinant plasmid pAX4b-VPl, -VP2, and -VPS in E. coli UT2300 cells. The
individual recombinant proteins were affinity purified using an APTG column. Lane 1:
Molecular weight marker. Lane 2: Fusion protein p-gal-VPS. Lane S: Fusion protein
p-gal-VP2. Lane 4: Fusion protein p-gal-VPl. Lanes 5 and : Molecular weight
markers.
6
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Table 2. ELISA with Rabbit Antiserum for Detecting Antigenicity of Affinity
Purified Recombinant HAV Capsid Proteins.

preimmune
serum

immune
serum
@ 1:500

anti- pgal
serum

no
serum

V P lIl
(P-gal-VPl fusion protein,
5 ^g/well)

0.208“

0.907

1.264

0.164

VP2B2
(p-gal-VP2 fusion protein,
5 ;ig/weli)

0.168

0.992

1.227

0.197

VP3T3
(P-gal-VP3T3 fusion protein,
5 /ig/well)

0.186

0.648

1.515

0.508

E. coli p-galactosidase,
5 fig/well

0.164

0.572

1.155

0.176

Formalinized intact
HAV particles
( ®virions/well)

0.162

0.820

0.354

0.176

1 0

absorbance @ 405 nm (in triplicate)
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less strongly albeit still at higher titers when compared with the negative controls. The
anti-p-galactosidase antibody, reacted very strongly with each of the recombinant
proteins as well as with native p-galactosidase and only poorly with intact HAV
particles. The rabbit pre-immune serum did not yield any significant titer against any of
the antigens tested.
DISCUSSION
Cloning and expression of PCR amplified HAV capsid genes in prokaryotic or
eukaryotic systems provide a convenient and safe alternative to isolation of viral proteins
by disruption of infectious and potentially hazardous virus particles. Purification of
HAV proteins from intact infectious virions is complicated by low and uiu'eliable yields
of the specific proteins extracted from either infected liver tissue or cell cultures
(Hughes, et al., 1984; Cromeans, et al., 1989).

A PCR amplified product which

includes an entire viral gene cloned and then expressed in a prokaryotic vector may
provide a superior and more convenient approach for immunogenic assessment of each
protein. The antigenicity of each recombinant protein can then be compared with the
intact capsid of native virions. It has been postulated that each of the three major viral
capsid peptides contribute to the conformation of the immunologically dominant and
relevant epitopes (Emini, eta l., 1985; Fayol, and Ville, 1991; Hughes, 1985). The goal
of this study was to determine whether large-scale stable expression of HAV peptides in
E. coli was possible and if it is, whether a substitution of tissue culture grown virus,
currently used in immunodiagnostic and serology, by recombinant viral capsid peptides
is practical and commercially feasible.
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The prokaryotic expression vector, pAX4b+ (Figure 3), was selected since it
would allow for fusion of the entire E.coli p-galactosidase protein with the N-terminus
of the foreign protein of interest, thereby enabling easy identification and purification of
the expressed fusion protein by APTG-affinity chromatography directed towards the pgalactosidase component. Furthermore, a hinge region of 62 amino acids derived from
the structural protein, collagen, which is positioned between the p-galactosidase and the
protein of interest following successful cloning, will permit independent folding of the
two components of the protein fusion. An endoproteinase Xa specific sequence exists
in the rigid hinge which permits cleavage of the protein of interest from p-galactosidase
upon exposure to endoproteinase Xa. Application of digested protein mixture onto the
same APTG-column will selectively bind and retain the E.coli p-galactosidase, while the
protein of interest is eluted and recovered as a pure fraction.
The incorporation of unique restriction endonuclease sites as flanking sequences
into each oligonucleotide primer facilitated directional cloning of the amplified PCR
products. Recombinant clones, each of which exhibited variable expression efficiency
the target gene products, were thus obtained. Significant morphological changes were
observed in the recombinant strains during expression of the recombinant viral proteins.
The appearance of elongated, filamentous cells which possessed polar inclusion bodies
and exhibited slower growth rates suggested that the cloned viral genes or their products
maybe toxic to and exert an impact on host bacterial cell metabolism.
The HAV capsid proteins expressed as fusions with the E. coli p-galactosidase
exhibited antigenic properties when assessed by Western Blot analyses using both
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polyvalent and monoclonal antibodies generated in animals immunized with intact
Hepatitis A virus. The VPl recombinant protein also reacted with MAb P2-G9 which
had been previously determined to possess neutralizing activity against intact HAV
particles (Baez, L.A., 1994). These findings suggest that the recombinant VPl may
contain epitopes that resemble those present on the intact Hepatitis A virion.
E. coli UT2300 cells exhibited a better level of fusion protein expression when
compared to the other strains tested, probably due to the fact that they are protease
deficient. A similar observation was made earlier (Lindler, et al., 1991) regarding a
marked difference in expression and stability of recombinant malarial peptides in £. coli
which was shown to be associated to the expression of proteases linked to the bacterial
heat shock response.

The simultaneous expression of both the 125kD E. coli p-

galactosidase and the —150 kD recombinant p-gal-VP fusions may have been due to
events such as premature termination of transcription by E.coli RNA polymerase due to
fortuitous intragenic terminators within the viral sequences, or a rapid mRNA turnover
due to formation of secondary structures recognized by host nucleases, or an inefficient
translation resulting from a biased codon usage. In addition, the possibility that a
specific autoproteolytic cleavage may have occurred in vivo during synthesis of the
recombinant proteins cannot be ruled out. Such an event could be mediated by capsid
sequences of the fusion proteins, although such an activity for HAV capsid proteins VPl
and VP3 has not been reported.
One persistent observation was serological cross reactivity which occurred
between the two proteins, p-galactosidase and the fusion proteins, during Western blot
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analysis with a panel of anti-HAV antibodies which included a neutralizing monoclonal
antibody used to screen and detect the expressed proteins. Further, preliminary studies
with human acute phase serum collected from patients who tested positive for HAV
revealed a similar cross reactivity between p-galactosidase and the recombinant HAV
proteins (data not shown) indicating that this phenomenon is not limited to a single
source of anti-HAV antibodies.

The possibility of non-specific binding to p-

galactosidase by goat anti-rabbit or anti-mouse alkaline phosphatase conjugated antibodies
was examined by omitting addition of anti-HAV antibodies during the blotting procedure.
The recombinant proteins were not stained by the goat antibodies alone.
Affinity purification of recombinant fusion proteins was complicated by co
expression of p-galactosidase in vivo during IPTG-induction of recombinant E.coli and
its interference in efficient purification of the individual fusion proteins. Early attempts
to cleave the fusion proteins with endoproteinase Xa following immobilization onto the
APTG-affinity column or attempts to purify capsid proteins by passage through the
APTG column subsequent to digestion of the fusion proteins outside the column failed.
Hence, we had to abandon this strategy to obtain individual HAV capsid proteins by
subjecting the affinity-purified fusion proteins to endoproteinase Xa cleavage.
The ELISA was used to detect antigenicity of affinity purified recombinant HAV
proteins. The ELISA results, while confirming specificity of absorbed rabbit antiserum
against intact HAV particles, also suggested an interaction between the anti-HAV
antibodies and E. coli p-galactosidase that resulted in a titer lower than any seen with
HAV proteins but nevertheless significant.

Moreover, rabbit anti-p-galactosidase
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antibody, which reacted strongly with both native p-galactosidase and recombinant pgalactosidase-HAV capsid proteins, exhibited a weak reaction with intact HAV particles.
It should be emphasized at this juncture that there have been no previously published
reports regarding non-specific recognition of E. coli p-galactosidase by rabbit or mouse
antibodies when used in either ELISA or Western blotting procedure. Therefore, the
serological observations strongly suggest a possible coincidental existence of certain
common epitopes between two ostensibly unrelated proteins, p-galactosidase and HAV
capsid proteins, at least in the SDS-mediated denatured state.
HAV fusion proteins sequestered in inclusion bodies following IPTG induction
of host cells could permit their isolation and manipulation as a distinct subcellular
fraction. The French Press-Sarkosyl extraction procedure enables efficient solubilization
of such inclusion bodies on a large scale.
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INTRODUCTION
Expression of heterologous proteins in Escherichia coli, subsequent to successful
cloning of the relevant gene into appropriate procaryotic plasmid vectors, requires
efficient transcription and translation of the gene of interest. It is often possible by
recombinant DNA techniques to engineer and produce successfully in E.coli any protein
that is not too small, too large, too hydrophobic, and does not contain too many
cysteines. However, expression of certain foreign cDNA or genes may present unique
challenges that must be overcome to achieve high-level expression. Our earlier attempts
at p-galactosidase-HAV VP fusion protein expression from expression vector pAX4b +
and their subsequent affinity-based purification were ftustrated by the simultaneous
expression of p-galactosidase without the viral protein components. Factors which may
have contributed to the dichotomous expression of the fusion proteins in E.coli include
premature termination of transcription, rapid decay of mRNA, poor translation, or
extreme instability or toxicity of the proteins expressed (Baibas and Bolivar, 1990; Das,
1990; Powdrill and Johnston, 1991).
We speculated that premature termination of transcription of p-galactosidaseHAV VP gene fusions may have been due to fortuitous terminator-like sequences in the
mRNA encoding the —150 kD fusion proteins. Presence of an intragenic terminator
within a foreign DNA insert would prevent a complete, high-level transcription of the
cloned gene.

Previously published reports suggest that an inclusion of various anti

termination sequences downstream of the promoter from which the recombinant genes
are transcribed might improve and ensure complete transcription of such messages
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(Salstrom and Szybalski, 1978; deCrombrugghe, etal., 1979; Gottesman, et at., 1980).
Such approaches for influencing gene expression have utilized, various components of
the A. early or late antitermination system s'mE.coli (Friedman, 1988; Podhajska, et al.,
1985; Hasan and Szybalski, 1987; Shatzman and Rosenberg, 1987). In addition to the
A.-derived antitermination systems, other mechanisms of transcriptional antitermination
are operative in the E.coli (Greenblatt, et al., 1993). One such antitermination system,
which shares several features in common with the A.-derived antitermination systems,
utilizes elements of the E.coli ribosomal RNA {rm) operon (Li, et al., 1984).
The bacteriophage A. antitermination systems in E.coli are mediated by nucleotide
sequences and protein factors derived from both the infecting bacteriophage and the host
bacterial cell (Friedman, 1988). Early transcriptional antitermination is mediated by the
A. N

gene product and a short nucleotide sequence, nut (the N utilization site) which is

thought to be functional only after its transcription into the RNA form (Das, 1992). The
nut site includes a seven-nucleotide boxA sequence followed by a stem-loop boxB motif.
In addition to the A. N protein and the antiterminator nucleotide sequences, four E.coli
Nus (N utilization substance) proteins namely NusA, NusB, NusE, and NusG, are
required for successful N-mediated antitermination (Li, et al., 1992; Nodwell, et al.,
1993) . The late antitermination system is much simpler and depends on a A. qut
sequence, the A, Q protein, and the E.coli NusA protein (Yamell and Roberts, 1992).
The E.coli ribosomal RNA {rm) operon leader sequences contain regions
homologous to the A, nut site. The boxA and boxB elements are similar but seem to be
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reversed in their corresponding locations (Figure 14). Recent studies have shown that
in the presence of E.coli Nus factors, transcription of a short, 12-nucleotide boxA
sequence, 5'-TGC TCT TTT AAC-3', is essential and maybe sufficient to render the
E.coli RNA polymerase terminator-resistant both in vivo and in vitro and cause readthrough of Rho-dependent terminators. However, the exact mechanism of anti
termination in the E.coli rm opérons remain to be elucidated.
The A. and rm antitermination systems along with the Nus factors induce and
maintain a long-lived modification of the E.coli RNA polymerase in the elongation
complex and enable transcription through multiple consecutive terminators (Albrechtsen,
et al., 1990). An alteration in the RNA polymerase function can exert several
consequences such as the protection of untranslated rRNA transcripts from premature
Rho-dependent termination, regulation of protein synthesis, RNA folding patterns and
maturation (Aksoy, er a/., 1984; Morgan, 1986).
To improve the expression of p-galactosidase-HAV VPl fiision-protein in E.coli.
it was assumed that premature termination of transcription may have been responsible
for the inefficient expression from the recombinant plasmids constructed earlier.

A

twelve nucleotide boxA sequence derived from the E.coli rm antiterminator sequence
was incorporated upstream of the HAV VPl sequence during cloning into plasmid
vector, pAX4b-t-.

Subsequently, to study the effects of the boxA sequence on fiision-

protein expression in vivo, the recombinant plasmid DNA was used to transform host
E.coli cells as a prelude to EPTG induction of fiision-protein expression. The resultant
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(i) Phage A, transcriptional antiterminator sequence of the nutR region.

S'-CGCTCTTACACATTCCAGCCCTGAAAAAGGGCATCAAATTAAArCACACCTATG O TG TA Tn-a '

BoxA

BoxB

BoxC

(ii) E.coli transcriptional antiterminator sequence of the rmG leader region.

A
G A
BoxB
A
A
G A
T-A
C-G
G-C
C
A
G A
C-G
G-C
C-G
C-G
5 •- ATCGATCG-CACTGCTCTTTAACAATTTATCAGACAATCTGTGTGGGGATCC-3 '

BoxA

BoxC

Figure 14. Transcriptional antiterminator sequences from phage A. and E.coli genomes.
Both sequences have been drawn as single-stranded DNA. The BoxA and BoxC
sequences are underlined. The ability of BoxB sequence from E.coli to form a stem-loop
structure also is shown.
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protein was subjected to analysis by SDS-PAGE, Western Blot and limited N-terminal
amino-acid sequencing techniques.
MATERIALS AND METHODS
Bacterial Strains and Plasmids : Bacterial strains and plasmids used in this
study are listed on Table 3.
Oligonucleotide Primers : The nucleotide sequences of each PCR primer used
in this study are listed in Figure 15. The primers were synthesized by beta cyanoethyl
phosphoramidite chemistry (Genelab, Dept, of Vet. Med. & Parasitol., School of
Veterinary Medicine, LSU, Baton Rouge, LA). Primer AXBOXAVPIPS included the
translational antiterminator BoxA sequence 5'-TGC TCT TTA ACA-3'

of E.coli

ribosomal RNA {rm) operon.
PC R Amplification and Cloning of HAV V Pl DNA with a S' Extension
C arrying the Antiterm inator BoxA Sequence :

Primers AXBOXAVPIPS and

AXVPINS were used in conjunction with linearized template pGEM-HAV DNA to
generate insert AXBoxAVPl DNA by PCR. Individual reactions were set up in 100 /xl
volumes in accordance with the procedure followed earlier for PCR amplification of
HAV V Pl, VP2 and VP3 DNA. Thermal cycling was performed through 30 cycles as
follows : dénaturation at 94°C for 90 sec, annealing at 55“C for 60 sec and elongation at
72"C for 90 sec with an elongation autoextension step of 10 sec per cycle. Following a
final elongation step of 10 min, the reaction mix was cooled to 4°C , separated from the
mineral oil overlay and transferred to a fresh microfuge tube. A five /il volume of the
products were screened by % agarose gel electrophoresis to determine if the specific
2
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Table 3. Bacterial strains and plasmid vectors used to study the effects of E.coli rrn
Strains/Plasmids
Escherichia coli
UT2300

Description
azi-6,fhuA23, la cY l, leu-6, m lt-\,
proC14, pufEAl, rpslAQf^, thi-l,
trpE38, tsx-61, entA403, purE*,
fh u A * ,fep A , A/on::TnlO

Reference
Elish, et a l., 1988

Plasmid
pAX4b +

United States
Biochemical Corporation,
Cleveland, OH

Plasmid pGEMHAV

R.H. Purcell (N.I.H.)
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Ax-BoxAVPl-PS
5'-d(CCG AAT TCT TGC TCT TTA ACA GTT GGA GAT GAT TCT)-3
EcoHtl

im boxA

Ax-VPl-PS
5 -dfCCG AAT TCT GTT GGA GAT GAT TCT GGA)-3'
EcoRl

Ax-VPl-NS
5 -dCCCC TGC AGG CTC AAA TCT TTT ATC TTC)-3
Pstl

Figure 15. Oligonucleotide primer sequences used for PCR amplification of insert HAV
BoxA V Pl capsid DNA for forced directional cloning into the pAX4b+ vector and for
verification of the presence of the insert DNA following successful cloning. (VP) Viral
Peptide, (tecZ) E.coli gene encoding the p-galactosidase protein, (PS) positive strand
primer and (NS) negative strand primer. The restriction endonuclease recognition
sequences (EcoRI, PstJ) within each primer are underlined.
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-950 bp AXBoxAVPl fragment had been amplified, before the remaining product mix
was precipitated in ethanol. The resulting undigested insert AXBoxAVPl DNA pellet
was resuspended in 20 fû of TE buffer and the DNA concentration estimated by Ai^o
measurements. The concentrated DNA stock was stored at -20°C.
Restriction digestion with £coRI and Pstl was performed sequentially on 5 /xg
of insert DNA to generate cohesive-ended double-digested insert DNA for a forced
directional cloning into a similarly digested pAX4b-H vector. The double digested insert
and vector DNA samples were purified separately by the GENECLEAN II procedure.
Ligation reactions were set up with Insert to Vector ratios of 1:1, 2:1 and 4:1 and
performed under conditons as outlined earlier for cloning HAV genes into the pAX
Next, freshly prepared electrocompetent host E.coli UT2300 cells were

vector.

transformed with DNA from the ligation reaction by electroporation. Recombinants on
SOC-Amp plates were identified and selected for the subsequent plasmid DNA
extraction, verification of the presence of insert AXBoxAVPl insert by PCR and for
IPTG induction studies by methods similar to those described in Chapter I. Conditions
for PCR were optimized for the pBoxAVPl template-AXBOXAVPIPS and AXVPINS
primer set combination by using the Opti-Prime™ kit (Stratagene, La Joila, CA) as
follows.
A structured trial-and-error optimization of buffer conditions for amplifying
insert AXBoxAVPl DNA from pAXBoxAVPl template was performed by constituting
12 individual 50 fi\ PCR reaction mixtures, each with identical template-primer-dNTPAmpliTaq polymerase content but with a different formulation of the PCR reaction
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buffer, as outlined below. A master mix consisting of 12.5

of Master Mix buffer (20

mM Tris-HCl, pHS.O, 250nM EDTA), 12.5 fil each of dATP, dTTP, dCTP and dGTP
(from individual dNTP stock solutions, each at 10 raM concentration), 2.5 ng of each
oligonucleotide primer (AXBOXAVPIPS and AXVPINS), 1.2 fig of pAXBoxAVPl
template DNA, 30 U of AmpliTaq DNA polymerase and %fil of sterile, redistilled water
to make up a final volume of 565 fil was prepared in a microfuge tube on ice. A set of
12 GeneAmp* thin-walled PCR reaction tubes were labeled 1-12 and 45 fil of the master
mix dispensed into each. Next, from a set of twelve lOx PCR reaction buffers, each
containing 100 mM Tris-HCl but different from the others in final pH, total MgCl; and
KCl concentrations (Figure 16), a 5 ^1 volume was added to the correspondingly
numbered PCR reaction tube. The lOX PCR Reaction buffers were provided with the
Opti-Prime™ kit. The contents of each reaction tube were vortexed and overlaid with 25
^1 of mineral oil before thermal cycling reaction in a GeneAmp Thermal Cycler 480
(Perkin-Elmer Cetus, Norwalk, CT) as suggested in the protocol (Instruction Manual
accompanying the Opti-Prime kit, Stratagene, La Jolla, CA).

Thermal cycling

parameters were as follows : Cycle 1, Dénaturation at 94°C for 3 min followed by
Annealing at 55°C for 2 min followed by Elongation at 72°C for 1.5 min ; Cycle 2-30,
Dénaturation at 94°C for 1 min. Annealing at 55°C for 1 min and Elongation at 72°C for
1.5 min.

After an additional

8

min elongation step at the end of cycle 30, each

samplewas cooled to 4“C, the aqueous layer from each reaction tube containing the PCR
products was separated from the mineral oil overlay and transferred to a fresh labeled
microfuge tube. Ten fil of each of the 12 PCR samples was subjected to 2% agarose gel
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10 mM Tris-HCl

MgClj

pH 8.3

1.5 mM

Buffer # 1

Buffer # 2

pH 8.3

3.5 mM

Buffer # 3

Buffer # 4

pH 8.8

1.5 mM

Buffer # 5

Buffer # 6

pH 8.8

3.5 mM

Buffer # 7

Buffer # 8

pH 9.2

1.5 mM

Buffer # 9

Buffer # 10

pH 9.2

3.5 mM

Buffer # 11

Buffer# 12

25mMKCl

75 mM KCl

Figure 16. Buffer matrix of the Opti-Prime™ PCR Optimization Kit (Stratagene, La
Joila, CA). The final reaction concentrations of the various buffer components are
shown in the top row. The first column specifies the pH of Tris-HCl in the buffers
appearing in the last two colums. The second column specifies the final concentration
of MgClj in the buffers appearing in the last two columns. The last two columns specify
the final KCl concentration of each buffer. For example, buffer #5 is lOmM Tris-HCl
(pH . ), l.SmM MgClj and 25mM KCl.
8

8
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electrophoretic analysis to determine the optimal pH, MgC12 and KCl concentrations
for each DNA template and primer set.
IPTG-induction of Protein Expression in Recombinant E .coli carrying
pAXBoxAVPl : Recombinant E.coli UT2300 cells were grown to log-phase in LBAmp-Glucose medium at 30°C with vigorous shaking following the procedure described
(Chapter I; Materials and Methods). Prior to addition of IPTG, cells were removed from
under glucose repression by centrifugation and resuspended in fresh LB-Amp without
glucose.

One ml samples of non-induced and IPTG-induced cells were collected

periodically for upto 4 h post-induction. Whole cell lysates were prepared for SDSPAGE analysis from cell pellets and stored at -20°C until required. Aliquots of whole
cell lysates were resolved on 1.5 mm gels and either Coomassie Blue stained to screen
for any IPTG-induced protein bands or transferred onto nitrocellulose for Western Blot
analysis with anti-HAV antibodies as previously.
Preparation of Recombinant Protein Samples for a Lim ited N-terminal
Protein Sequencing Analysis: Whole cell lysates of E.coli recombinant BoxA VPl were
resolved on 14 X 16 cm vertical slab gels by preparative denaturing gel electrophoresis
using a Standard Cooled Dual Vertical Slab Unit-SE 600 Series (Hoefer Scientific
Instruments, San Francisco, CA). Two SDS-polyacrylamide gels (12.5%) of 0.75 mm
thickness were set up fully immersed in the SDS-PAGE running buffer (0.025 M Tris,
0.192 M Glycine, 0.1% SDS, pH 8.3) in the SE 600 electrophoresis unit following the
manufacturer's instructions (Basic techniques and Exercises in Electrophoresis, Hoefer
Scientific Instruments, San Franscisco, CA) and aged for 24 h. The gels were then pre
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run in the presence of the SDS-PAGE running buffer containing 0.1 mM sodium
thioglycollate (Sigma Chemical Company, St.Louis, MO) for 30 min at 30 mA before
loading the protein samples. Whole cell lysate samples of IPTG-induced BoxA VPl in
SDS gel-loading buffer were heated in a boiling water bath for 90 sec, centrifuged at
12,000 X g for 2 min and loaded at 50 /ig of total protein onto individual lanes.
Electrophoresis was carried out at 10 mA overnight. One gel was Coomassie Bluestained while the other was subjected to electroblotting onto a PVDF membrane in a
procedure similar to the one described already for Western blotting.
For electroblotting, the SDS-PAGE gel was pre-equilibrated for 15 min in CAPS
transfer buffer [10 mM CAPS (3-[Cyclohexylamino]-l-propanesulfonic acid]; Sigma
Chemical Company, St.Louis, MO), 10% methanol, pH 11.0] and placed on a 14 X
14 cm piece of WESTRAN™ PVDF protein transfer and sequencing membrane
(Schleicher & Schuell, Keene, NH) that had been briefly immersed in 100% methanol
(2-3 sec), rinsed with distilled water (2-3 sec) and also pre-equilibrated for 15 min in
CAPS transfer buffer. Next, the gel and the membrane were sandwiched together with
3MM paper sheets and filter pads as done before for Western blotting with nitrocellulose
membranes. The assembled sandwich was then placed into a hinged blotting cassette and
electroblotted using a Transphor Tank Electro-Transfer Unit model TE-50 (Hoefer
Scientific Instruments, San Franscisco, CA) at a constant current o f 0.5 A for 1 h.
Following transfer, the membrane was rinsed several times with sterile double
distilled deionized water. Protein bands were visualized either by transillumination by
rewetting the blot in

2

0

% methanol and was placed on a white-light illumination box or
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by reversible staining with 0.5% Ponceau Red (Sigma Chemical Company, St. Louis,
MO) in 1 % acetic acid. The protein bands of interest were identified by comparing to
molecular weight standards included on the gel, excised with a clean scalpel, cut into 2-3
mm^ fragments, and placed into sterile 0.5 ml microfuge tubes. The samples were sent
to Dr.Richard G. Cook, Director, Protein Chemistry Core Facility, Baylor College of
Medicine, Houston, TX and a limited (20 cycles) N-terminal Amino acid sequencing
was performed subsequently on 150 pmoles of the recombinant protein.
BLAST and BLITZ Protein Sequence Homology Searches:

Protein sequence

information obtained by the limited N-terminal aminoacid sequencing was compared
with known protein sequences by performing online, non-redundant database searches
using a Gateway 2000 P5-75 personal computer (Gateway 2000, Inc., N. Sioux City,
SD). The various protein and nucleotide sequence databases for BLAST (Basic Local
Alignment Search Tool) search are accessible on the internet at the worldwide website
"http://www.ncbi.nlm.nih. gov/ BLAST" by the National Center for Biotechnology
Information, Bethesda, MD.

Similarly, the BLITZ-Version 1.5 search tool for

comparison of the sequence in question against the latest version of the Swiss-Prot
Protein

Sequence Database,

is

available

"http://www.ebi.ac.uk/searches/blitz.html".

and

online

at

the

web

address

BLITZ is an automatic electronic mail

server for the Mpsrch program of Shane Sturrock and John Collins, Biocomputing
Research Unit, University of Edinburgh, UK.
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RESULTS
A positive strand PCR primer for amplification of HAV VPl sequence which also
contained the E.coli rm operon anti-terminator BoxA sequence upstream of the
translational start codon for VPl was designed and used successfully to amplify insert
BoxA-VPl DNA from plasmid, pGEM-HAV. The PCR amplified insert DNA was then
cloned into pAX and E.coli cells carrying recombinant pAX-BoxAVPl plasmid were
subjected to PCR verification for the presence of BoxA-VPl insert sequence prior to
IPTG induction (Figure 17), Next, SDS-PAGE analysis of IPTG-induced BoxA-VPl
clones revealed the appearance of a new, 33-kD protein band following induction of
BoxA-VPl clones (Figure 18).

However, in stark contrast to the earlier induction

experiments with V P lIl clones without the BoxA modification of insert VPl sequence,
the fusion protein band (expected size ~ 150 kD) was not seen. Western Blot analysis
of whole cell lysates of IPTG-induced BoxA-VPl showed the 33-kD protein reacted
weakly or failed to react with any of the anti-HAV antibodies (rabbit, mouse or human
sources) or with rabbit polyvalent anti-p-galactosidase antibody. The 125-kD protein
band corresponding to non-fusion form of p-galactosidase continued to persist in the
IPTG-induced BoxA-VPl lysates.
N-terminal amino acid sequence analysis performed at the Protein Sequencing
Facility, Baylor College of Medicine, revealed that the 33-kD protein possessed the
sequence NH^+-MRLASRFGRYNSIHRERPLT-COO which did not correspond to any
stretch in either E.coli p-galactosidase or HAV VPl protein sequences. Therefore,
theN-terminal sequence of the 33-kD protein was analyzed further by comparison against
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Figure 17. Agarose gel analysis of HAV VPl insert DNA amplified by PCR (i) from
parent plasmid pGEM-HAV prior to cloning and (ii) from recombinant plasmids
pAXBoxAVPl and pAXVPlIl following successful cloning and transformation o f E.coli
UT2300 cells. Lane 1: BioMarker low molecular weight DNA standard. Lane 2;
BoxA VPl DNA amplified from pGEM-HAV template, Lane 3; Insert DNA amplified
from pAXBoxAVPl template, Lane 4: VPl DNA (without BoxA sequence) amplified
from pGEM-HAV template, and Lane 5: Insert DNA amplified from pA X V PlIl
template. The samples in lanes 4 and 5 were prepared from positive control reactions.
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Figure 18. SDS-PAGE analysis of fusion proteins expressed from recombinant plasmid
pAX4b-BoxAVPl. Whole cell lysates of recombinant host E. coli UT2300 cells from
various time points before and after IPTG induction were examined. Lane I : Host cells
without any vector. Lane 2: Biorad molecular weight marker. Lane 3: Cells under
glucose repression. Lane 4: Cells at 1 mM IPTG induction (Tq). Lane 5: 1 h after
induction. Lane : 2 h. Lane 7: 3 h. Lane : 4 h. Lane 9: Rainbow™ molecular
weight marker. Lane 10: Host cells carrying vector pAX4b+ .
6

8
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sequence data for a total of 208,180 sequences through a computerized search of protein
sequence databases [Genebank, PDB, SwissProt, SPupdate and PIR using the basic
BLAST algorithm (Altschul, et al., 1990) and the BLITZ/MPsrch program version 1.5
(Sturrock and Collins, 1993]. Homologous protein sequences obtained following the
database search are listed in Figure 19. The sequence of the 33 kD protein displayed a
97% identity with the N-terminus of a highly conserved open reading frame (0273) that
lies within the leading region adjacent to the origin of transfer (OriT) of conjugative
Plasmid F (Loh, et a i,

1989), a 97% homology with a hypothetical 32 kD protein

sequence (gene YFJQ) encoded by the E.coli ALPA-GABD intergenic region (Plunkett,
1995), a 89% homology with the N-terminus of a hypothetical 32 kD protein sequence
from the leading region of the E.coli resistance plasmid Rl(Graus, et al., 1990), and a
78% homology with protein derived from an open reading frame, ORF298, within the
Rhs elements of E.coli K12 (Zhao, et al., 1993; Takemoto, et al., 1996). The Rhs
elements are accessory genetic elements that share extensive homology with one another
and are present in many but not all wild-type E.coli isolates. In addition, the N-terminal
sequence of interest displayed varying degrees of homology (Table 4 & 5) with short
motifs from a diverse set of previously documented protein sequences such as E.coli
ADP-ribosyltransferase (Fitzmaurice, et al., 1989), Bordatella pertusis Outer membrane
usher protein FIMC precursor (Willems, et al., 1992), Sindbis virus structural
polyprotein (Strauss, et a i, 1984), a hypothetical 31.4 KD protein encoded by E.coli
gene f268b in the TSR-MDOB intergenic region (Burland, et al., 1995), an inclusion
body matrix protein (viroplasmin) from Cauliflower Mosaic Virus (Stratford, R., et al..
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(i)
(ii)
(iii)
(iv)
(v)
(vi)
(vii)
(viii)
(ix)
(x)
(xi)

1

1

38
1

155
123
490
485
96
37
901

MRLAS
MRLAS
MRLAS
MRLAS
RLAS
S

RFGGY
RFGRY
RFGRY
RFGRY
RFGAA
RFGLF
RFGLY
RLKETTAGY
KFGRY
GGS SYGQY

NSIHR ERPLT
NSIHR ERPLT
NSIHR ERPLT
NSIRR ERPLT
NLIRR DRPLT
PTFHR E-PIT
SLLGR ERP
ITMHR PRP
NLIHS EK
NSLHR ETPV
EAMHN QMPMT

2

0

2

0

57
2 0

173
137
502
501
107
47
410

Figure 19. Comparison of sequences in search for homology of the N-terminal
sequence of the 33-kD protein expressed in recombinant E.coli BoxA-VPl cells, with
other protein sequences retrieved from protein databases using the basic BLAST or
BLITZ algorithms. The actual position occupied by each amino acid residue in a given
protein sequence can be inferred by referring to the Indo-Arabic numerals preceding and
following each sequence. The mismatched aminoacid residues are depicted in bold. A
gap in a given sequence (necessisated only for the sake of comparison, not present in the
actual protein) is shown by (-). Sequences listed and their original source are as
follows: (i) the N-terminal sequence o f the 33 kD protein/recombinant E.coli BoxAV P l clones, (ii) Hypothetical protein 273 (OriT 5' region)/E.co& Conjugative Plasmid
F, (iii) Hypothetical Gene YFJQ Protein from the ALPA-GABD intergenic region!E.coli,
(iv) Hypothetical 32K Protein/£.coü Plasmid R l, (v) Unknown Reading Frame lE.coli,
(vi) ADP-Ribosyltransferase/Rhodospirillum rubrum, (vii) Outer Membrane Usher
Protein FIMC VreoxxsovlBordeteUa pertusis, (viii) Sindbis Virus Structural
Polyprotein/Alphaviruses; Togaviridae; ss-+RNA enveloped viruses, (ix) Hypothetical
31.4 KD Protein in TSR-MDOB Intergenic Region (F268B)/J?.co/i, (x) Inclusion Body
Matrix Protein (Viroplasmin)/Cauliflower Mosaic Virus; Caulimoviridae; dsDNA non
enveloped viruses, and (xi) Nuclear DNA-binding Protein/dead ringer gene
product/Drosophila melanogaster.
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Table 4. Analysis of N-terminal Sequence of the 33 kD Recombinant Protein from E.coli

I

Description/Source

Length

Hypothetical Protein 273
(OriT 5' region)/£. co/(

273

Db
Qy

++ + + + +++ + +++++ ++ + + +
1 MRLAS RFGRY NSIHR ERPLT 20
1 MRLAS RFGGY NSIHR ERPLT 20

273

Db
Qy

+ ++ ++ ++ + + +++++ + ++ ++
38 MRLAS RFGRY NSIHR ERPLT 57
1 MRLAS RFGGY NSIHR ERPLT 20

273

Db
Qy

++ + + + ++ + + ++-F + + ++ + +
1 MRLAS RFGRY NSIRR ERPLT 20
1 MRLAS RFGGY NSIHR ERPLT 20

425

Db
Qy

++++ +++
+ + + 0++++
155 RLAS RFGAA NLIRR DRPLT 173
2 RLAS RFGGY NSIHR ERPLT 20

276

Db
Qy

123
4

+ +++ O O ++ + +0+
S RFGLF PTFHR E- PIT 137
S RFGGY NSIHR ERPLT 20

873

Db
Qy

490
5

++ + + o o + + ++
RFGLY SLLGR ERP 502
RFGGY NSIHR ERP 18

1245

Db
Qy

++
++ 00++ ++
485 RLKE TTAGY ITMHR PRP 501
2 RLAS RFGGY NSIHR ERP 18

268

Db
Qy

96
6

522

Db
Qy

37
8

Db
Qy

395
5

Plasm id

2

3

4

F

Hypothetical Gene YFJQ
Protein from the ALPAGABD intergenic
region/F. co/i
Hypothetical 32K
Protein/E. co/i Plasmid R l
Open Reading Frame within
Rhs elements !E.coli

5

ADP-Ribosyltransferase/
Rhodospiriilum rubrum

6

7

Outer Membrane Usher
Protein FIMC
Precursor/0on/ete//a pertusis
Sindbis Virus Strucmral
Polyprotein/Alphavinises;To
g-aviridae; ss-+RNA
enveloped viruses

8

9

Hypothetical 31.4 KD Protein
in TSR-MDOB Intergenic
Region (F268B)/£. co/i
Inclusion Body Matrix Protein
(Viroplasmin)/Cauiiflower
Mosaic Virus;
Caulimoviridae; dsDNA non
enveloped viruses

10

Nuclear DNA-binding
Protein/dead ringer gene
product/Drosophila
melanogaster

Alignment

901

0 + + + + + ++ +o
KFGRY NLIHS EK 107
RFGGY NSIHR ER 17

++ ++0++ + +0
GG- NSLHR ETPV 47
GGY NSIHR ERPL 19

+ 0+0+
00+ O +0+
S SYGQY EAMHN QMPMT 410
S RFGGY N SI HR E RPL T 20

ABBREVIATIONS: D b = Sequence from Protein Sequence Database; Q y = Query
Sequence derived from the 33 kD recombinant protein; + = Perfect Match; 0 = Partial
match or Conserved Substitution.
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Table 5. Results of Sequence Homology Search for N-terminal Sequence of the 33
kD Protein derived from E.coli BoxAV Pl Clones with Protein Sequence Databases.
Description

Length

Residue
Matches

Partial
Matches

Mismatches

% Match

Predicted
Number

Hypothetical Protein
273 (OriT 5' region)E .coli Plasmid F

273

19/20

0/20

1/20

97

4.07e-20

Hypothetical Gene
YFJQ Protein/E. co/i

310

19/20

0/20

1/20

97

4.07e-20

Hypothetical 32K
Protein-E. co/t Plasmid
Rl

273

18/20

0/20

2/20

89

5.40e-17

425

14/19

1/19

4/19

78

3.54e-09

ADPRibosyltransferase

276

9/16

3/16

3/16

41

4.60e-01

Outer Membrane Usher
Protein FIMC
Preciursor

873

8/13

2/13

3/13

39

1.66e-FOO

Sindbis Virus Structural
Polyprotein

1245

8/17

2/17

7/17

39

1.66e+00

268

7/12

2/12

3/12

39

1.66e-t-00

522

8/11

2/11

1/11

39

1.66e+00

901

6/16

6/16

4/16

38

3.09e4-00

Open Reading Frame
within Rhs elements
{E.coli)

Hypothetical 31.4 KD
Protein in TSR-MDOB
Intergenic Region
(F268B)-E.co/i
Inclusion Body Matrix
Protein (Viroplasmin)
D.melanogaster

Nuclear DNA-binding
Protein/dead ringer
gene product
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1988), and a Drosophila melanogaster nuclear DNA-binding protein/dead ringer gene
product (Gregory, et al., 1996). A non-recombinant expression in E.coli of a protein
corresponding to these sequences has not been documented previously.
DISCUSSION
Earlier attempts at p-galactosidase-HAV VP fusion protein expression and their
affinity-based purification were frustrated by the simultaneous appearance of

p-

galactosidase, apparently without the viral protein components. Further, the anti-HAV
antibodies displayed cross reactivity with native E.coli p-galactosidase when used to
verify antigenicity of the recombinant HAV proteins by Western Blotting and ELISA.
Subsequent attempts to express the HAV capsid proteins in the non-fusion form from
various prokaryotic vectors were unsuccessful and found to induce toxic effects in host
E.coli cells. Therefore, various strategies were considered to improve the efficiency of
fusion protein expression from recombinant pAX vectors in E.coli and efforts were
initiated simultaneously to identify suitable vector-host E.coli systems for expression of
HAV capsid proteins in a non-fusion form.
Premature transcriptional termination of recombinant mRNA synthesis was one
explanation considered which could lead to expression of the non-fusion form of pgalactosidase in addition to the fusion proteins. Hence, the hypothesis that incorporation
of the E.coli rm operon antiterminator sequence, BoxA, upstream of the HAV VPl
coding sequence, could lead to improved transcription of full length messages for fusion
protein and render overall expression of fusion protein more efficient, was tested. If

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

81

successful, this approach would possibly minimize expression of the non-recombinant pgalactosidase protein encountered previously.
However, contrary to expectations, induction of fusion protein expression from
recombinant E.coli carrying plasmid pAXBoxAVPl resulted in overexpression of a new
-33 kD protein species and no expression of the expected -150 kD p-galactosidaseH A W P l fusion protein. Host cells grown in the presence of glucose and prior to
addition of IPTG did not display either -125 kD p-galactosidase or the 33 kD proteins
in detectable levels when analyzed by SDS-PAGE. The appearance of both protein bands
on SDS-PAGE, following IPTG induction, strongly suggested the possibility of
temporally synchronized fiision-protein expression and post-translational processing
events in vivo. Host E.coli proteases could have cleaved the fusion protein into its
constituent ~ 125 kDp-galactosidase and the 33 kD HAV VPl components. However,
subsequent Western Blot studies were inconclusive and a limited N-terminal aminoacid
sequencing of the 33 kD protein yielded sequence information that did not corroborate
either the cloned HAV sequence or any putative protein-encoding open reading frame
(ORE) present on the plasmid pAX4b+ vector. Rather, amino acid sequence of the 33
kD protein, upon a computerized search of protein sequence databases, showed varying
degrees of homology with a spectrum of protein sequences from diverse sources (Figure
19).
Nineteen of the possible twenty amino acid residues in the N-terminal region
of the 33 kD protein displayed exact matches with the N-terminal protein sequence
derived from a putative open reading frame, ORF273, within the origin of transfer
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(OriT) or the leading region of the E.coli K12 conjugative F plasmid (Loh, et at., 1989).
The leading region, which is that portion of plasmid DNA that is transferred first to the
recipient cell during conjugation, including ORF273 shares extensive sequence homology
with the leading regions of related plasmids such as the IncFII R group of plasmids R l,
R6-5 and RlOO (Sharp, et al., 1973) as well as a wide range of unrelated, non-F-like
conjugative plasmids belonging to various Incompatibility (Inc) groups (Bergquist, 1988;
Bukhari, et al., 1977). The well-conserved homology of the leading region may be
relevant in conjugal DNA transfer and plasmid maintainence. Analysis of the putative
ORF273 suggests that upon transcription and translation, this ORF could encode a
mainly hydrophilic polypeptide of - 3 2 kD residing in the cytoplasm. In addition, the
putative ORF273 appears to share limited homology, mostly within the N-terminal
region, with several prokaryotic DNA-binding proteins involved in replication functions
such as the E.coli single-stranded DNA-binding (SSB) protein and the F plasmid SSB
(Chase, et al., 1983). SSB activity is essential in protecting DNA from nucleases during
conjugal plasmid DNA transfer and DNA replication.
In addition to a shared homology with the F plasmid ORF273 derived protein
sequence, the N-terminal sequence of the 33 kD protein of interest showed significant
homology with proteins encoded by E.coli chromosomal DNA and E.coli plasmid R l.
The sequence also exhibited limited homology with a diverse set of proteins, both
procaryotic and eukaryotic in origin, and with potential for binding nucleotides or DNA
(Table 4 & 5).
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The reasons for apparent lack of expression of HAV VPl component o f the fusion
protein and for the evident expression of a 33 kD protein with putative DNA-binding
activity in E.coli AXBoxAVPl clones remain unclear. In this context, we have to note
that the antiterminator BoxA sequence is present within an untranslated leader region in
the E.coli rrn operon.

In contrast, in our construct of the recombinant plasmid,

pAXBoxAVPl, the antiterminator sequence was placed within a open reading frame
contiguous to the hinge region and following the p-galactosidase gene but upstream of
the HAV VPl gene.

Also, caution was exercised during PCR amplification and

preparation of insert VPl DNA to ensure that the BoxA sequence would itself remain in
the appropriate reading frame without causing any disruption in the ability to translate
the downstream VPl sequence.

The boxA sequence would merely lengthen the

recombinant protein in its hinge region by four amino acid residues which was assumed
to be innocuous. The hinge region of the recombinant protein, which is designed to keep
the p-galactosidase and the foreign protein components of the fusion protein discrete, is
derived from collagen and contains recognition sites for collagenase, endoproteinase Xa
and similar proteases (Markmeyer, et al., 1990). It was possible that a full length fusion
protein was expressed in the host cells subsequent to IPTG-induction, but the VPl
component was degraded soon after due to host proteolytic activity, leaving behind the
-125 kD p-galactosidase. The initial cleavage may have been aided by extension of the
rigid hinge region of the expressed recombinant protein due to additional amino acid
residues contributed by the boxA sequence. Also, another possibility is that expression
of viral protein may have been toxic to host E.coli cells.
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Another possibility is the misincorporation of nucleotides during the preparation
of HAV VPl insert DNA by PCR. The use of the AmpliTaq DNA Polymerase, which
lacks the 3’-5' proofreading exonuclease activity, in PCR may be accompanied by
incorporation of missense and nonsense errors within protein coding sequences of
clonedDNA inserts at a rate of 10"* per base per cycle (Lundberg, et a i , 1991; Barnes,
1994). Such errors may lead to premature termination of translation or synthesis of
proteins with altered amino acid sequences resulting in abnormal, truncated proteins or
peptides. Also, a rapid, overexpression of recombinant proteins, whether normal or
abnormal, may not allow for proper folding into their native, stable conformations.
Instead, the improperly folded proteins may begin to aggregate, become sequestered into
inclusion bodies or begin to precipitate in vivo. Such events can potentially trigger the
SOS or heat shock responses in host E.coli cells and induce host proteases which degrade
the recombinant proteins (Gottesman, 1984; Goff and Goldberg, 1985; Meyer, et al.,
1985; Goldberg and Goff, 1986). One fallout of the SOS response could have been the
induction of the 33 kD protein of interest although its purpose during such events
remains to be defined.
The gene responsible for expression of the 33 kD protein in the recombinant
AXBoxAVPl cells remains to be identified. Plasmids pAX4b+ or pGEM-HAV were
ruled out as possible candidates by a careful study o f their nucleotide sequences. The
genotype of host E.coli UT2300 cells, to the best of our knowledge, does not indicate
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the presence or absence of any F or F-related plasmids which could have been potential
sources (Elish, et a i, 1987). Still, the presence of cryptic F or related plasmids cannot
be ruled out. In addition, there is a much closer correspondence of the exact positions
of individual amino acid residues (the first twenty residues from the N-terminus for each)
between the sequence of the protein in question and those derived from plasmids F and
R l, as versus the sequences derived from E.coli chromosomal DNA such as the gene
YFJQ encoded hypothetical protein or the hypothetical protein encoded by ORF298
within the Rhs elements of E.coli K12. Hence, it is very likely that an unreported F or
similar plasmid, present within the host cells as an episome, is the likely origin for the
33 kD protein seen in E.coli AXBoxAVPl cells.

However, the reasons for over

expression of such a protein upon IPTG induction of host cells to express fusion proteins
still remain obscure. It is interesting to note that no such protein was evident upon SDSPAGE analysis when we induced overexpression of HAV V P l, VP2 and VP3 as pgalactosidase fusions without additional residues owing to the antiterminator BoxA
sequence (Chapter I, this dissertation) and that a non-recombinant overexpression of the
ORF273 protein, even with F plasmid containing host cells, has not been hitherto
reported.
In conclusion, our attempts to improve the expression of p-galactosidase-HAV
VPl fusion protein through the inclusion of an E. coli antiterminator sequence upstream
of the viral DNA insert, although unsuccessful, revealed a rather novel phenomenon with
an overexpression of a putative single-stranded DNA-binding protein, the reasons for
which remain unclear. The expression of the 33 kD protein with putative DNA-binding
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properties, although much needs to be learned about its exact nature and functions, may
have been triggered as part of a general stress response (such as akin to the heat shock
response) to overexpression of seemingly toxic proteins in the host cells. Such a protein
may be essential for replication or maintainence of the relevant plasmids that it is derived
from, while within host cells that are undergoing a stress-induced, active SOS response.
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INTRODUCTION
Recombinant DNA technology bas permitted production of high-levels of various
proteins in both prokaryotic and eukaryotic systems, thereby making available many
proteins whose supply from natural sources were previously limited. Escherichia coli
still remains the leading host organism for expression of heterologous proteins due to
several reasons such as, a short generation time of cells, low-cost culture conditions
essential for growth and ease of manipulation by simpler techniques as compared to the
more time-consuming and expensive methods like tissue culture. Proteins over-expressed
and purified from E.coli can be subsequently used, (i) to study their properties such as
structure, biological activity, antigenic and immunological potential; (ii) to produce
antibody reagents useful in research and diagnostics; (iii) as replacements in therapy of
human diseases, for example, recombinant insulin for diabetes mellitus, and human
somatostatin (hGH) for growth hormone deficiency; and (iv) in the development of
safer, subunit vaccines (Itakura, eta l., 1977; Goeddel, eta l., 1979a; Goeddel, e ta l.,
1979b) . However, for an overproduction of a heterologous protein in E.coli following
a successful cloning of the gene encoding the protein o f interest, several crucial events
have to occur in an optimal fashion.

These include an efficient transcription and

translation of the cloned gene, and stabilization of the resulting mRNA and the protein
product. In addition, the expressed protein should not be very toxic to the host cells.
In this context, each gene can present its own unique expression problems. Despite
standard cloning procedures having become routine and a large variety of host/vector
systems being available, no single set of procedures is currently available that can
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guarantee successful production of every protein in an useful format. Hence, in the
absence of a universal solution when difficulties in expression of recombinant proteins
are encountered, an investigator has to apply a host of strategies, some novel and some
already well-documented, in seeking appropriate redressai of the individual and specific
expression problems. (Goeddel, 1990; Das, 1990).
In our efforts to express HAV capsid proteins as E.coli p-galactosidase fusions,
we discovered problems such as an apparent co-expression of recombinant fusion protein
and the non-recombinant p-galactosidase, a cross-reactivity of anti-HAV antibodies with
native p-galactosidase and potential toxic effects induced in host cells by the recombinant
proteins or their overexpression (Chapter 1, this dissertation). Our subsequent attempt
to improve the transcription of the recombinant genes through introduction of an E.coli
antiterminator sequence also was not successful (Chapter 2, this dissertation). Hence,
in continuing to pursue our primary objectives of cloning and expression of HAV capsid
proteins in E.coli, we decided to explore alternatives such as new cloning vectors and
host strains. In addition, we refocused our studies toward expression of HAV capsid
proteins in their native forms and as chimeric proteins displayed on the surface of host
E.coli cells and on the surface of filamentous coliphages that infect and replicate in
E.coli.
Plasmid pT7-7 is a prokaryotic expression vector that allows cloning of genes for
high-level expression and contains the bacteriophage T7 RNA polymerase promoter <j>10
upstream of a multiple cloning site (Figure 20). The T7 promoter sequence is rarely
encountered in DNA unrelated to that from phage T7 and the T7 RNA polymerase is
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colEl Ori
RBS
MCS

pT7-7
2473 bps
bla

T7 genelO promoter______
77:22896 5’-AAA1TAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAA
RBS
M A R I
R A R G S
TTTTGTTTAAACTTTAAGAAGGAGATATACATATG GCT A G A ^^^ C GC GCC CGG GGA TCC
S R
V D L Q P K L I
I
TCTAGA GTC GAC CTG CAG CCC AAG CTT ATC ATC GAT-3' 77:22972
C la llB sp im

Figure 20. A schematic diagram of plasmid vector pT7-7 used in cloning HAV capsid
genes for expression in a non-fusion format. Sequence of the cloning region containing
the phage promoter, ribosome binding site, translational start codon (ATG) and the
multiple cloning site are shown underneath the plasmid diagram. P*10=Phage T7
gene 10 promoter which is recognized by T7 RNA Polymerase only; RBS= Ribosome
Binding Site; MCS= Multiple Cloning Site which includes EcoRl and Clal/Bspl06l
restriction enzyme sites;
bla= beta-lactamase gene for antibiotic selection of
recombinants; colEl O ri= Origin of plasmid DNA replication.
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uniquely and extremely specific for this particular promoter (Dunn and Studier, 1983).
Since foreign genes cloned under the transcriptional control of a T7 promoter will not
be expressed until the T7 RNA polymerase is made available, the pT7-7 vector is suited
well for a selective cloning and amplification of genes whose product may be potentially
toxic to the host cells, such as those encoding HAV capsid proteins, and for their
subsequent controlled exclusive expression (Tabor and Richardson, 1985). The T7 RNA
polymerase exhibits at least a five-fold higher process ivity ( —300 ribonucleotides per
second) compared to that of E.coli RNA polymerase ( ~ 50 bases per second). The phage
transcribes DNA independent of translation, unlike its E.coli counterpart, thereby making
the T7 expression system ideal for genes with a potential preponderance of low-usage
codons.

Transcription of the cloned genes from recombinant pT7-7 may occur

relentlessly, if the T7 RNA polymerase is introduced into the host cells carrying the
plasmid, and target RNA can accumulate to levels comparable to that of ribosomal RNA
(Studier, eta l., 1990).
E.coli B strain BL-21 are host cells deficient in certain proteases such as the Ion
protease and ompT outer membrane protease (Studier and Moffat, 1986). Both of these
proteases can degrade foreign proteins expressed in E.coli, and potentially jeopardize
expression and purification procedures. BL-21 (DE3)pLysS are BL-21 derivatives that
carry a plasmid, pLysS, and are lysogenic for a lambda bacteriophage DE3.
Bacteriophage DE3 is a lambda phage derivative that carries the phage 21 immunity
region, the la d gene and the /acUV5-driven T7 RNA polymerase expression cassette
(Studier and Moffatt, 1986). Plasmid pLysS, derived from pACYC184, carries an
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expression cassette for a low level expression of phage T7 lysozyme which binds and
inhibits T7 RNA polymerase if a premature, low-level "leaky" production of the
polymerase were to occur (Chang and Cohen, 1978).

Thus, a tighter control of

expression is exerted until expression of T7 RNA polymerase can be induced by addition
of IPTG (Doherty, et al., 1994). Recombinant pT7 derived plasmids carrying certain
toxic target genes reportedly are tolerated better and unstable plasmids become stable in
host strains carrying the gene for T7 lysozyme (Studier, et al., 1990).
The SurfZAP™ vector is a bacteriophage vector derived from the Lambda
ZAP® n vector which is suited for cloning and expression of foreign protein sequences
on the surface of single-stranded filamentous (fl or M13) phage as fusions with the
aminoacids 198-406 (membrane-anchoring domain) of its minor coat protein, cpin
(Short, etal., 1988; Parmley, and Smith, 1988; Amberg, e t al., 1993; Smith and Scott,
1993).

Cloning into bacteriophage lambda derived vectors with the subsequent

packaging and infection of host E.coli allows for a rapid and easy amplification of
recombinant DNA, including those containing genes for potentially toxic proteins, at an
efficiency that exceeds that of plasmid transformation by 100-fold. The cloning site for
foreign DNA insertion is contained within a phagemid, pSurfscript™ SK (-), which itself
is an integral part of the larger XSurfZAP™ vector (Figure 22) . Since the pSurfscript
is bound by the initiation (I) and termination (T) sequences of the phage fl origin of
replication, the entire phagemid (3.64 kb in size without any insert DNA) can be excised
in vivo following infection of the host E.coli with helper fl or M13 phage (Dotto, et al.,
1984; Short and Sorge, 1992). Subsequently, the excised phagemid containing phage fl
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Figure 21. A schematic diagram representing relevant regions of SurfZAP™ (Stratagene
Corporation, La Jolla, CA) vector and its derivative, pSurfscript™ employed in cloning
for surface expression in E.coli and chimeric coliphages. Amp=Ampicillin Resistance
marker; lacZ=Cloning region containing Natl and Spel restriction enzyme sites for target
foreign DNA insertion; colEl O ri= Origin of plasmid DNA replication; and fl
O ri= Origin of phage fl replication.
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or M13 origin of replication, bacterial colEl origin, and ampicillin-resistance marker
(AmpO can be propagated either as double-stranded plasmid DNA within appropriate
host E.coli grown in the presence of ampicillin, or as single-stranded phagemid DNA
that is packaged into M13 particles in the presence of an infecting M13 helper phage.
Recombinant protein expression from the A.SurfZAP™ or its pSurfscript derivative
is under the transcriptional control of the lacZ promoter. Following induction with
IPTG, the expressed fusion protein, containing the pelB leader sequence and the
membrane anchoring domain of cpIU, is directed for embedding into the inner membrane
o f the host E.coli with the foreign protein sequence oriented in the periplasmic space
(Boeke and Model, 1982; Skerra and Pluckthun, 1988). If a helper phage is present
within the host cells, the recombinant protein is utilized in packaging single-stranded
phagemid DNA resulting in chimeric phagemid particles which display fusion protein of
interest on their surface and carry the cloned insert DNA sequence within. Thus, this
vector has been used previously to express on the surface of filamentous phage, a
heterogenous group of peptide and protein molecules including Staphylococcal protein
A, human growth hormone, bovine pancreatic trypsin inhibitor, alkaline phosphatase and
ricin B, and to clone from large random libraries of peptides and antibodies (Smith,
1985; Huse, et al., 1989; Bass, eta l., 1990; Cwirla, eta l., 1990; McCafferty, et al.,
1990; Pluckthun, 1990; Hogrefe, etal., 1993; Kushwaha, e ta l., 1994).
We report here our studies on cloning and expression strategies for HAV capsid
protein production in E.coli, either as non-fusion proteins from a T7 expression system,
or as chimeric proteins from a bacteriophage-derived surface-display system.
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MATERIALS AND METHODS
Vectors, Phage and Bacterial Host Strains: The SurfZAP™ cloning kit which
contains a phage X derived vector, relevant bacterial host strains and f l helper phage was
purchased from Stratagene, La Jolla, CA (Table ). The bacterial host strain which
6

carries the pT7-7 plasmid was kindly provided by Dr. Stanley Tabor, Dept, of Biol.
Chem., Harvard Medical School, Boston, MA (Table 7).
Insert Design for Cloning into SurfZAP™ and pT7-7 Vectors: Oligonucleotide
primers were designed for PCR amplification o f selected HAV capsid genes and to
facilitate the cloning of the resultant DNA into the SurfZAP or pT7-7 vectors. These
primer sequences are listed in Figures 22 and 23. The SurfZAP primers would result
in DNA which contained a 5' Notl site and a 3' Spel site. The need to accomodate a
portion of the pelR DNA leader sequence downstream of the Notl site during PCR
amplification of insert DNA for cloning into SurfZAP vector mandated designing two
partially overlapping 5' (or positive strand) primers. The features of insert DNA that are
essential for a successful cloning are shown schematically in Figure 24. Therefore,
amplification of insert DNA for SurfZAP cloning by PCR required two separate PCR
reactions with a speciBc 5' primer for each and in a defined sequence (i.e. SurfVPlPSl
primer in Reaction 1 and SurfVPlPS2 primer in Reaction 2). Also, different sources of
template DNA (pGEM-HAV in Reaction 1 and SurfVPl DNA from Reaction 1 as
template in Reaction 2) were used. However, a single PCR reaction with pGEM-HAV
as template and with primers for PT7-7 cloning would result in insert DNA with a 5'
EcoRI site and a 3' ClallBsplQ6l site. The primers listed in Figures 22 and 23 were
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Table 6. Bacterial strains, phage and plasmid vectors for
surface expression of HAV capsid proteins
Strains/helper
phage/vectors

Description

Reference

Bacterial
Strains
Escherichia
coli UT2300

azi-6 fliuA23 lacYl leu-6 mlt-1 proCI4 purE42
rpsL109 thi-1 trpE38 tsx-67 entA403 purE*
fliuA^fepA 6lon::lnlO

Elish, et al.. 1988

Escherichia
coli XL-1 Blue

recAl endAl gyrA96 thi-1 hsdRI7 supE44 relAl
lac\¥' proAB lacPZàmlS TnJO (Tef)]'

Bullock, etal., 1987

Escherichia
coli SOLR™

el4 (McrA ) A(mcrCB-hsdSMR-mrr)171 sbcC
recB recJ uvrC umuC::lT\5 (KanO lac gyrA96
relAl thi-1 e n d A l [F' proAB laclqZAMlSY
Su (nonsuppressing)

Stratagene, La Jolla,
CA

Escherichia
coli BL21

E.coli B F dcm ompThsdS{r^ mg.) gal

Weiner, etal., 1994

for in vivo excision of pSurfscript phagemid
from ^.SurfZAP™ vector; single-strand size
- 5 kb

Stratagene, La Jolla,
CA

A.SurfZAP™

a lambda phage derived vector for surface
expression of cloned genes in E.coli

Stratagene, La Jolla,
CA

pGEM-HAV

plasmid carrying HAV DNA including the
capsid genes; used as template in PCR to
generate insert HAV DNA

R.H. Purcell (N.I.H.)

I Helper Phage
ExAssist™
interferenceresistant helper
phage

FbageZPlasmid
Vector and
Template DNA
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Table 7. Bacterial strains and plasmid vectors for phage T7 RNA polymerasedependent expression o f HAV capsid proteins
Strains/helper
phage/vectors

Description

Reference

Bacterial

Suains
Escherichia
coli BL21

Exoli B F dcm ompT hsdS(j^ mg.) gal

Weiner, etal., 1994
Studier, etal., 1990

Escherichia
coli
BL21(DE3)
pLysS

Exoli B F dcm ompT hsdS(Ta. me.) gal
X(DE3) [pLysS CamT

and Template
DNA
pT7-7

plasmid vector for T7 RNA polymerasedependent expression of cloned genes

S.Tabor, Harvard
Medical School, Boston,
MA

pGEM-HAV

plasmid carrying HAV DNA including the
capsid genes; used as template in PCR to
generate insert HAV DNA

R.H. Purcell (N.I.H.)

pSup2021

plasmid carrying the transposon Tn5
including the Kan' gene; used as template in
PCR to generate insert Kan"^ DNA

A.J. Biel, L.S.U., Baton
Rouge, LA
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A. Prim ers for PC R amplification of insert HAV V P l DNA for cloning into the
XSurfZAP™ vector

1. SurfVPlPS2
5'-d(TTGCCTACGfi£fifiCCfiCAGGTCTCCTCCTCTTAGCACAACCA)-3'
Noll

2. SurfVPlPSl
5'-d(TTAGCAGCACAACAACCAGCAATGGCCGTTGGAGATGATTCTGGA)-3'

3. SurfVPlNS
5'-d(ACCCCTACCTCCAClA£ÈICTCAAATCTTTTATCTTCCTCTGATCTAGG)3'

jSpel

B. Prim ers for in vitro excision of pSurfVPl phagemid from recombinant ÀSurfVPl
DNA template

1. FIORIPS
S’-dfCCCGATATCCAACACTCAACCCTATCTO-3'
EcoKV

2. FIORINS
S'-d(CCCGATATCTTCCAGTTTGGAACAAGAG^-3'
EeoKV

Figure 22. Oligonucleotide primer sequences for (A) PCR Amplification of Insert HAV
Capsid DNA for forced directional cloning into the XSurfZAP vector and (B) PCR based
in vitro excision of phagemid pSurfVPl. (FIORI) Phage fl origin of replication, (VP)
Viral peptide, (PS) positive strand primer and (NS) negative strand primer. The
restriction endonuclease recognition sequences (EcoKV, Notl, Spel) within each primer
are underlined.
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T7-VP1-PS2
5'-d(CCCGCTAGAAH£AGGTTGGAGATGATTCTGGAGGT)-3'
EcoKl

T7-VP1-NS2
5'-d(CCCGTCGACATCGATTCAAATCTTTTATCTTCCTCT)-3'
BsplOa/Oal

T7-VP3-PS2
5 d(CCCGCTAGAAHCAGATGATGAGAAATGAATTTAGG) 3
EcoRI

T7-VP3-NS2
S'-d(CCCGTCGACATCGATTTGTGTAGTAACATCCATAGO-3'
BsplOeVOal

T7-KAN-PS1
5'-d(ATGGCTAGAATTCAGATGATTGAACAAGATGGATTG)-3'
EcoRI

T7-KAN-NS1
5'-d(CCCGTCGACATCGATTCAGAAGAACTCGTCAAGAAG)-3'
BsplOSVOal

Figure 23. Oligonucleotide primer sequences for PCR amplification of insert HAV
capsid DNA for cloning into the pT7-7 vector. (KAN) Tn5 gene encoding kanamycin
resistance, (VP) Viral peptide, (PS) positive strand primer and (NS) negative strand
primer. The restriction endonuclease recognition sequences (EcoRI, Bsp 1061, C/al)
within each primer are underlined.
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Left Arm o f the SurfZAP™ Vector Subsequent to Cloning of Insert SurfVPl DNA;
Oligonucleotide primer SurfVPlPSl and SurfVPlPSl were designed such that, following PCR
amplification and ligation into the left arm of the SurfZAP vector, the 5’ end of insert HAV VPl would
include a complete Notl site and the remainder of the pelB leader sequence downstream of the Notl site.

5 - AATTAACCCTCACTAAAGGGAACAAAGCTGGAGCTTGAATTCTTAACTCGr
T3 Promoter
£coRI
<---------------------------------------------------------------------- pelB leader
M K Y L L P T
A
A
A G L L
CAAGGAGACAGTCATAATG AAA TAG CTA TTG GCT ACG GCG GCC GGA GGT GTC GTG
RBS
Notl
sequence---------------------------------------------L L A A Q P A M A
GTG TTA GGA GGA GAA GGA GGA ATG GGG GTT GGA GAT GAT TGT GGA ................-3’.
HAV V P l

Right Arm of the SurfZAP™ Vector Subsequent to Cloning of Insert SurfVPl DNA:
Oligonucleotide primer SurfVPlNS was designed such that, following PGR amplification and ligation into
the right arm of the SurfZAP vector, the 3' end of insert HAV VPl (shown upstream of the Spel site)
would include a complete Spel site and would be in ft-ame with the downstream sequences encoding the
carboxyl terminal domain (amino acids 198-406) of phage cpIII protein.

HAV VPl
5 -..............................................................GGT AUA 1'Ca ÜAG GAA GAT AAA AGA Ti'i' GAG
G G
G G
S «-— sequence encoding carboxy terminal domain (198-406)
AGT AGT GGA GGT GGA GGT AGG CCAATTTGGTTTGTGAA.............................................. (
Spel
198
of phage cplll protein
-»
)..................................... TCTTAAATGATGGGAGTTGAAAAGGGTATTGGATTATTGTAGAGTTAA
406 Stop
GGGGGGGTGGAGGGGGGGGGGGGTAGGGAATTGGGGGTA TAGTGAGTCGTATTA-3 *
T7 Promoter

Figure 24. A schematic diagram representing the design of insert DNA for cloning
into the SurfZAP™ vector.
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synthesized by beta-cyanoethyl phosphoramidite chemistry (Genelab, Dept, of Vet. Med.
& Parasitol., School of Veterinary Medicine, LSU, Baton Rouge, LA).
PCR Amplification Purification and

Preparation

of Insert DNA for

SurfZAP and pT7-7 Cloning: PCR used to amplify insert HAV V Pl DNA for cloning
into the SurfZAP vector was performed in two steps. A 100 ^1 reaction containing 200
nM of dATP, dCTP, dTTP and dGTP; 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5
mM MgClz, 0.01% gelatin, 2.5 units of Amplitaq DNA polymerase (Perkin-Elmer
Cetus, Norwalk, CT), 1.0 fiM each of SurfVPlPSl and SurfVPlNS primers and 500 ng
template pGEM-HAV DNA was set up in step 1. This PCR reaction mix was then
subjected to 30 cycles of amplification in a Perkin-Elmer model 9600 Programmable
Thermal Cycler as follows: Dénaturation at 95“C for 30 sec followed by 94°C for 1 min,
annealing at 55°C for 90 sec, extension at 72°C for 90sec, with a cycle extension of 10
sec per cycle and then cooling to 4°C. Following amplification, the PCR reaction
mixture was separated from the upper oil layer, and 10 ^1 of the reaction mixture was
subjected to a 2% agarose gel electrophoretic analysis to detect amplified products. The
remaining reaction mixture was diluted with 2 ml of TE buffer (10 mM Tris, pH 8.0, 1
mM EDTA), transferred into a Centricon-100 device (Amicon, Beverly, MA) and
subjected to centrifugation at 1000 X g for 20 min to remove non-incorporated primers
and dNTPs. The PCR product concentrated in the retentate was recovered by inverting
the Centricon device and centrifuging at 500 X g for 2 min. The concentration of DNA
calculated after measuring the A

2 6 0

of diluted samples. A second PCR reaction was then

set up under the same conditions except that 1(X) ng of PCR product from Step 1 was
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used as templaie and 1 /xM of SurfVPlPS2 primer was used instead of SurfVPlPSl
primer. Following completion of thermal cycling, the products were recovered by using
the Centricon-100 device. A 2% agarose gel electrophoresis and A

200

were used to

analyze the second PCR reaction. The concentrated PCR product from the Step 2,
SurfVPl insert DNA, was further purified by the Geneclean n method to remove
remaining pGEM-HAV template DNA. DNA concentration of the purified insert DNA
was measured and 5 ng of the DNA was digested with the restriction enzymes, Notl and
Spel (Stratagene, La Jolla, CA), in separate but successive reactions to generate
compatible, cohesive ends for forced directional cloning into the SurfZAP vector. The
double-digested insert DNA was purified and concentrated by centrifuging in a
Centricon-100 device to remove oligonucleotide fragments which could interfere in the
subsequent ligation reaction. The DNA concentration was determined as before.
PCR reactions for amplifying insert DNA for pT7-cloning were performed by the
same approach followed for the pAX-cloning. Plasmid pGEM-HAV DNA was used as
the template for HAV genes and specific primer sets for VPl or VP3. A 794 gene
segment from Transposon 5 (Tn5) encoding resistance to Kanamycin was chosen as a
positive control to be used throughout the course of the pT7-cloning experiments.
Plasmid pSup2021 (provided by Dr. Alan Biel, Dept, of Microbiology, LSU, Baton
Rouge, LA) which carries the Tn5 insert was used as the template in the control PCR
reaction with the specific primer set, T7KANPS and T7KANNS (Figure 24). Depending
on the outcome of these PCR reactions and where it was deemed necessary, a structured
trial-and-error optimization of the PCR buffer conditions for each individual template-
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primer set combinations was performed by using the Opti-Prime kit (Stratagene, La Jolla,
CA) as outlined previously under Materials & Methods in Chapter 2.

Following

successful PCR amplification, as verified by agarose gel analysis, and subsequent
Centricon-1(X) purification, DNA concentrations were determined for each insert DNA
sample. Five ftg of each insert DNA was subjected to successive restriction enzyme
digestions with EcoRL and Rsp 1061 enzymes to generate cohesive ends compatible for
ligation into a similarly digested vector pT7-7 plasmid. The double digested insert DNA
samples were purified and concentrated by using Centricon-100 devices and DNA
concentrations were determined by A^go measurements. Each digested insert DNA sample
was stored frozen at -20°C until their further use.
Plasm id Extraction and Preparation of Vector pT7-7 DNA fo r Cloning:
Plasmid pT7-7 DNA was extracted from E.coli host strain D H l by a modification of the
alkaline lysis method (Bimboim and Doly, 1979) and then purified by the Geneclean n
method. Competent E.coli host strain BL21 (Stratagene, La Jolla, CA) was transformed
with the purified plasmid pT7-7 DNA by the calcium chloride method, described earlier
(Chapter I: Materials & Methods). Transformants were used in a large scale plasmid
extraction. Briefly, plasmid DNA was extracted from 1 liter LB broth culture of E.coli
BL21 cells carrying pT7-7 by the modified alkaline lysis method. The DNA pellet from
the final step of the procedure was treated as follows. DNA pellets were dissolved in 10
ml of acetate-MOPS buffer (O.IM Sodium Acetate, pH 8.0, 3-[N-MOrpholino]PropaneSulfonic acid), precipitated by addition o f 20 ml cold absolute ethanol and incubated at
-20°C for 10 min. The precipitate was pelleted by centrifugation at 10,000 rpm for 10
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min and the supernatant discarded. The pellet was resuspended in 2 ml of TE buffer and
to this an equal volume of a Lithium Chloride solution (5M LiCl, 0.05M MOPS) was
added. After an incubation at 0°C for 15 min, the resulting precipitate was removed by
centrifugation at 10,000 rpm for 10 min. The supernatant fluid was reprecipitated with
absolute ethanol and the resulting pellet was dissolved in TE buffer by heating to 65°C
for 10 min. Next, the DNA preparation was treated with DNase-ffee RNase (at a final
concentration of 100 fig of RNase/ml of DNA solution) and incubated at 37°C for 30 min
followed by 65°C for 5 min.. Then, 0.6 ml of 10% SDS and 0.6 ml o f 5M NaCl were
added to the DNA solution, mixed and the solution was extracted one time with an equal
volume of Phenol-Chloroform solution (Phenol: Chloroformrlsoamyl alcohol = 25:24:1)
and then with an equal volume of Chloroform The resulting aqueous phase was mixed
with 720 /il of 3M Sodium acetate at pH 5.2 and precipitated with two volumes of
absolute ethanol as before. The solution was incubated at -80°C for 30 min, centrifuged
at 10,000 rpm for 20 min to harvest the precipitate. The resultant DNA pellet was
washed one time with 70% ethanol, dried under vacuum at room temperature and
dissolved in 1 ml of TE buffer. DNA concentration of this plasmid preparation was
estimated by measuring Ajm- Approximately 250 fig of plasmid DNA was subjected to
sequential restriction enzyme digestions with

EcoRI and Clal (Gibco BRL,

Gaithersburg, MD) and purified by Geneclean H. The DNA concentration of purified,
double-digested vector DNA was calculated following Ajm measurement of sample
dilutions. The double-digested DNA and residual undigested plasmid DNA in TE buffer
were stored separately at -20°C until needed.
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Transform ation of Host £. coli BL-21 Cells with Recombinant pT7 DNA by
Electroporation ; Individual ligation reactions were set up to join restriction digested
insert DNA with vector pT7 DNA following procedures similar to those described
previously (Materials and Methods, Chapter 1). Competent E.coli BL21 cells were
prepared as follows. E.coli host cells were grown in a salt-free growth medium, YENB
broth (Bacto yeast extract [0.75%], Bacto Nutrient Broth [0.8%]; Difco Laboratories,
Detroit, MI) at 30°C with shaking. These steps were taken to decrease the incidence of
arcing during electroporation and if possible, to improve the efficiency of
electroporation.
Fresh or frozen cells (that had been gently thawed) were used in the
electrotransformation reaction as outlined previously. Following electroporation, cells
were immediately resuspended in 1 ml SOC medium (2% Bacto Tryptone, 0.5% Bacto
yeast extract, 10 mM NaCl, 2.5 mM Kcl, 10 mM MgCl^, 10 MgSO^ and 20 mM
glucose;

Bacto tryptone was from Difco laboratories, Detroit, MI and the other

chemicals were from EM Science, Gibbstown, NJ).

The cell suspensions were

transferred into Falcon sterile polypropylene tubes (17 X 100 mm, Becton Dickinson and
Company, Lincoln Park, NJ) and incubated at 30®C for 1 h. Following incubation, the
cells were transferred to microfiige tubes, sedimented at 3,000 X g for 5 min and then
gently suspended in 300 til fresh SOC medium which contained 100 /ig/ml ampicillin.
They were plated on selective SOC-amp plates in triplicate. The SOC-amp plates were
incubated overnight at 30°C and then examined for recombinant colonies, and selected
recombinants were chosen at random for further studies.
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Plasmid DNA isolation was performed on selected recombinants to identify
potential candidates for HAV protein production. Plasmid DNA was extracted from 3
ml cultures of each recombinant following overnight incubation in SOC-amp broth, by
the PERFECT prep™ plasmid DNA kit (5 Prime-3 Prime, Inc., Boulder, CO). Cells
were pelleted in microfiige tubes from 3 ml overnight cultures by centrifugation at
12,000 X g for 30 sec. The cellular pellets were suspended in 100 /il of Solution I (50
mM Tris-Cl, pH 7.6, 10 mM EDTA, pH 8.0, 100 pig/ml RNase A), the cells lysed by
addition of 100 ^1 of Solution II (0.2 N NaOH, 1.0% SDS) and mixed well by repeated
gentle inversion. Each lysate was neutralized by addition of 100 /il of Solution III (1.32
M Potassium Acetate, pH 5.2) while mixing by vigorous inversion. The lysates were
subsequently centrifuged at 16,000 X g for 2 min to remove cell debris and other
insolubles. The supernatant fluids were transferred to individual PERFECTprep spin
column-collection tube assemblies, 450 /il of a thoroughly resuspended PERFECTprep
DNA binding matrix in Guanidine-HCl was added, mixed and centrifuged as before.
After discarding the filtrates, 400 fil of a diluted Purification Solution consisting of
ethanol, Tris-Cl, NaCl and EDTA (NOTE; individual concentrations were not provided
by manufacturer) was added to each spin column which were shaken briefly and then
centrifuged for 60 sec. After discarding the filtrate, the columns were sedimented again
and transferred to fresh collection tubes. Plasmid DNA were eluted by suspending the
DNA binding matrix in 50 /xl of TE buffer and vortexing briefly followed by
centrifugation. Eluted plasmid DNA was recovered in the filtrates. About 5 /tl of each
plasmid DNA sample was digested with EcoRI and Clal and analyzed by 0.8% agarose
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gel electrophoresis. DNA concentrations of positive recombinant DNA preparations
were determined by A

2 6 0

measurements and stored at -40°C as described before.

Linearized recombinant plasmid DNA was used as the template along

with the

corresponding sets of V Pl or VP3 or KAN primer sets for individual PCR reactions done
to confirm the presence of the relevant insert DNA. The reaction conditions for each
template-primer set were the same as previously optimized. Following confirmation o f
the presence of insert DNA, representative bacterial clones were chosen for the studies
which involved the induction of HAV capsid protein expression from the recombinant
pT7-7 vectors.
Expression of HAV Capsid Proteins from Recombinant pT7-7 Vector:
Recombinant pT7 plasmids carrying HAV VPl or VP3 inserts and KAN insert DNA
were used to transform freshly prepared, electroporation competent E.coli BL-21 (DE3)
pLysS cells (Table 7). Following transformation and isolation of recombinants on SOCamp plates, representative clones were confirmed by plasmid DNA isolation and PCR
verification for insert DNA. Frozen stocks of each recombinant, for each insert DNA,
were prepared. In addition, three recombinant E.co// BL-21 bacterial clones; T7-VPl#le,
T7-VP3#3a and T7KAN#6b were chosen for studying the IPTG-induction of recombinant
protein expression by methods elaborated upon earlier with one modification. Cells were
grown at 30“C throughout the experiment.

Samples representing glucose induced

catabolite repression of protein expression from the lac promoter (gr), time 0 (T^; i.e.
at the time of IPTG addition to cells removed previously from under glucose repression),
and one, two, three and four hours post-induction (T,, T;, T and T ) were obtained.
3
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Samples for SDS-PAGE analysis were prepared from cell pellets of IPTG-induced cells
and stored at -20°C until needed.
Whole cell lysates were analyzed by 12% SDS-PAGE and Coomassie blue
staining for expression of recombinant proteins using polyacrylamide gels of

1 . 5

mm

thickness along with a Modular Mini-PROTEAN II Electrophoresis System (Bio-Rad
Laboratories, Hercules, CA).

Depending on the outcome of the IPTG-induction

experiments, Western Blots were done on selected recombinants by methods described
earlier.
Cloning of Insert HAV DNA into A.SurfZAP Vector ; E.coli XL-1 Blue was
selected as the host strain for the initial transduction experiments. A broth culture of
the host cells was started in 10 ml LB broth by inoculating with a single colony from a
fresh LB-tetracycline (LB medium containing tetracylcine at 12.5 /xg/ml) streak plate.
Following overnight incubation at 37°C with vigorous shaking, the 10 ml culture was
transferred into 1(X) ml of fresh, sterile LB medium with 0.2% (v/v) maltose and lOmM
MgS04 and incubated for 2-3 hours or until the culture attained an optical density at 600
nm (ODfioo) of 0.2-0.3.

The cells were sedimented at 1000 X g for 10 min and

suspended in sterile 10 mM MgSO^ to a final ODgoo of 1.0 and were used immediately
in the transduction experiment.
Ligation reactions to generate concatameric, recombinant XSurfZAP DNA were
set up with Notl-Spel double-digested insert HAV SurfVPl and XSurfZAP DNA based
on the manufacturer's recommendations (Section IV: Instruction Manual for SurfZAP™
Cloning Kit, Stratagene, La Jolla, CA). Insert to vector molar ratios were calculated by
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using the following formula; picomole ends/fig of DNA =

1 0

®h-( number of base pairs

X 660). Insert to vector ratios of 1:1, 2:1 and 4:1 were employed to set up individual
ligation reactions in a final volume of 5 fil (consisting of 1.0 (d SurfZAP vector arms at
1 ng/fil concentration, 0.5 /xl of 10 X ligase buffer [500 mM Tris-HCl, pH 7.5, 70 mM
MgCl and 10 mM DTT], 0.5 /xl of 10 mM rATP, 0.5 /xl of T4 DNA ligase enzyme [0.2
2

U] in addition to insert DNA and dHzO). A mock ligation reaction without insert DNA
was included as a negative control.

All ligation reactions were incubated at 4“C

overnight. Next, one /xl of each ligation reaction was packaged into viable lambda
bacteriophage particles using Gigapack® U Gold packaging extracts (Stratagene, La Jolla,
CA) in accordance with the manufacturer's suggested protocol. The packaging extracts
were removed from from storage at -80°C and placed on dry ice. Each set of packaging
extract contained a yellow colored tube with the Sonic extract and a red colored tube with
the Freeze-Thaw extract. The Sonic extract was thawed on wet ice at 4°C while the
Freeze-Thaw extract was thawed between fingers. One /xl of XSurfZAP DNA from a
ligation reaction was added immediately to the Freeze-Thaw extract as soon as it began
to thaw. Then, fifteen /xl of thawed Sonic extract was quickly added to the ffeeze-thaw
extract containing the DNA and the tube contents were mixed well with a pipet tip. The
reaction mixture was centrifuged for 3-5 sec and then incubated at 22“C for 1.5 to 2 h.
Next, 500 /xl of sterile SM buffer (each liter containing 5.8 g of NaCl, 2.0 g of MgSO^
HgO, 50.0 ml of IM Tris-HCl at pH 7.5, 5.0 ml of 2% (w/v) gelatin in addition to
distilled water to make up the rest of the volume) and

2

0

/xl chloroform were added

successively to each packaging reaction mix, the reaction mix was centrifuged briefly for
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3-5 sec to sediment debris and the supernatant fluid was transferred to a new tube prior
to setting up appropriate dilutions in SM buffer to titer lambda phage and thereby
evaluate the success of the ligation and packaging reactions.
Serial dilutions of lambda phage, 1:10^, 1:10* and 1:10’, were prepared in sterile
microfiige tubes in SM buffer.

About 1-10 ii\ of each dilution was mixed with 200 /nl

of freshly prepared E.coli XLl-Blue cells (ODggo = 0.5). The phage-bacteria mixture
was incubated with occasional shaking, at 37“C for 15 min to permit phage adsorption
onto host cells.

Next, the

phage-bacteria mixture was transfered to tubes which

contained 3 ml of melted and cooled NZY top agar at 50°C (each liter containing 5 g of
NaCl, 2 g of MgSO^.VHzO, 5 g of yeast extract, 10 g of NZ amine [casein hydrolysate;
Difco laboratories, Detroit, MI] and 7 g agarose; pH of the medium adjusted to 7.5 with
NaOH) and vortexed briefly to ensure even mixing of contents. The top agar was
immediately poured onto prewarmed (to 37°C) NZY agar plates (same formulation as
NZY top agar except that the final amount of agarose added was 15 g/liter) and the
plates were incubated at 37°C overnight. The NZY plates were examined for plaques
and the phage titer [in plaque-forming units per milliliter (pfii/ml)] was calculated using
the following formula: (Number of plaques X dilution factor X 1000) - Volume of
4

phage solution added to host cells in milliliters. The plates were sealed with paraftlm
and stored at 4°C until their use in PCR to verify the presence of cloned insert DNA.
PCR Screening and Verification of Plaques Containing Recombinant %phage
carrying SurfV Pl DNA; A simple miniprep procedure was used to isolate and purify
XSurfVPl DNA from multiple phage lysates prior to rapid PCR screening and
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identification of recombinant plaques. A 10 ml culture of lambda sensitive host E.coli
XLl-Blue cells was grown overnight in LB broth (containing 0.2% maltose and lOmM
MgSO^ ) at 37°C with vigorous shaking. Five ml of the culture was inoculated into 60
ml of fresh LB-Maltose-MgSO^ medium in a 250-ml Ehrlenmeyer flask and incubated
at 37°C with shaking for 2 hours.

Three ml of the log phase culture was aliquoted into

each of 20 sterile 17 X 150 mm test tubes. Next, plaques selected from the lambda
plates from the phage titer experiment were toothpicked individually and inoculated
separately into 3 ml cultures of E.coli XLl-Blue cells. Each phage inoculated cultures
was incubated in shaker-incubator or on a rotating wheel in an incubator at 37°C for 4h
or until lysis of bacterial cells was evident. Fifty ^1 of chloroform was added to each
tube, and the contents were vortexed for 1 min to lyse the remaining cells. Then, 1.5
ml of each lysed culture was transferred into sterile, labeled microfiige tubes. Two /xl
each of DNAse (5mg/ml) and DNAse-free RNAse (lOmg/ml) were added to each tube,
mixed, and the cultures were incubated for 15 min in a 37°C water bath. The cultures
were then centrifuged at 10,0(X) X g for 10 min to pellet cell debris and the supernatant
fluid from each culture was aliquoted into two microfiige tubes. Next, 750 /xl of ice-cold
Isopropanol was added to each tube, the contents mixed thoroughly by vortexing and the
tubes were centrifuged as before. The supernatant from each tube was carefully drained
and the tubes were laid inverted on absorbent paper or kimwipes for 5 min. Each
translucent phage pellet was resuspended in 1(X) /xl of TE buffer. The resuspended pellet
from both tubes corresponding to a single phage plaque originally were pooled into one
tube. Then, 200 /xl of buffered phenol was added to each pooled phage suspension.
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vortexed vigorously for 10 min and centrifuged at 14,000 rpm for 2 min. The resulting
aqueous layer was reextracted with buffered phenol and the aqueous layer from the
second phenol extraction step was transferred into a fresh microfiige tube. Next, 200 ^1
of chloroform was added to each tube, mixed well and centrifuged as before. The
aqueous layer was carefully removed into a fresh tube and the chloroform extraction
repeated one more time. The aqueous layer from the second extraction was treated with
20 ^1 of 3 M Na-acetate at pH 4.8 and mixed well. 500 /xl of ice-cold 100% ethanol was
added to each tube to precipitate phage DNA at room temperature for 15 min. Then, the
tubes were centrifuged at 14,000 rpm for 10 min to pellet DNA. After discarding the
supernatants, the pellets were washed once with 1 ml of 70% ethanol and centrifuged
again. The supernatants were carefully drained and the phage DNA pellets were dried
under vacuum for 5 min prior to resuspending each in 100 /xl of sterile TE buffer. Two
n\ of each phage DNA sample was used as template DNA in the subsequent individual
PCR reactions while the remaining sample was stored frozen until needed.
Individual PCR reactions to verify the successful cloning of insert SurfVPl into
the ISurfZAP vector were set up in 100 ^1 volumes (10 /*1 of 10 X PCR buffer,

8

/xl of

25 mM MgCl;, 2 /tl of each of dNTPs, 0.5 /xl of AmpliTaq DNA Polymerase, 2/xl of
SurfVPlPSl primer, 2/xl of SurfVPlNS primer and 67.5 /xl of sterile distilled H O).
2

Thermal cycling was performed for 30 cycles as follows: Cycles 1-3, 95°C/2 min
followed by 55°C/1 min followed by 72°C/90 sec; Cycles 4-30, 94°C/90sec followed by
50°C/1 min followed by 72°C/90°C with a cycle extension of 10 sec/cycle. Following
the PCR, 10 /xl of each reaction mix was mixed with 5 /xl of DNA loading dye and
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electrophoresed on a % agarose gel, stained with ethidium bromide and photographed.
2

A positive amplification of a -9 5 0 bp DNA fragment was considered as evidence of
successful cloning and the corresponding recombinant XSurfVPl plaques identified. Ten
such recombinant plaques were chosen for generation of 50 ml lysates for short term
storage at 4°C, for long term storage at -80”C and for the single clone in vivo excision
experiments to produce the plasmid equivalents (i.e. pSurfVPl) of recombinant DNA
from their corresponding X phage forms.
For the long term storage of the individual phage lysates, 930 fi\ aliquots of each
phage lysate were added to several microfuge tubes and 70 fil of filter-sterilized DMSO
(DiMethylSulfOxide; Mallinckrodt Inc., Paris, KY) was added to each tube, mixed well
by pipetting and the tubes were stored frozen at -80°C.
Single Clone in vivo Excision of Recombinant pSurfV PI from iS u rfV P l
clones: Transduction competent host E.coli XLl-Blue and SOLR strains were prepared
as described in a previous section and used in the in vivo excision experiments to convert
recombinant DNA from the initial lambda phage DNA form to a final plasmid form via
a single-stranded filamentous phage DNA form.

XLl-Blue cells and SOLR cells were

freshly prepared each time from log-phase cultures and the cells were resuspended in
sterile MgSO^ to the required ODg^o just prior to their use.
The ExAssist™ interference-resistant helper phage, which is a derivative of the
single-standed fl coliphage, was part of the SurfZAP™ cloning kit and was used in the
in vivo excision following the manufacturer's suggested protocol. Prior to the in vivo
excision experiment, the helper phage was titered with XLl-Blue cells. Phage dilutions
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(10"* to 10'’) in TE buffer were prepared and 1 /d of each dilution was mixed with 200
/il of XLl-Blue cells (ODgoo)- The phage-bacteria mix was incubated for 15 min at 37°C
to allow for phage adsorption, mixed with premelted and precooled NZY top agar at
50°C, poured onto prewarmed (37°C) NZY plates and incubated at 37°C overnight. The
next day, the plates were screened for turbid plaques and the phage titer determined as
before.
For in vivo excision of pSurfVPl, ten individual recombinant phage lysates that
had been identified previously by PCR were selected. Each recombinant phage was
combined with 40 ^1 of transduction competent XLl-Blue cells (ODgoo=5.0) in separate,
sterile 15 ml capped conical centrifuge tubes (Coming Costar Corporation, Cambridge,
MA) at a multiplicity of infection (MOI) of 1:80 lambda phage-to-host cell ratio
(assuming that a OD^oo of 5.0 for XLl-Blue cells = 4 X 10’ cells/ml).

Next, the

ExAssist helper phage was added to the lambda phage-bacteria mix at a MOI o f 2:1
helper phage-to-host cell ratio and the reaction mix was incubated at 37°C for 15 min.
Then, 5 ml of LB broth was added, the contents of the tube mixed well by gentle
pipetting and the culture incubated at 37°C overnight with gentle shaking. The following
day, the cultures were placed in a water bath at 70°C for 30 min to lyse the lambda
particles and XLl-Blue cells and then centrifuged at 2500 X g for 10 min to pellet the
cell debris. The supernatants containing the excised recombinant single-stranded phage
were recovered into fresh sterile tubes and stored at 4“C until further use.
E.coli SOLR cells harboring pSurfVPl were produced from the supernatants of
the in vivo excision experiment by preparing dilutions in TE buffer of the supernatants
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as was done in the helper phage titration experiment. One to ten ^1 of each dilution was
then mixed with 200 fil of SOLR cells (OD«x) = 1 0 ) and preincubated at 37°C for 15
min. Then, the SOLR cells were spread uniformly on the surface of LB-Amp agar (with
50/ig/ml ampicillin) with a sterile glass hockey stick and incubated overnight at 37°C.
The next day, the plates were checked for Ampicillin resistant (AmpO bacterial colonies.
The titer of recombinant phagemid was estimated [in colony-forming units per milliliter
(cfti/ml) using the formula, (Number of colony-forming-units X Dilution factor X 1000)
Volume of SOLR cells plated. Several of the Amp"^ colonies were selected for
plasmid DNA extraction by the PERFECTprep procedure described previously. The
plasmid DNA obtained were screened for presence of SurfVPl insert by restriction
ezyme analysis with EcoRI and by PCR following procedures outlined already. Frozen
stocks of bacterial cells that were confirmed as recombinants were generated for long
term storage at -80°C. The pSurfVPl plasmid DNA samples were stored at -20°C until
needed.
Recombinant Lam bda DNA Isolation and Purifîcation: The ten recombinant
A.SurfVPl phage isolates that had been identified previously by PCR were chosen for the
extraction and purification of recombinant phage DNA. A A.QUICK!™ kit (Bio 101,
Inc., La Jolla, CA) was used for a rapid isolation and purification of phage DNA from
a 100 ml culture of each infected/lysed host bacteria as follows. A fresh overnight 5 ml
culture of lambda sensitive E.coli XLl-Blue cells was grown at 37°C in LB-MaltoseMgSO^. The next morning, the 5 ml culture was infected with 10*^ pfii of a recombinant
phage lysate and incubated for 20 min in a 37°C water bath. Next, the 5 ml culture was
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added to 50 ml of fresh, sterile LB-Maltose-MgSO^ medium in a 250 ml Ehrlenmeyer
flask and incubated on a shaking platform in a 37°C incubator for 4-5 hours. Then, 500aiI
of chloroform was added and the culture was shaken vigorously at 37°C for 15 minutes.
Phage lysate was obtained by centrifugation of the lysed culture at 10,000 X g for 10 min
to pellet cell debris. The supernatant containing phage particles in suspension was
transferred into a sterile, polypropylene centrifuge bottle.

An equal volume of

isopropanol was added, mixed well and the mixture was centrifuged as before to obtain
a translucent phage pellet. The supernatant was removed carefully to the maximum
extent possible and the pellet was resuspended in

1.2 ml TE buffer.

The phage

suspension was then removed into a microfuge tube and centrifuged at 14,000 rpm for
2 min to pellet any remaining cell debris. The supernatant containing the phage particles
was filtered through a 0.45^M Nalgene™ syringe filter (Nalge company, Rochester, NY)
and collected in a fresh microfuge tube. Then, 0.5 nl of NUCLEASE MIXX (supplied
with the XQuick! kit) was added to the phage suspension and incubated at 37°C for 15
min. Next, 0.4 ml of A.PHAGE DROP BUFFER (supplied with the kitO was added to
the suspension, mixed well and left at 37°C for 20 min to precipitate phage. Phage
particles were pelleted by centrifuging at 10,000 X g for 5 min and discarding the
supernatant. After resuspending the pellet in 150 ^1 of TE buffer, 150 ^1 o f ÀPHAGE
LYSIS/BINDING BUFFER (supplied with kit) was added, mixed well until the solution
became clear and incubated at 70°C for 10 min to lyse the phage particles. Next, 10 n\
of AGLASSMDJC™ (supplied as part of kit) was added to the solution, mixed gently but
thoroughly and incubated for 5 min at room temperature to allow for phage DNA binding

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

117

to the glassmilk. The solution was then spun for 30 sec in a microcentrifuge at 14,000
rpm and the resulting supernatant removed. The A.DNA/GLASSMILK™ pellet was
washed with 300 fil ofADNA wash (supplied with kit) and spun for 30 sec to remove the
supernatant. Without resuspending the pellet, the washing step was repeated. Then, the
washed pellet was resuspended gently in 20 /xl of TE buffer and incubated at 37°C for
5 minutes before centrifuging again at 14,(X)0 rpm for 30 seconds.

The resulting

recombinant k DNA was transferred into a new microfuge tube, DNA concentration of
the solution measured by determining ODieo of diluted samples and the undiluted solution
was stored frozen at -20°C until later.
The recombinant k DNA samples were used as a source of template DNA in
PCR reactions to verify the presence of insert SurfVPl DNA as well as in experiments
concerning the in vitro excision of pSurfVPl by PCR.
In vitro Excision-PCR to Generate Recombinant Phagemid DNA with Insert
HAV V P l DNA from Recombinant

1

S urfV Pl Clones: The essential steps of this

procedure are depicted schematically in Figure 25. Oligonucleotide primers, positivestrand (PS) primer F 1GRIPS with the sequence 5 -CCC GAT ATC CAA CAC TCA
ACC CTA TCT C-3' and negative-strand (NS) primer FIORINS with the sequence 5'CCC GAT ATC TTC CAG TTT GGA AC A AGA G-3' were synthesized by beta
cyanoethyl phosphoramidite chemistry (Genelab, Dept, o f Vet. Med. & Parasitol.,
School of Veterinary Medicine, LSU, Baton Rouge, LA).

Primers FIORIPS and

FIORINS are derived from the nucleotide sequence of the bacteriophage f l functional
origin of replication (Dotto et al., 1984), parts of which are represented in the
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in vitro E x cision -P C R to R escu e R ecom b in an t p S u rfV P l

from ASurfZ A P C arrying H A V V P l cD N A Insert
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Figure 25a. A schematic representation of the essential steps in the in v/rro-Excision
PCR procedure employed in the amplification of the entire pSurf-VPl phagemid DNA
from within the larger A.Surf-VPl DNA, as an alternative to the E.coli and phage
dependent in vivo excision and rescue.
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Isolation and by P C R with SurfV Pl Primers

Figure 25b. A schematic representation of the essential steps in the in vitro-Excision
PCR procedure employed in the amplification of the entire pSurf-VPl phagemid DNA
from within the larger XSurf-VPI DNA, as an alternative to the E.coli and phage
dependent in vivo excision and rescue.
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terminator (T) and initiator (I) sequences that constitute the boundaries of the phagemid
(pSurfscript) portion of the XSurfZAP™ vector. The XSurfZAP vector also contains the
lacZ. promoter for transcription of cloned DNA inserts, multiple cloning site (MCS) with
flanking T3-T7 promoters for insertion of foreign DNA, Ampicillin resistance gene
(Amp"^ ) as a selective marker and the colEl replication origin (Figure 22) within the
region flanked by the T and I sequences. In the recombinant XSurfVPl phage DNA, the
insert HAV VPl DNA is cloned between the Notl and Spel sites at the multiple cloning
site. All of the phagemid DNA located between and including the T and I sequences is
essential for successful in vivo or in vitro excision of recombinant phagemids and for
their subsequent replication and maintainence as double-stranded plasmid DNA within
bacterial host cells. Both primers were designed to include a recognition site for the
restriction enzyme, fcoRV, towards their respective 5 'ends to assist in the
recircularization of the plasmid following a successful amplification of phagemid DNA.
The entire recombinant phagemid DNA between the T and I sequences of X
SurfV Pl was amplified by PCR using the Expand™ Long Template PCR System
(Boehringer Mannheim corporation, Indianapolis, IN). Since this resulted in a double
stranded plasmid form of the recombinant DNA that could be easily circularized
subsequently, this procedure was termed in vitro Excision-PCR. The PCR reaction itself
was set up as follows by preparing Master mix 1 and 2 in separate microfuge tubes.
Master mix 1 contained 1 ix\ of A-SurfVPl DNA (from theXQuick! procedure) as
template, 300 nM each of the PS and NS primers and sterile redistilled water to make up
a total final volume of 25 pi in a thin-walled PCR reaction tube (Perkin-Elmer Cetus,
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Norwalk, CT) on ice. Master mix 2 consisted of 350

each of dATP, dTTP, dGTP

and dCTP, 5 ^1 of lOX PCR buffer with MgClzCSOO mM Tris-HCl, pH 9.2, 160 mM
(NH ) S
4

2

0

4

and 17.5 mM M gC y, 0.5-1 /xl of enzyme mix (a mixture of Pwo and Taq

DNA polymerases) and sterile redistilled water to a final volume of 25 /xl in a regular
microftige tube on ice.
A modified "hot start" protocol (Chou, et al., 1992) was employed for the
thermal cyling steps of the Excision-PCR using a Gene Amp System 9600 Thermal
Cycler (Perkin-Elmer Cetus, Norwalk, CT). Master mix 2 was heated to 94°C for 5 min
to denature the XSurfVPl template DNA completely and then cooled to 65°C to allow for
annealing of primers before adding the master mix
at

6

8

2

to initiate the first elongation step

°C for 10 min. Thereafter, thermal cycling was continued with dénaturation at 94°C

for 30 sec followed by annealing at 62°C for 30 sec followed by elongation at
6

6

8

°C for

min for the next 30 cycles. A cycle elongation step of 20 sec per cycle was added to

the elongation step beginning with cycle # 1 1 and extending through cycle # 30. After
a final extension step at

6

8

°C for 10 min, the reactions were cooled to 4“C and thermal

cycling was stopped. The PCR product was separated from the upper oil overlay and
collected into a fresh, sterile microfuge tube. A five /xl volume of the product was
subjected to a

0

. 6

% agarose gel electrophoretic analysis to confirm if the amplified

product was of the anticipated size. The remaining PCR product was purified by using
Centricon-100 filter devices as described earlier. DNA concentration of the purified
PCR product was determined following ODjeo measurements of diluted samples. A PCR
with

SurfVPlPS2 and SurfVPlNS primers and 100 ng of purified product from
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Excision-PCR was performed under the same thermal cycling conditions as was
mentioned for amplification of insert SurfVPl DNA from pGEM-HAV to confirm that
the template DNA was indeed a PCR-amplified linear form of pSurfVPl plasmid. The
products of this reaction were analyzed by a % agarose gel electrophoresis as before.
2

The remaining purified pSurfVPl preparation was stored at -80°C until needed.
Restriction enzyme digestion with EcdRW (Gibco BRL, Gaithersburg, MD) of 5
11% of

in vitro excised and purified pSurfVPl was performed and the enzyme digested

DNA was purified by GENECLEAN II procedure as outlined earlier. After estimating
the DNA concentration, individual ligation reactions were set up with 125 ng, 250 ng
and 500 ng of EcoRV digested pSurfVPl to circularize the plasmid DNA. The ligation
reaction conditions were the same as was decribed earlier for cloning into plasmid
vectors. Next, the recircularized pSurfVPl was used to transform freshly prepared host
E.coli BL-21 cells by electroporation and several successful recombinants that resulted
were chosen at random for further studies.
Plasmid DNA were extracted by the PERFECT prep™ procedure from several
recombinants that resulted from transformation experiments involving in vitro excised
and recircularized pSurfVPl.

Restriction analysis with EcoW. and PCR with

SurfVPlPS2 and SurfVPlNS primers were used to positively identify recombinants
carrying pSurfVPl as was done earlier.

Frozen stocks of such recombinants were

generated for long term storage at -80°C and for future experiments.
Expression of recombinant HAV SurfV Pl protein : Representative bacterial
recombinants were selected from amongst the pool of in vivo and in vitro excision
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derived clones for studies aimed at expression of recombinant HAV VPl protein. Logphase cultures of recombinant cells were produced and induced with IPTG according to
a protocol similar to the one described already for IPTG-induction of pT7-7 vector
derived recombinants carrying HAV genes. Timed samples before and following the
IPTG-induction were collected and whole cell lysates prepared for analysis by 12 %
SDS-PAGE as described earlier. Any unused whole cell lysate samples were stored at
-20°C until needed later.
Codon Usage Preference Frequencies in E.coli for HAV Genes: A computerbased analysis of frequency of preferred codon usage in E.coli for HAV capsid protein
genes VPO, VPl and VP3 was performed using a Gateway 2000 P5-75 personal
computer (Gateway2000, Inc., N. Sioux city, SD).

The codon usage database, an

extended world wide web (WWW) version of Codon Usage Tabulated from Genbank
(CUTG) genetic sequence database, was utilized for this purpose by accessing the WWW
site "http://www.dna.affrc.go.jp/~nakamura/codon.html" (Nakamura, et al., 1997).
The database consists of all of the complete sequenced and reported protein coding
sequences (CDS). Codon frequency tables showing frequency (per thousand) and count
for each codon as a sum of all CDS's for a given species were obtained and used for
comparison between HAV, E.coli (Host cells used in our study for expression of
recombinant HAV proteins), Homo sapiens (natural host for HAV replication) and
Human Poliovirus (a member of Picomaviridae related to HAV whose proteins have
been successfully expressed in E.coli) sequences.
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RESULTS
Oligonucleotide primers were designed to enable successful PCR amplification
of HAV VPl insert DNA for cloning into the iSurfZAP and pT7-7 vectors (Figures 21
and 22). The primers for iSurfZAP cloning ensured the inclusion of the Notl and Spel
restriction enzyme sites and the essential portions of the pelB DNA leader sequence that
is lacking in the double-digested vector DNA supplied by the manufacturer (Figure 25).
All positive-strand (PS) primers for pT7-cloning also included the essential recognition
site for EcoiRl enzyme and all negative-strand (NS) primers included a site for
flspl06I/C/aI enzyme.
Insert SurfVPl DNA was generated by successful amplification by two separate
PCR reactions performed in a pre-determined sequence (Figure 26). The first PCR
reaction which included plasmid template pGEM-HAV, primers SurfVPlPSl and
SurfVPlNS, resulted in a 945 bp DNA fragment that included the downstream Spel site
and part of the upstream pe/B leader sequence. The subsequent PCR reaction which
employed the 945 bp PCR amplified DNA from the previous reaction as template and
with SurfVPlPS2 and SurfVPlNS primers, yielded a 978 bp complete SurfVPl insert
DNA that now contained the Notl restriction enzyme site in addition to the pelB leader
sequence (Figure 24).
Insert DNA for pT7-cloning were generated by PCR in separate reactions as
described under material and methods and resulted in successful amplification of a 929
bp T7VP1 and 766 bp T7VP3 DNA from template pGEM-HAV and a 823 bp T7KAN
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Figure 26. Agarose gel analysis of insert Surf VPl DNA amplified by PCR for cloning
into the SurfZAP vector. Lane 1: BioMarker low molecular weight DNA standard, Lane
2: V P l DNA (945 bp) following the first round of amplification using pGEM-HAV as
template, Lane 3: Insert SurfVPlDNA (978 bp) amplified during the second round of
PCR using VPIDNA (945 bp) from the first round as template, and Lane 5: BioMarker
low molecular weight DNA standard.
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DNA from template pSup2021. The PCR conditions were optimized for each insert DNA
amplification using the Opti-Prime kit.
Each insert DNA for pT7-cloning was subjected to sequential digestion with the
appropriate restriction enymes and purified by Geneclean II procedure. Plasmid vector,
pT7-7, was also digested and purified in a similar fashion. Ligation reactions with
insert:vector ratios of 1:1, 2:1 and 4:1 were set up initially. Prior to using E.coli BL21
host cells, we attempted without much success, electro-transformation in several E.coli
strains like UT2300, DHl (recAl endAl gyrA96 thi-1 hsdRlJijy^. mR+) supE44 relAl),
JM lOl (supE thi-1 ^(lac-proAB) [F' troD36proAB tocFZAAf75])and HBlOl {supE44
aral4 galK2 lacYlùk(gpt-proA)62 rpsL20 (StrO xyl-5 mtl-1 recA13 L(jncrC-mrr) HsdS
( r m )).

No stable transformants were recovered by varying insert: vector ratios or

conditions of temperature, enzyme source, or duration of ligation reactions. However,
when E.coli BL21

host cells were used,

the efforts were successful and stable

recombinants were obtained with a transformation frequency of ~ lO’ transformants/^g
of vector DNA with respect to HAV V Pl and VP3 inserts and —10* transformants/^g
of vector DNA with respect to KAN insert. Control reactions which were done with
undigested pT7-7 vector DNA yielded ~ 10’ transformants//xg of vector DNA while
those with cut (with EcoRI) and religated vector produced —10* transformants//ig of
vector DNA. Several recombinants were chosen as candidates and examined by plasmid
DNA isolation, digestion with EcoRl and Clal enzymes, and agarose gel electrophoretic
analysis (Figure 27). The presence of specific insert DNA in each of the template pT7V P l, pT7-VP3 and pT7-KAN recombinant plasmids was independently confirmed by
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Figure 27. Agarose gel analysis of restriction enzyme digests of recombinant pT7derived plasmids carrying HAV genes, V Pl ( - 9 0 0 bp) or VP3 (-7 5 0 b p ), or Tn5
derived KAN ( —800 bp) gene insert. The plasmid DNA samples were digested with
FcoRI and Clal enzymes in separate but successive reactions. Lanes 1,7,11: Vector pT77 without insert. Lanes 5, 10, 15: BioMarker low molecular weight DNA standard.
Lanes 2-4: pT7VPl DNA samples from different clones. Lanes 8-9: pT7VP3 DNA
samples, Lanes 12-14: pT7KAN DNA samples.

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

128

PCR.

Subsequently, E.coli BL-21(DE3)pLysS cells were transformed with these

plasmids by electroporation and individual colonies were selected for induction of protein
expression. The BL-21 (DE3) pLys host cells, but not the BL21 host cells, contain a A.
lysogen, DE3. Phage DE3 encodes the T7 RNA polymerase under the control of lacUVS
promoter. Controlled protein expression of specific genes placed downstream of the
T7 RNA polymerase binding site (promoter) on vector pT7-7 is possible through IPTG
induction of the lacUVS promoter.
Several recombinant E.co/i BL-21 (DE3) pLysS clones, [T7-VP1 clones la, le
and 2b; T7-VP3 clones 3a, 4b, and 4c; and T7-KAN clones a and b] were subjected
6

6

to IPTG induction of recombinant protein expression from cloned genes carried on the
recombinant pT7 vector. Induction of log-phase cells of each recombinant culture in
concert with control bacterial cultures (BL-21 (DE3) pLysS cells without any
recombinant pT7 plasmid and BL-21 (DE3) pLysS with pT7 plasmid without any insert)
was performed with addition of IPTG to a final 1.0 mM concentration in each culture.
Hourly samples were collected from each culture. Each sample was prepared for SDSPAGE analysis on 12% discontinuous polyacrylamide gels. Gels were stained with
Coomassie blue

and examined for evidence of successful recombinant protein

expression. Although the SDS-PAGE gel corresponding to T7-VP3 clones showed the
appearance of a new protein band at —30 kD (Figure 28), there were no new protein
bands corresponding to the expected size of V Pl ( —33 kD) on the SDS-PAGE gel
representing T7-VP1 clone (not shown).
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Figure 28. SDS-PAGE analysis for recombinant HAV VP3 protein expression from
pT7-VP3 carrying E.coli BL-21 (DE3) pLysS cells. Whole cell lysates prepared from
various recombinant clones, 3 h after IPTG induction of T7 RNA polymerase expression
in host cells, are shown. Lane 1: Molecular weight marker. Lane 2: T7-VP3 ë 3a.
Lanes 3 and 4: Host cells carrying pT7 vector without any insert DNA. Lanes 5 and
: T7-VP3 ë 4b and 4c. Lane7: Host cells carrying recombinant pT7-KAN (Clone ë
; Positive control). Lane : Molecular weight marker.

6

6

8

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

130

Cloning of insert SurfVPl DNA into the SurfZAP vector was performed
successfully. PCR amplified insert SurfVPl DNA (978 bp) was digested sequentially
with the restriction enzymes, Notl and Spel. Ligation reactions to generate concatameric
recombinant lambda DNA suitable for packaging into phage particles were set up at
insert:vector ratios of 1:1, 2:1 and 4:1 using the double-digested insert and the vector
DNA arms, supplied predigested by the manufacturer. Following overnight incubation
at 4°C, one /xl of each ligation reaction was packaged into infective X phage particles by
using the Gigapack® II Gold packaging extracts. Next, each packaged reaction was used
in preparation of serial dilutions in SM buffer. About 1-10 /xl of each dilution was then
used to infect transduction competent E.coli XLl-Blue host cells to the phage titer from
each packaging reaction. After incubation of each phage-bacteria mix, the phage infected
bacteria were plated onto individually labeled NZY plates and incubated overnight to
allow for development of recombinant phage plaques. Plaque counts were performed and
phage titers ranging from - 1 X 10^ - 1 X 10’ recombinant plaques or plaque forming
units (pfu)//xg of vector arms were obtained. The highest titer of recombinant plaques
resulted from the ligation reaction containing a calculated insert SurfVPl:vector SurfZAP
ratio of 2:1 and the lowest, at the ratio of 4:1. A negative control reaction corresponding
to the vector self-ligation, which had been set up along with the test ligation and
packaging reactions to help determine the potential background resulting from any
undigested vector, resulted in fewer than 1 X lO’ plaques.
Next, several recombinant XSurfVPl plaques were selected for PCR verification
of the recombinant nature of the corresponding phage particles. A miniprep procedure
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was designed to extract X DNA from 3 ml lysates of host E.coli XLl-BIue cells
following infection with phage toothpicked from the isolated plaques. The isolated X
DNA was used as template DNA in individual PCR reactions to confirm the presence of
insert SurfVPl DNA. A total of 150 plaques were screened by this approach and 138
were identified as recombinants based on successful amplification of the SurfVPl DNA.
The results of eight such PCR reactions with eight different DNA templates derived
from recombinant X plaques by the lambda miniprep procedure and as analysed by a 2%
agarose gel electrophoresis are shown in Figure 29.
Ten recombinant XSurfVPl isolates, RJS3, RJS4, RJS5, RJS7, RJS , RJSIO,
8

R JS ll, RJS12, RJS13 and RJS 16, each identified by PCR as mentioned previously,
were chosen for single clone in vivo excision of recombinant phagemid, pSurfVPl from
within the larger XSurfVPl DNA. Recombinant E.coli SOLR colonies on LB-Amp agar
medium resulting from the first round of this experiment were counted to determine the
titer of phagemid lysates following in vivo excision. Titers which ranged from 0.5-1.0
X 10^ cfii/ml were obtained from individual phagemid lysates derived from
corresponding iSurfVPl phage progenitors. Since each ^.SurfVPl phage was used at a
concentration of ~ 2 X 10® pfii/m vivo excision reaction to generate phagemid lysates
from E.coli XLl-Blue cells, the resulting phagemid titer represented one excised and
rescued phagemid for every 20 to 40 input A,SurVPl phage or an in vivo excision
efficiency of 2.5-5.0 %.
Several Amp^ colonies of recombinant E.coli SOLR cells were selected for
plasmid DNA extraction to isolate recombinant pSurfVPl DNA as a prelude to
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Figure 29. Agarose gel analysis of PCR products to verify the presence of insert
SurfVPl DNA during screening for recombinant A.SurfVPl plaques. Lane 1: BioMarker
low molecular weight DNA standard, Lanes 2-6 and 8-9: insert SurfVPl DNA (945 bp)
amplified from individual recombinant A. DNA templates using HAVVPl specific
primers, SurfVPlPSl and SurfVPlNS. Lane 7 did not reveal any positive amplification
of insert from the corresponding A. DNA template.
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restriction analysis and PCR studies to confirm the presence of insert DNA. Plasmid
DNA was isolated by two different miniprep procedures, alkaline lysis (Bimboim, and
Doly, 1979) and PERFECT prep™ (5 Prime -* 3 Prime, Inc., Boulder, CO). A 2%
agarose gel electrophoretic analysis of plasmid DNA isolated by the alkaline lysis method
is shown in Figure 30. Ethidium bromide stained bands on the agarose gel revealed
DNA of higher than the anticipated molecular weight for pSurfVPl ( - 4 .5 kb). Figure
31 shows a 2% agarose gel electrophoretic analysis of plasmid DNA samples isolated by
the PERFECT prep™ procedure. The PERFECT prep™ procedure yielded plasmid DNA
that was relatively free of contaminating genomic DNA as compared with the alkaline
lysis method. However, the molecular size of the plasmid DNA samples ( > 1 2 kb)
isolated by this procedure was several fold greater than that expected. The precise
reasons for this phenomenon remained unclear at this juncture. Therefore, while it was
decided to repeat the in vivo excision experiment again, alternatives were also
considered.
Recombinant A, phage DNA were isolated from 100 ml lysates of ten iSurfV Pl
isolates by using the A,QUICK!™ kit. The ten isolates were the same as those used in the
earlier in vivo excision experiment namely, RJS3, RJS4, RJS5, RJS7, RJS , RJSIO,
8

R JS ll, RJS12, RJS13 and RJS16. Using the DNA samples isolated as template DNA,
a general strategy of employing long range PCR with a mixture of thermostable DNA
polymerases was developed to precisely amplify and subclone the entire phagemid DNA
sequences in vitro from within the larger A,SurfZAP or similar vectors, referred to as in
vitro Excision-PCR.

Primers complementary to the fl phage initiator and terminator
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Figure 30. Agarose gel analysis of plasmid pSurfVPl DNA extracted from recombinant
E.coli SOLR cells by the alkaline lysis method following the in vivo excision procedure.
Lanes 1, 11, 21 and 31 contained the one KB DNA ladder while lanes 2-10, 12-20, 2230 and 32-39 contained plasmid DNA samples from individual recombinant clones.
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Figure 31. Agarose gel analysis of plasmid pSurfVPl DNA extracted from
recombinant E.coli SOLR cells by the PERFECT prep™ procedure following the in vivo
excision experiment. Lane 1: One KB DNA ladder, Lanes2-8: Plasmid DNA isolated
from different recombinant clones.
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sequences that constitute the essential and terminal flanking sequences of phagemid
pSurfscript DNA in its linear form within the XSurfZAP genome were designed. These
primer sequences, the positive strand FIORIPS and the negative strand FIORINS, are
shown in Figure 21. Both primers contain the recognition sequence for the restriction
enzyme, EcoRV on the 5' side of the fl sequences so that the double-stranded phagemid
DNA, if successfully amplified using these primers, would contain identical restriction
enzyme sites at both ends. Such a PCR amplified product could then be subjected to
EcoRV digestion and self-ligation and thereby recircularized into a double-stranded
plasmid form capable of transforming appropriate host E.coli. We chose the DNA from
the iSurfVPl clone RJSIO as template DNA to optimize the conditions for the in vitro
Excision-PCR reaction using the Expand™ Long Template PCR system. Three separate
in vitro Excision-PCR reactions were set up differing only in the total amounts of the
enzyme mix consisting of thermostable Taq and Pwo DNA polymerases. The volumes
of the thermostable enzyme mix tested were 0.5 ^1, 0.75 /il and 1.0 /il. A control PCR
in which the Amplitaq DNA polymerase replaced the thermostable enzyme mix was also
set up. The results from this pilot experiment were analyzed by 0.6% Agarose gel
electrophoresis (Figure 32). The PCR reactions containing 0.75 fil and 1.0 fil of the
thermostable enzyme mix as well as the control reaction with Amplitaq alone yielded
products within the anticipated size ( - 4 .5 kb). However, the reactions performed with
the thermostable enzyme mix gave better yields when compared to the reaction with
Amplitaq alone. In addition, we also noted that there was little amplification of the
desired product with 0.5 fil of the enzyme mix. Therefore, 0.75 fil of the thermostable
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Figure 32. Agarose gel analysis of pSurfVPl DNA amplified by in v/iro-Excision PCR
using A.Surf-VPl template DNA. Lane 1: One KB DNA ladder, Lanes2-4: PCR
amplified DNA samples from reactions containing 0.5 /^l, 0.75 /d and 1.0 /xl of the
Expand™ thermostable enzyme mix of Rwo and Taq DNA polymerases, and Lane 5:
DNA from reaction containing 0.5 /xl of AmpliTaq DNA polymerase (ref. Materials and
Methods).
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enzyme mix was used as a standard amount in the in vivo Excision-PCR reactions
involving other iSurfVPl DNA templates.

Subsequently, pSurfVPl DNA was

successfully amplified from all ten iSurfVPl DNA templates. Next, the PCR-generated
linear pSurfVPl DNA was purified and used as template DNA along with SurfVPl
specific primers in PCR reactions to verify that the DNA from the in vitro Excision-PCR
did contain the SurfVPl insert and it was in fact the recombinant pSurfVPl DNA. The
results of the PCR verification of pSurfVPl generated by the in vitro Excision-PCR are
shown in Figure 33.
The purified, linear pSurfVPl DNA samples were subjected to restriction
digestion with EcoRW and purified again by the GENECLEAN II procedure. Then,
ligation reactions were set up to circularize the plasmid and the products from the
ligation reaction used to transform E.coli BL-21 host cells by electroporation. Several
recombinants were chosen randomly for plasmid DNA extraction by the PERFECTprep™
procedure prior to restriction analysis and PCR to confirm their recombinant status and
also the success of the in vitro excision experiment. One clone, # 26, was chosen for
further studies.
The in vivo excision experiment was repeated again, during the time that we were
engaged in developing the in vitro Excision-PCR experiment as a viable alternative if
necessary. The plasmid DNA samples extracted from the various recombinant E.coli
SOLR clones that were obtained from this round of in vivo excision and rescue of the
pSurfVPl phagemid, were analysed by 0.8% agarose gel electrophoretic analysis
following restriction digestion with EcoRl. The results of a comparative analysis of
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Figure 33. Agarose gel analysis of PCR products to verify the presence of insert
SurfVPl DNA in pSurfVPl following in vtrro-Excision PCR. Lane 1: 100 bp DNA
marker, Lanes 2-5: SurfVPl DNA amplified using different in vitro amplified and
genecleaned pSurfVPl DNA templates.
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pSurfVPl DNA from clone #2 obtained by the in vivo excision method and clone # 26
obtained by the in vitro Excision-PCR method are shown in Figure 34. The recombinant
nature of each plasmid was subsequently confirmed by PCR with SurfVPl specific
primers.
Recombinant E.coli clones which carry pSurfVPl were subjected to 1.0 mM
IPTG induction for production of recombinant V Pl fusion protein, according to
procedures described earlier for expression of p-galactosidase fusions (Chapter , this
1

dissertation). Whole cell lysates were prepared and analyzed by 12% discontinuous
SDS-PAGE. No new protein bands corresponding to the expected size of recombinant
Surf-VPl protein ( - 5 7 kD) were detected following Coomassie blue staining of the
SDS-PAGE gel.
The HAV nucleotide sequences encoding VPO, VP3 and VPl capsid proteins
were analysed for presence and frequency of rare codons with respect to the protein
synthetic machinery of the host E.coli cells which may have resulted in a biased codon
usage, since protein expression from cells containing pT7-VPl or pSurf-VPl plasmids
was poor even after IPTG induction. The results of the computer-aided analysis of codon
usage are tabulated in Table

8

and Table 9. The HAV sequences for V Pl and VP3

display a preponderence of codons corresponding to the rarer tRNA species in E.coli
for amino acids Ser, Pro, Ala, Arg, Leu, Val, Thr, Glu and Gly. In the sequence for
VP3 (246 aa), there are a total of 134 codons representing the nine amino acids listed
previously, of which 114 represent rarer codons. Similarly, in case of VP1(294 aa), out
of a total 183 codons for the same set of nine amino acids, 163 are represented by rarer
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Figure 34. Agarose gel analysis of plasmid pSurfVPl DNA extracted from recombinant
clones # 2 and # 26. Clone ë 2 was obtained by in vivo excision and Clone ë 26, by in
vitro excision and subsequent transformation of appropriate host cells. Lane 1 and 2;
Undigested and EcoiBl digested pSurfVPl DNA from clone ë 2 respectively, Lane 3 and
4: Undigested and EcoRI digested pSurfVPl DNA from clone ë 26. Lane 5: One KB
DNA ladder.
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Table » A comparison of codon usage for selected amino acids in HAV VP genes
8

Amino Acid

Codon*

Frequency of Codons used per thousand*"
E.coli

Homo
sapiens

Human
Poliovirus

HAV
ORE

HAV
VPO

HAV
VP3

HAV
VPl

Leucine

UUA
UUG
CUU
cue
CUA

13.0
12.6
11.0
10.4
3.9
51.8

6.5
11.6
11.8
19.5
6.4
40.2

10.4
19.8
9.0
12.4
15.9
14.6

19.3
37.8
16.0
3.2
2.9
8.6

12.2
44.9
8.2
12.2
4.1
16.3

12.2
28.5
16.3
0.0
0.0
4.1

13.6
51.0
6.8
0.0
0.0
6.8

Valine

GUU
GUC
GUA
GUG

19.4
14.6
11.4
25.4

10.7
15.4
6.6
29.7

13.1
11.4
11.3
28.6

41.1
5.7
7.6
18.7

57.1
4.1
4.1
16.3

56,9
0.0
4.1
20.3

23.8
6.8
6.8
23.8

Serine

UCU
UCC
UCA
UCG
AGU
AQÇ

9.8
9.2
7.7
8.4
8.7
15.4

14.2
17.7
10.9
4.3
11.3
19.1

8.4
15.6
19.3
2.9
10.9
9.5

31.2
7.8
26.0
1.6
9.3
1.4

36.7
4.1
28.6
0.0
8.2
0.0

28.5
8.1
28.5
0.0
4.1
0.0

44.2
13.6
37.4
3.4
6.8
0.0

Proline

ecu
CCC
CCA

7.0
5.0
8.4
22.8

16.8
19.9
16.3
6.9

8.6
10.1
26.3
5.7

20.5
4.2
18.2
0.3

20.4
8.2
12.2
0.0

28.5
4.1
20.3
0.0

30.6
6.8
23.8
0.0

Threonine

ACU

9.7
23.0
7.7
13.4

12.8
20.9
14.8
6.6

23.9
19.4
20.5
5.0

27.5
4.9
25.3
1.3

49.0
8.2
24.5
0.0

44.7
16.3
28.5
4.1

27.2
3.4
54.4
0.0

GCU
GCC
GCA

16.6
24.9
20.4
32.3

18.6
28.9
15.3
7.5

23.4
19.0
26.8
6.0

28.5
7.9
17.5
0.2

28.6
8.2
20.4
0.0

32.5
12.2
24.4
0.0

23.8
17.0
17.0
0.0

GAG

GAA

40.3
19.1

28.1
40.6

23.9
29.0

29.9
23.6

16.3
32.7

20.3
8.1

13.6
37.4

Arginine

£2Li
CGC
CGA
CGG
AGA
AGG

21.3
21.5
3.5
5.4
2.7
1.7

4.7
11.0
6.0
11.3
10.9
10.9

3.6
5.4
2.0
1.8
22.8
8.9

0.9
0.8
1.0
0.1
30.2
7.2

4.1
0.0
4.1
0.0
20.3
16.3

0.0
0.0
0.0
0.0
37.4
10.2

Glycine

QGJJ

25.6
29.0
8.2
10.7

11.1
23.7
16.9
16.6

19.2
11.1
18.2
17.1

16.3
8.1
27.8
9.8

16.3
0.0
16.3
12.2

10.2
10.2
47.6
6.8

ACA
ACG
Alanine

Glutamate

GGA
GGG

0.0
0.0
0.0
0.0
24.5
8.2
32.7
8.2
24.5
8.2

•Preferred codons in E.coli are underlined ; •’Codons for a given amino acid with the highest frequency of
usage are depicted in bold.
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Table 9. A comparison of codon usage frequency in £.co//for select amino acids
encoded in the capsid protein genes o f HAV.
U of Preferred codons/Total # of
codons for the given amino acid
in the entire gene

Frequency (per thousand) of usage for preferred
codons/Total frequency (per thousand) of all codons
for the given amino acid

Amino
acid

HAV
VPO
(245 aa)

HAV
VP3
(246aa)

HAV
VPl
(294 aa)

E.COH

HAV
VPO

HAV VP3

HAV VPl

Leucine

4/24

1/15

2/23

51.8/102.7

16.3/97.9

4.0/60.9

6.8/78.2

Valine

4/20

5/20

7/18

25.4/70.8

16.3/81.6

20.3/81.2

23.8/61.2

Serine

0/19

0/17

0/31

15.4/59.2

00.0/77.5

00.0/69.0

0.0/105.4

Proline

0/10

0/13

0/18

22.8/43.2

00.0/40.8

00.0/52.8

00.0/61.2

Threonine

2/20

4/23

1/25

23.0/53.8

8.16/81.6

16.2/93.4

3.4/85.0

Alanine

0/14

0/17

0/17

32.3/94.2

00.0/57.1

00.0/69.0

00.0/57.8

Glutamate

4/12

5/7

4/15

40.3/59.4

16.3/49.0

20.3/28.4

13.6/51.0

Arginine

0/8

1/11

0/14

42.8/56.1

00.0/32.6

4.1/44.7

00.0/47.6

Glycine

10/18

4/II

6/22

54.6/74.1

40.8/73.4

16.2/44.7

20.4/74.8

Note: Data pertaining to those amino acids for which the preferred codon usage in HAV
VPl or VP3 is zero are depicted in bold.
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codons. A complete codon frequency table for comparison of codon usage for all amino
acids in E.coli is provided in Appendix.
It is interesting to note that only i l l of the 294 codons for V P l, 111 of 246 for
VP3 and 104 of 245 for VPO are represented by the preferred codons of E.coli
translational machinery. The codon bias indices (codon bias index is defined as fraction
of total codons in a given gene that are preferred codons; de Boer and Kastelstein, 1986)
were calculated for HAV VPl, VP3 and VPO and corresponded to 0.38, 0.45 and 0.43
respectively.

Genes which are highly expressed in E.coli such as those encoding

elongation factor Tu (EF-Tu; 200,000 to 1,000,000 copies per cell), and ribosomal
proteins L7 and L12 (140,000 to 300,000 copies per cell) have a codon bias index of
0.84 whereas that encoding lac repressor (10 copies per cell) has a codon bias index of
0.18 (Bennetzen and Hall, 1982).
DISCUSSION
Our earlier studies, as outlined in chapters I and U, involving expression of HAV
capsid proteins as E.coli p-galactosidase fusions were only moderately successful.
Attempts to improve the transcriptional efficiency in the gene region concerning the
cloned V Pl segment on the recombinant plasmid vector, pAXBoxAVPl yielded
unexpected results incompatible with the overall objectives of our study. Subsequently,
we decided to attempt cloning of HAV genes in a non-fusion format into appropriate
E.coli plasmid vectors and try to express the viral proteins as close as possible to their
native form in both sequence and structure. At the same time, we also have explored
approaches to find a suitable, inexpensive and safe alternative to the time-consuming and
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costly tissue-culture method to produce HAV particles for use in antibody production,
to develop assays for fast and reliable detection from clinical and environmental
specimens and for potential use in vaccine production.
Several attempts were made to clone and express HAV capsid genes from vector
pSE420 (Invitrogen Corporation, San Diego, CA) (i) as proteins without any fusion
component and (ii) as epitope-labelled proteins carrying multiple myc tags (Roth, et al.,
1991) without much success. The frequency of transformation was very low (greater
than a

1 0

0

-fold reduction as compared with transformantion with vector only) and no

stable recombinants were recovered following transformation of host E.coli strains,
GWIOOO, UT2300 or ToplO. We also tried to clone a Xbal-Xhol restriction enzyme
digested fragment from pGEM-HAV representing the complete HAV ORE, except
portions of VP4 and SD*”*genes, into vector pBC (Stratagene, La Jolla, CA). hoping
that if successful, this would permit us to generate ssHAV RNA for use in assays to
develop protocols for detection of HAV from shellfish. Again, we observed that the
frequency of transformation was very low and any recombinants recovered following
several individual cloning and transformation experiments were not stable. Cultures
inoculated with the few recombinants from these experiments showed poor and very slow
growth as seen by the naked eye and upon phase contrast microscopy, revealed signs
such as increased filamentation, inclusion body formation and cell death. All attempts
to isolate the recombinant plasmids from these cells were futile. These findings strongly
suggested the possible toxicity of cloned HAV genes or their products, prematurely
expressed, to host E.coli.
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Therefore, we decided to employ a phage T7-promoter based vector-host system
which would enable a controlled exclusive expression of the cloned HAV genes and
thereby address the question if premature expression of native HAV capsid proteins was
indeed responsible for the earlier findings. We also have used a phage A,-derived vectorhost system in this study in parallel with the phage T7 system as an alternative approach
to circumvent problems in cloning, to sucessfiilly amplify and recover the recombinant
DNA prior to attempts at finding appropriate E.coli host strains that would enable their
stable maintainence and expression. The latter approach had the extended appeal of
allowing in vivo excision of the recombinant DNA into a plasmid form, expression of
recombinant HAV proteins on E.coli surface and of generating single-stranded,
recombinant filamentous phage particles that display the HAV capsid proteins on their
surface while simultaneously containing the corresponding gene sequence within.
Escherichia coli BL-21 host cells were transformed successfully with recombinant
pT7-VPl and pT7-VP3 plasmids at a reasonable frequency of transformation. Since
there is was known source of T7 RNA polymerase within these host cells, any premature
expression of the HAV genes was not possible and may have aided in a more efficient
transformation and stable maintainence of the recombinant pT7-VPI and pT7-VP3
plasmids.

Host E.coli cells with these recombinant plasmids, upon phase contrast

microscopy, displayed no appreciable differences in their morphology as compared to the
control cell populations (i.e. cells without and with vector pT7-7). Also, plasmid DNA
extraction from the recombinant cells was fruitful in contrast to our earlier attempts with
other vector/host systems used for expression of HAV capsid proteins in a non-fusion
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format. The presence of the cloned insert DNA in several of the recombinant plasmids
was confirmed by restriction digestions and by PCR.
The recombinant plasmids were then transformed into host BL-21 (DE3)pLysS
cells which carried the gene for T7 RNA polymerase under the inducible transcriptional
control of the lacUVS promoter and thereby could allow for a controlled expression of
the HAV genes. Subsequently, cells carrying pT7-VP3 plasmids displayed a new protein
band correponding in size to that of HAV VP3, following an IPTG induction of T7 RNA
polymerase expression in the host cells. However, none of the recombinant clones
screened similarly for expression of VPl showed any new bands on SDS-PAGE which
was intriguing. Also, Western blot analyses of IPTG-induced bacterial cell lysates of
host cells carrying pT7-VP3 and pT7-VPl, did not show any recognition by the antiHAV rabbit polyclonal or mouse monoclonal antibodies of protein bands at the expected
size (data not shown).

Possible explanations for these observations include poor

translation and post-translational degradation by host proteases in the case of V P l, and
lack of proper conformation due to improper folding in vivo or due to dénaturation
induced by SDS during the analysis in the case of VP3.
A poor translation of mRNA encoding HAV VPl may have been due to nonsense
and missense mutations introduced into the DNA encoding VPl during PCR
amplification with Taq DNA polymerase prior to cloning. Instability of target mRNA
could be another reason for poor expression of protein of interest although previous
reports suggest that in a T7 RNA polymerase dependent expression system, amounts of
stable mRNA produced are not only sufficient

but substantial enough to actually

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

148

overwhelm the normal mRNA degradation mechanisms of host E.coli (Studier, and
Moffatt, et al., 1986). Still, factors such as an unfavorable distribution of rare codons
and interfering secondary structures within the target mRNA which can result in
ribosomal stalling, and translational ffameshifting which can lead to premature
termination of translation, cannot be ruled out and may contribute to poor translation o f
the target mRNA. In addition, the possibility exists that VPl protein, in whatever
amounts it was expressed, may have been toxic leading to an induction of a heat-shock
like response in host cells resulting in rapid breakdown of the expressed protein. The
host cells, although deficient in Ion and ompT proteases, still possess other proteases
capable of degrading abnormal and toxic proteins (Goldberg, and Goff, 1986).
Cloning of HAV VPl DNA sequence into the XSurfZAP™ vector and the
subsequent subcloning into the phagemid pSurf-VPl form were accomplished
concurrently with our attempts to clone HAV capsid genes into the pT7-7 vector. During
the process, we developed a miniprep procedure for screening of recombinant plaques
and an alternative to the in vivo excision and rescue of phagemid pSurfVPl DNA as
outlined in the materials and methods earlier. Both procedures also involved different
applications of the ubiquitous PCR.
The miniprep procedure was designed to enable simultaneous extraction and
preparation of template recombinant phage X DNA from several recombinant plaques
following inoculation of multiple, small scale (3 ml) broth cultures of phage-sensitive
host cells. The standard protocols in common use for preparing A. DNA from small scale
liquid lysates require at least 50-ml liquid phage lysates per plaque screened, and involve
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prolonged ultracentrifugation steps (Davis, et al., 1980; Ausubel, et al., 1992;
Sambrook, et al., 1989), both of which were avoided in our miniprep procedure.
Recombinant phage DNA was successfully recovered from 20 recombinant phage lysates
at a time by the miniprep procedure. A small volume of each DNA preparation (two ftl
out of a final 1(X) nl obtained from each three ml lysate) was found sufficient to act as
template DNA in the PCR reactions that were carried out subsequently to confirm the
presence of the cloned insert DNA. Thus, the combined miniprep procedure and PCR
not only enabled a rapid and specific screening for recombinant phage but also helped
reduce the amounts of reagents needed significantly.
Following confirmation of the recombinant nature of several A,Surf-VPl plaques,
we attempted in vivo excision and rescue of recombinant phagemid pSurf-VPl DNA
(Short, et a i, 1988; Short and Sorge, 1992). In our first attempt at excision and rescue
of the recombinant phagemids, we utilized ten different ÀSurf-VPl phage lysates and
obtained several recombinant E.coli SOLR™ colonies on LB-amp medium. However,
plasmid DNA extracted from these cells revealed DNA bands at higher (> 1 2 kb) than
anticipated (4.5 kb) molecular size for the recombinant phagemid.

Also, the

PERFECTprep™ procedure for plasmid DNA extraction yielded DNA samples that
appeared realtively free of protein and chromosomal DNA contamination when compared
with those obtained by alkaline lysis procedure (Figure 30 and Figure 32). Since the
reasons for the apparent increase in the observed molecular weight of the recombinant
plagemid DNA were unclear, we decided to repeat the experiment and also to develop
alternative protocols for recovering phagemid DNA successfully. Upon repeating the in
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vivo excision and rescue procedure, we recovered several recombinants which were
verified to contain pSurfVPl by restriction analysis and by PCR. Selected recombinants
were then used in induction experiments to study expression of surface-directed fusion
protein containing HAV V P l.
The in v/rro-Excision PCR procedure, as outlined schematically in Figure 25a and
b, was developed as a feasible alternative to the in vivo excision and rescue procedure.
The entire pSurf-VPl DNA ( —4.5 kb) including the fl phage-derived, flanking initiator
(I) and terminator (T) sequences was amplified as double-stranded linear DNA by "long
PCR" (Cohen, 1994). A mixture of thermostable DNA polymerases, Taq polymerase
(without 3'-5' exonuclease or proofreading activity) and Pwo polymerase (with active
proofreading capability), was used to ensure a high yield of target DNA without
compromising the fidelity of DNA replication (Barnes, 1994; Cheng, et al., 1994).The
restriction enzyme site, EcoKY, was engineered into the flanking primers used in this
PCR so that restriction digestion and ligation reactions could be performed at a later time
on the resulting linear DNA to generate a covalently closed ciruclar pSurfVPl DNA.
Neither the insert VPl nor the parent phagemid pSurfscript DNA inherently contain an
EcoRV site. Following a successful amplification, the pSurfVPl DNA was circularized
by EcoRW digestion and ligation with T4 DNA ligase and used to transform host E.coli
cells by electroporation. Plasmid DNA extracted from the resulting recombinants was
confirmed by restriction analysis and PCR for carrying the previously cloned insert VPl

R eproduced w ith perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

151

DNA. Thus, this procedure enabled the subcloning of DNA of interest from within the
larger A.SurfVPl ( - 4 5 kb) into the smaller pSurfVPl phagemid ( —4.5 kb).

The

intricate essential steps of in vivo excision and rescue procedure, such as the need to use
of two or more different E.coli host strains (XL-Blue for excision and SOLR™ for single
stranded rescue of phagemid DNA) and ExAssist helper phage, and the necessity to
transform the recombinant plasmids following rescue into new host strains later on since
SOLR cells do not permit single-standed phagemid replication, are bypassed completely
by the in v/rro-Excision procedure which is based on the long PCR. In addition, the in
v/rro-Excision PCR also allows amplification of large amounts of the complete phagemid
portion of the popular A,ZAP vectors or its derivatives including ASurfZAPregardless of
the size of any cloned foreign DNA inserts they might carry, in a relatively inexpensive
and time-saving manner and employing a common set of primers directed towards the
phage f l I and T sequences. Although the in vivo excision and rescue may be very
efficient for mass excision of libraries prepared in lambdaZAP vector or its derivatives,
the in vitro-PCR may be more convenient and advantageous in situations where a precise
subcloning of only a single or few A.-derived clones is desired or where the protein
product of the cloned sequence may be too toxic to certain host E.coli cells. In the latter
instance when subcloning based solely on in vivo methods may be difficult if not
impossible, the in vitro-Excision PCR method also will be useful for generating large
amounts of recombinant phagemid DNA in vitro from the parent A.-derived clones prior
to a simultaneous transformation and screening of multiple host E.coli strains to select
the ideal one for an optimal expression of the target gene on the relevant phagemid DNA.
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Recombinant E.coli clones containing pSurf-VPl, obtained by either one of the
two approaches discussed earlier, were subjected to induction of target protein by IPTG.
However, our efforts have not been successful so far. The recombinant BL-21 host cells
under IPTG induction were examined by phase contrast microscopy and did not exhibit
any discernible changes in morphology when compared with controls that did not carry
any plasmids. Western blot analysis of whole cell lysates of recombinant cells subjected
to IPTG induction did not reveal any bands of recognition with the various anti-HAV
antibodies tested (Rabbit, mouse and human). The reasons for such a poor expression
concerning HAV VPl remain obscure although it is noteworthy that a similar problem
was encountered earlier during our attempts to express VPl from other prokaryotic
expression vector systems such as the T7 promoter/T7RNA polymerase expression
system. Hence, we decided to explore the likelihood that an inefficient codon usage
pattern concerning HAV gene expression in E.coli may have been responsible for poor
levels of expression. However, it is possible that other factors such as rapid mRNA
degradation, potential toxicity of VPl to host cells leading to induction of host proteases,
and errors introduced into the coding sequences by PCR may also produce similar
effects. It has been suggested previously that the Taq polymerase (which does not
possess any 3'-5' exonuclease activity) may have an error rate of —1 mismatched base
per 10-50,000 bases added (Cheng, et al., 1994) and may significantly affect the fidelity
of amplification of sequences longer than 10 kb when used alone.
The study of codon usage profile for HAV gene expression in E.coli was based
on Grantham's genome hypothesis, which states that taxonomically related organisms
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have similar codon usage (de Boer and Kastelein, 1986). Previously reported
observations have shown that each gene in a given organism conforms to a distinct codon
usage pattern of the species and exhibits a bias regarding the choice of synonymous
codons consistent with the other genes from the same or closely related genomes
(Grantham, et al., 1980a, b). Highly expressed genes (such as membrane and ribosomal
proteins) use only a limited number of available codons as compared to poorly expressed
genes (regulatory proteins like lac repressor) and the degree of codon usage bias for
many genes in various organisms, including E.coli, is directly related to the cellular
levels of their protein products (Gouy and Gautier, 1982; Beimetzen and Hall, 1982).
In E.coli, there is a strong and interesting correlation between the codon usage profiles
of highly expressed genes and the relative abundance of each tRNA species. The tRNA
levels correponding to codons preferred frequently are higher than the tRNA species for
rarer codons and highly expressed genes display a strong preference for codons
corresponding to major tRNA species and avoid the use of minor tRNAs. Conversely,
genes expressed at low levels tend to exhibit a relatively frequent use of minor codons
and the availability of the corresponding minor tRNA species may be a rate-limiting
factor in the translation of such genes (Ikemura, 1981a, b).
The codon usage database, searchable by name of organism through the World
Wide Web, contains all reported data pertaining to codon usage in individual genes from
various species. Codon usage data contained in this database is for complete genes only
and is calculated using the nucleotide sequence data obtained from the GenBank Genetic
Sequence Database. In addition, the compilation is synchronized with each major release
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of Genbank (Nakamura, et al., 1997). Using the codon usage database, we obtained
individual codon usage frequency tables for HAV, E.coli, Human poliovirus 3 and
Human protein coding sequences as a sum of the codon usage for each species. The
study of codon usage profile in E.coli for HAV sequences revealed several interesting
features (Table 8 and 9). In the HAV VPl sequence, only 111 of 294 codons are codons
recognized by major tRNA species in E.coli. Similarly, the VP3 sequence utilizes only
111 preferred codons in a total of 246 for the protein. There are no preferred codons
corresponding to amino acids, Ser, Pro, Ala and Arg, in either VPl or VP3 sequences.
In addition, the amino acids. Leu, Val, Thr, Glu, and Gly are encoded mostly by rarer
codons in both genes. The codon bias indices calculated for VPl (0.38) and VP3 (0.45)
correspond to genes that are expressed at low levels in E.coli such as the RNA
polymerase p subunit (codon bias index=0.53; cellular levels estimated to be 7000 to
15000 protein molecules per cell). However, it has to be noted that in case of HAV VPl
and VP3 sequences that are carried on multicopy expression vectors such as pT7,
mRNA levels following induction will be several fold higher compared with those of the
E.coli genes and may contribute significantly to the total levels of protein that can be
expressed. Still, if tRNA availability is the rate-limiting factor during translation, the
expression o f HAV genes could be adversely affected despite an abundance of target
mRNA within the E.coli, since shortage of appropriate, charged tRNA species can lead
to ribosomal pausing, rapid mRNA degradation in the regions not protected by the
translating ribosomes and also an increase in the misincorporation rate during translation.
This could result in prematurely truncated proteins, or proteins with miscorporated amino
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acids, both of which may assume improper conformation and can be recognized as
abnormal by the host cell protein degradation machinery.

In addition, the abnormal

proteins could provoke a host cell stress response similar to that observed during heat
shock, resulting in their selective degradation (Goldberg and Goff, 1986).
A comparison of the codon usage profile of E.coli, HAV, Human poliovirus and
Human protein coding sequences for the selected amino acids which are preferentially
encoded by rarer codons in HAV (Table 8), shows that the biased codon usage by
Human Poliovirus 3 is more closely related (such as for amino acids Leu, Val, Thr, Ala,
and Gly) to those of human and E.coli profiles than that exhibited by HAV. Although
the significance of this finding needs further clarification, it is tempting to speculate the
correlation between the relative ease of propagation of poliovirus in tissue culture and
the expression of its proteins in E.coli as compared to the difficulties faced with HAV.
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CONCLUSIONS
Cloning and Expression of the Capsid Proteins of Hepatitis A Virus in

Escherichia coli as p-Galactosidase Fusion Products: The cDNA regions encoding
Hepatitis A Virus (HAV) capsid proteins VPl, VP2 and VP3 were individually amplified
by PCR and cloned successfully into prokaryotic expression vector, pAX4b + , for
expression of recombinant HAV proteins as p-galactosidase fusions in host Escherichia
coli cells. Recombinant protein expression, upon IPTG-induction, was comparatively
better in host cells deficient in Lon protease (UT2300 strain) than in those that were not
(GWIOOO or TOPlO strains). Microscopic studies of IPTG-induced host cells revealed
the formation of intracellular inclusion bodies.

The inclusion bodies containing

recombinant proteins were extracted and partially purified by employing a French Press
lysis-Sarkosyl extraction procedure. The recombinant fusion proteins, V PIII, VP2B2
and VP3T3, exhibited antigenic properties when assessed by ELISA and Western Blot
assays with anti-HAV polyvalent and monoclonal antibodies generated in animals
immunized with intact HAV HM-175 particles.
However, the expression of recombinant HAV proteins and the intended affinitybased purification of these proteins ( - 1 5 0 kD) were complicated by an apparent co
expression of p-galactosidase ( —125 kD).

Factors that needed to be studied as

possibilities for the simultaneous appearance of

both p-galactosidase and the

recombinant p-gal-VP fusion proteins in host cells following their exposure to IPTG
included premature termination of transcription, rapid decay of recombinant mRNA,
inefficient translation due to a biased codon usage, autoproteolytic or host-protease
156
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mediated cleavage of nascent recombinant fusion proteins. Some of these concerns were
addressed in the later studies. Further, the anti-HAV antibodies cross-reacted with the
p-galactosidase during Western blot analysis, suggesting a putative sharing of epitopes
in the SDS-mediated denatured state between HAV capsid proteins and E.coli pgalactosidase which are apparently unrelated to one another.
Effects of an Anti-term inator Sequence on Recombinant HAV Protein
Expression in Escherichia coli: Premature termination of transcription was considered
as one of the chief factors that may have been responsible for the observed phenomenon
of co-expression of E.coli p-galactosidase and the p-gal-VP fusion proteins in
recombinant host cells.

Hence, the hypothesis that inclusion of an anti-terminator

sequence upstream of HAV VP coding sequences might result in full-length transcripts
and thereby render translation of fusion protein more efficient to yield the recombinant
VPl protein ( -1 5 0 kD) without a simultaneous expression of the non-recombinant E.coli
p-galactosidase ( ~ 125 kD), was tested. The BoxA antiterminator sequence from the
E.coli rrn operon was incorporated upstream of the HAV VPl and cloned into pAX4b+
vector.

However, induction of fusion protein expression from host cells carrying

pAXBoxAVPl did not lead to any discernible expression of HAV V Pl fusion protein.
Rather, in addition to the p-galactosidase ( —150 kD), a novel, 33 kD protein band was
observed upon SDS-PAGE analysis of IPTG-induced recombinant whole cell lysates.
A limited N-terminal aminoacid sequence determination of the —33 kD protein was
obtained, and a computerized search and comparison with previously reported sequences
in the protein databases was performed. The results revealed that the - 3 3 kD protein
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shared varying degrees of homology with a host of protein sequences from various
sources. Significant homology was discovered between the ~ 33 kD protein, N-terminal
sequences from the leading regions of conjugative plasmids, F and R l, and putative open
reading frames (gene YFJQ and Rhs elements) found in E.coli chromosomal DNA which
display characteristics of DNA-binding proteins. However, the gene responsible for
expression of the 33 kD protein in the recombinant E.coli cells carrying plasmid
pAXBoxAVPl was obscure and remains to be identified. In addition, the reasons for an
apparent lack of expression of recombinant HAV VPl fusion protein in the same cells
were unclear. While it is tempting to speculate that the expression of the 33 kD protein
with putative DNA-binding properties may have been a result of a generalized stress
(SOS) response in host cells involving events such as overexpression and degradation of
seemingly toxic recombinant HAV proteins, further investigations are essential to
definitively resolve this mystery.
Alternative Approaches for Cloning of HAV Capsid Genes for Expression in
Escherichia coli: Since our earlier efforts at expression of HAV capsid proteins as
E.coli p-galactosidase fusions were only moderately successful, we considered alternate
strategies such as (i) cloning and expression of HAV capsid genes in a non-fusion format
from a phage T7-promoter based vector-host system and (ii) to clone HAV genes for
surface expression of recombinant proteins on host E.coli membrane and to obtain
chimeric, single-stranded, filamentous coliphages which could potentially replace the
tissue-culture grown HAV particles in diagnostic assays and in immunological studies.
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Recombinant pT7-VPl and pT7-VP3 plasmids were generated by following
standard molecular biological techniques and host E.coli BL-21 cells were transformed
successfully to yield several stable recombinant clones. Plasmid DNA samples from
several of these recombinants were then utilized to transform host E.coli BL21 (DE3)pLysS cells as a prelude to induction of recombinant protein expression.
However, subsequent experiments revealed that only those recombinants that carried
pT7-VP3 plasmids expressed a new protein corresponding in size to that of HAV VP3
while recombinants carrying pT7-VPl plasmids did not show any protein product
corresponding to HAV VPl upon SDS-PAGE and Western Blot analyses. It is possible
that poor translation and/or post-translational degradation by host proteases could have
contributed to the results observed. Nonsense or missense mutations could have been
introduced into the cDNA encoding the HAV VP proteins by the error-prone Taq DNA
polymerase ( ~ 1 mismatch per 10-50,000 bases added) during the PCR amplification step
prior to cloning, resulting in a poor translation, premature termination of protein
synthesis and formation of aggregates of truncated protein fragments that would trigger
the host SOS response and subsequent protease-mediated degradation. Factors such as
an unfavorable distribution of rare codons and translational frameshifting were also
considered to potentially contribute towards a premature termination of translation of
target mRNA.
Cloning HAV VPl sequence into a phage k derived vector, ASurfZAP™, was
performed to obtain recombinants with potential for expression of HAV proteins on
E.coli and filamentous coliphage surfaces. Novel procedures were designed and tested
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successfully to meet the following objectives : (i) rapid preparation of template k DNA
templates from multiple, small scale (3 ml) broth cultures of phage-sensitive host cells
as a prelude to a PCR-based verification of their recombinant nature and, (ii) subcloning
phagemid DNA carrying the HAV VPl insert as an alternative to the in vivo excision and
rescue procedure.

We have termed the latter procedure as in vitro Excision-PCR.

Following subcloning of ASurf-VPl clones, several recombinant host £.co// BL-21 cells
carrying the plasmid pSurf-VPl were obtained and verified by PCR to contain the HAV
VPl DNA. However, subsequent experiments to induce expression of recombinant
protein were unsuccessful. This problem was similar to what we had encountered earlier
in our efforts to express HAV VPl from various prokaryotic expression systems.
Hence, we investigated further the likelihood of an inefficient codon usage pattern as a
possible reason for the apparent lack of recombinant protein expression.
Codon usage profiles in E.coli for HAV sequences were obtained by a computerassisted search of the codon usage databases and compared with those for E.coli, Human
poliovirus 3 and human protein coding sequences. The HAV V Pl and VP3 sequences
showed a preponderance of rare codon usage for several amino acids, suggesting that
codon usage bias in these sequences could have adversely affected their successful
translation. A shortage of appropriate, charged tRNA species which occurs when rare
codons are used at a higher than usual frequencies, can lead to ribosomal pausing, rapid
mRNA turnover and an increase in the misincorporation rate of non-cognate aminoacids
during translation.

All of these would result in prematurely truncated, abnormal

proteins which would provoke a host cell response akin to that observed during heat
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shock, resulting in their selective degradation. Hence, it appears that if HAVcapsid
sequences have to be expressed efficiently in E.coli, one has to seriously consider
modifying the DNA sequences for VPl and VP3 by replacing rarer codons with
synonymous codons that are frequently employed in E.coli and for which the
corresponding tRNA species are present in relative abundance.
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APPENDIX
A Comparison of Codon Usage for HAV VP genes
with that of Escherichia coli genes.
Amino Acid

Codon“

Frequency of Codons used per thousand"
E.coli

HAV
VPO

HAV
VP3

HAV
VPl

HAV
ORF

Polio
virus 3

Human

Phenylalanine

UUU
UUC

21.2
17.1

32.7
12.2

48.8
16.3

40.8
17.0

40.5
15.5

18.7
18.8

16.3
21.2

Leucine

UUA
UUG
CUU
cue
CUA
CUG

13.0
12.6
11.0
10.4
3.9
51.8

12.2
44.9
8.2
12.2
4.1
16.3

12.2
28.5
16.3
0.0
0.0
4.1

13.6
51.0
6.8
0.0
0.0
6.8

14.6
41.3
14.6
4.3
1.7
11.2

10.4
19.8
9.0
12.4
15.9
14.6

6.5
11.6
11.8
19.5
6.4
40.2

Isoleucine

ALLU
AUG
AUA

29.0
25.4
5.2

36.7
16.3
12.2

44.7
0.0
12.2

34.0
3.4
10.2

43.9
6.0
14.6

28.4
21.0
11.8

15.8
23.5
6.8

Methionine

AJLLG

27.0

16.3

28.5

23.8

26.7

30.6

22.6

Valine

GUU
GUC
GUA
GUO

19.4
14.6
11.4
25.4

57.1
4.1
4.1
16.3

56.9
0.0
4.1
20.3

23.8
6.8
6.8
23.8

38.8
3.4
4.3
20.7

13.1
11.4
11.3
28.6

10.7
15.4
6.6
29.7

Serine

UCU
UCC
UCA
UCG
AGU
AQC

9.8
9.2
7.7
8.4
8.7
15.4

36.7
4.1
28.6
0.0
8.2
0.0

28.5
8.1
28.5
0.0
4.1
0.0

44.2
13.6
37.4
3.4
6.8
0.0

34.5
7.8
26.7
1.7
7.8
1.7

8.4
15.6
19.3
2.9
10.9
9.5

14.2
17.7
10.9
4.3
11.3
19.1

Proline

ecu
cec
CCA
CCG

7.0
5.0
8.4
22.8

20.4
8.2
12.2
0.0

28.5
4.1
20.3
0.0

30.6
6.8
23.8
0.0

19.8
4.3
17.2
0.0

8.6
10.1
26.3
5.7

16.8
19.9
16.3
6.9

Threonine

ACU
ACC
ACA
ACG

9.7
23.0
7.7
13.4

49.0
8.2
24.5
0.0

44.7
16.3
28.5
4.1

27.2
3.4
54.4
0.0

33.6
6.9
30.1
0.9

23.9
19.4
20.5
5.0

12.8
20.9
14.8
6.6

Alanine

GCU
GCC
GCA
GCG

16.6
24.9
20.4
32.3

28.6
8.2
20.4
0.0

32.5
12.2
24.4
0.0

23.8
17.0
17.0
0.0

26.7
11.2
17.2
0.0

23.4
19.0
26.8
6.0

18.6
28.9
15.3
7.5

“Preferred codons in E.coli are underlined.
"Codons for a given amino acid with the highest frequency of usage are depicted in bold
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Amino Acid

Codon*

Frequency of Codons used per thousand"
E.coli

HAV
VPO

HAV
VP3

HAV
VPl

HAV
ORF

UAU
UAC

16.3
12.7

28.6

28.5

30.6

12.2

12.2

6.8

CAU
CAC

12.3
10.0

32.7

20.3

13.6

19.8

8.4

0.0

3.4

4.3

14.1

CAA

14.1

40.8

24.4

6.8

11.5

CAfi

24.5

28.5

17.0

21.5
23.3

22.1

29.2

16.4

33.7

AAV

18.0
22.1

28.6

37.9

20.9

8.2

48.8
4.1

37.4

AAC

6.8

6.9

27.5

16.7
20.9

AAA

35.1

24.5

28.5

12.1

12.2

12.2

20.4
20.4

36.2

AAG

32.7
27.8

23.4
33.9

GAV

32.1

24.5

44.7

54.4

44.8

GAG

20.2

16.3

8.1

10.2

9.5

26.8
27.8

22.2
26.9

GAA

40.3

16.3

20.3

13.6

19.1

32.7

8.1

37.4

26.7
26.7

23.9
29.0

28.1

GAG

VGV
VGC

5.0
6.4

4.1
4.1

24.4

6.8

14.6

4.1

0.0

2.6

9.8
7.8

9.6
12.7

Tryptophan

VGG

13.7

12.2

16.3

13.6

16.4

12.3

n 3

Arginine

CGV
CGC

21.3
21.5

CGA
CGG
AGA
AGG

3.5
5.4
2.7
1.7

0.0
0.0
0.0
0.0

4.1
0.0
4.1
0.0

0.0
0.0
0.0
0.0

0.9
0.0
0.9
0.0

3.6
5.4
2.0
1.8

20.3
16.3

37.4

30.1

22.8

8.2

10.2

11.2

8.9

GGV
GGÇ

25.6
29.0

32.7

16.3

16.4
6.0

11.1

0.0

10.2
10.2

19.2

8.2

111

23.7

GGA
GGG

8.2
10.7

24.5

16.3

47.6

29.3

8.2

12.2

6.8

9.5

18.2
17.1

16.9
16.6

Tyrosine
Histidine
Glutamine
Asparagine
Lysine
Aspartate
Glutamate
Cysteine

Glycine

8.2

24.5

Polio
virus

Human

28.4

16.3

6.9

29.3

12.3
17.0

18.9

9.7
14.6

40.6

4.7

11.0
6.0

11.3
10.9
10.9

“Preferred codons in E.coli are underlined.
Codons for a given amino acid with the highest frequency of usage are depicted in bold
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